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5Summary
In eukaryotic cells, a subset of proteins is attached to the outer leaflet of the plasma
membrane by a glycosylphosphatidylinositol (GPI) anchor. Apart from providing stable
membrane anchorage, GPI anchors are thought to be associated with other functions, such
as signal transduction and protein targeting. The biosynthesis of the GPI anchor and its
transfer to proteins is highly conserved in eukaryotes. The common GPI backbone, (EthN-
P)-6Manα1-2Manα1-6Manα1-4GlcNα1-6myo-inositol-PO4-lipid, is assembled by the
sequential additions of sugar and ethanolaminephosphate to phosphatidylinositol. The
conserved GPI core is modified by various side chains in different organisms. Side chain
modification of mannoses with EthN-P has been described in mammalian cells and
recently also in the yeast Saccharomyces cerevisiae. Several genes involved in GPI
biosynthesis have been cloned by complementation of GPI-deficient yeast and mammalian
mutants. We have studied GPI anchoring in Saccharomyces cerevisiae, because this
organism is amenable to genetic studies and has advantages such as relevance to higher
systems. In comparison to the complete GPI precursor glycolipid CP2, the most polar GPI
accumulating in yeast gpi7 mutants lacked a HF-sensitive side chain on Man2, suggesting
that the corresponding protein, Gpi7p, might be involved in the addition of a side chain to
the second mannose of the GPI core. It was therefore tempting to speculate that the
proteins encoded by the two yeast homologues of GPI7, YLL031c/GPI13 and MCD4, might
play a role in the transfer of EthN-P to the first and third mannose of the GPI core. This
study had as major objective the characterization of the enzymes involved in EthN-P
transfer to the GPI precursor in Saccharomyces cerevisiae. Depletion of GPI13 resulted in
cell wall fragility, and a reduction of GPI anchor addition to proteins. The most polar GPI
glycolipid that accumulated in vivo in cells depleted of Gpi13p lacked the bridging EthN-P
on Man3 of the GPI core, suggesting that Gpi13p is involved in the transfer of EthN-P to
Man3. A glycolipid with the same mobility also accumulated in in vitro experiments with
microsomes from Gpi13p-depleted cells. Similarly, mutation or depletion of Mcd4p resulted
in accumulation of GPI intermediates lacking EthN-P on Man1. These results are
compatible with the idea that Gpi13p transfers EthN-P to the inner α1-2-linked mannose,
and that Mcd4p transfers EtN-P onto the α1-4-linked mannose of the GPI core. A tagged
form of Gpi13p was shown to be localized in the ER. In contrast, the bulk of Gpi7p was
localized on the cell surface. Depletion of Gpi13p or Mcd4p induced a stress response
known as the Unfolded Protein Response, providing further evidence that GPI anchoring is
an essential process in Saccharomyces cerevisiae.
6Zusammenfassung
Die Verankerung von bestimmten Proteinen an der Aussenseite der Plasmamembran mittels eines
Glycosylphosphatidylinositol (GPI)-Ankers ist in eukaryontischen Zellen weit verbreitet. Es gibt
Hinweise, dass GPI-Anker neben ihrer Funktion als stabiler Anker auch eine wichtige Rolle in der
Uebertragung von Signalen und in der Sortierung von Proteinen spielen. Sowohl die Biosynthese
des GPI-Ankers als auch seine Anheftung an Proteine sind konservierte Prozesse. Das
Grundgerüst aller GPI-Anker, (EthN-P)-6Manα1-2Manα1-6Manα1-4GlcNα1-6myo-inositol-PO4-lipid,
wird durch schrittweise Addition von Zuckern und Ethanolaminphosphat an das Lipid
Phosphatidylinositol, aufgebaut. Diese konservierte Grundstruktur der GPI-Anker ist in
verschiedenen Organismen mit verschiedenen Seitenketten dekoriert. Dass GPI-Anker in
Säugerzellen EthN-P-Seitenketten haben, ist schon seit mehreren Jahren bekannt. In der Hefe
hingegen wurden EthN-P-Seitenketten erst kürzlich entdeckt. Mehrere Gene, die in der Biosynthese
von GPI-Ankern eine Rolle spielen, wurden durch Komplementierung von GPI-defizienten Hefe- und
Säugetierzellen kloniert. Viele zelluläre Prozesse sind sehr ähnlich in der Hefe Saccharomyces
cerevisiae und in höheren Zellen. Weil Hefe für genetische Studien sehr geeingnet ist, erforschen
wir die GPI-Biosynthese in diesem Modellorganismus. Auf dem hydrophilsten GPI-Vorläufer in gpi7
Mutanten fehlte eine Seitenkette mit Phosphodiester-Bindung auf Man2 im Vergleich zum
kompletten GPI Vorläufer CP2, was vermuten liess, dass das zugehörige Enzym Gpi7p nötig ist
zum Anhängen einer Seitenkette an die zweite Mannose. Daher war es verlockend zu spekulieren,
dass YLL031c/GPI13 und MCD4, Gene mit grosser Sequenzhomologie zu GPI7, eine Rolle spielen
in der Anheftung von Seitenketten an die erste und dritte Mannose von GPI-Ankern. Das Ziel dieser
Arbeit war die Charakterisierung von Proteinen, die für das Anheften von Seitenketten an Hefe-GPI-
Anker nötig sind. Eine Verringerung der Menge des Proteins Gpi13p verursachte eine geschwächte
Zellwand und eine Verminderung der Menge GPI-verankerter Proteine. Weiter führete die
Verringerung von Gpi13p in vivo zur Akkumulierung eines GPI-Glycolipids, dem die EthN-P-
Seitenkette auf der dritten Mannose fehlte, was darauf deutete, dass Gpi13p nötig ist für den
Transfer von EthN-P auf Man3. Ein Glycolipid mit der gleichen Mobilität akkumulierte auch in in
vitro-Experimenten mit Microsomen. Mutation oder Verringerung der Proteins Mcd4p verursachte
die Akkumulierung von GPI-Vorläufern, denen EthN-P auf der ersten Mannose fehlte. Diese
Resultate sind in Einklang mit der Idee, dass Gpi13p EthN-P auf die innere α1-2-gebundene
Mannose, und Mcd4p EthN-P auf die α1-4-gebundene Mannose überträgt. Wir konnten zeigen,
dass eine etikettierte Form von Gpi13p im Endoplasmatischen Reticulum (ER) lokalisiert ist. Im
Gegensatz dazu war der grösste Teil des Proteins Gpi7p auf der Zelloberfläche lokalisiert. Eine
Reduzierung der Menge von Gpi13p oder Mcd4p in Hefezellen führte zur Aktivierung einer
Signalkaskade als Antwort auf Stress im ER, was ein weiterer Hinweis darauf ist, dass GPI-
Verankerung von Proteinen für Saccharomyces cerevisiae ein lebenswichtiger Prozess ist.
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1. Introduction
Discovery of GPI anchors
In virtually all eukaryotic organisms, many cell surface proteins are membrane anchored
via glycosylphosphatidylinositol (GPI). Evidence for the existence of these anchors came in
the 1960s with a report on the selective release of alkaline phosphatase from the surface of
mammalian cells by a bacterial phospholipase C (Slein and Logan, 1963). These studies
were confirmed several years later, when highly purified phosphatidylinositol-specific
phospholipase C (PI-PLC) was shown to release alkaline phosphatase and other
membrane proteins (reviewed by Low, 1987). In the mid-1980's, it was shown that the
Trypanosoma brucei variant surface glycoprotein (VSG) is covalently linked to a
phosphatidylinositol-containing glycolipid (Ferguson et al., 1985). This finding was a major
breakthrough, since VSG is present at 107 copies per cell, and could thus easily be purified
in sufficient amount for structural analysis. The complete structure of the VSG GPI-anchor
was elucidated in 1988 (Ferguson et al., 1988) and its structure is shown in Figure 1-1.
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Figure 1-1. Structure of the VSG GPI anchor from Trypanosoma brucei.
Ins, myo-inositol; GlcN, glucosamine; Man, mannose; Gal, galactose.
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The experimental strategies developed for the elucidation of the VSG GPI anchor structure
have been used for similar studies on a number of other proteins (reviewed by McConville
and Ferguson, 1993).
Occurrence and roles of GPIs
GPI-anchored proteins have been found in virtually all eukaryotes (Tiede et al., 1999), and
are particularly abundant in parasitic protozoa, where the majority of coat glycoproteins,
surface hydrolases and receptors are GPI-anchored. In mammalian cells, GPI-anchored
proteins comprise a large number of glycoproteins of various functions, including cell
surface enzymes, receptors, complement defense proteins, and molecules involved in cell
adhesion and activation. In Saccharomyces cerevisiae, GPI-anchored proteins were first
reported in 1988 (Conzelmann et al., 1988). Recently, GPI-anchored proteins have also
been described in plants (Morita et al., 1996; Takos et al., 1997; Youl et al., 1998).
Although the GPI glycolipids were discovered as covalently linked to cell-surface proteins,
many cells contain non-protein linked or "free" GPIs (reviewed by McConville and Menon,
2000).
GPI-anchored proteins in Saccharomyces cerevisiae
In Saccharomyces cerevisiae, GPI-anchored proteins are found attached to the plasma
membrane or as an intrinsic part of the cell wall. For some proteins, the presence of the
GPI anchor has been proven, whereas for other proteins, a potential GPI anchor
attachment signal has been predicted by sequence analyses, which were made possible
after the sequencing of the complete Saccharomyces cerevisiae genome (Goffeau et al.,
1996). A total of 53 (Hamada et al., 1998) or 58 (Caro et al., 1997) GPI-anchored proteins
have been predicted for Saccharomyces cerevisiae, and when considering also data from
the YPD database (www.proteome.com/databases/index.html, July 19th, 2001), 68 proteins
are predicted to be GPI-anchored. Table 1-1 shows the 52 experimentally verified GPI-
anchored proteins in Saccharomyces cerevisiae and key references. A recent study on the
number of GPI-anchored proteins however predicts 41 to 55 (depending on the level of
certainty) GPI-anchored proteins in Saccharomyces cerevisiae, which corresponds to 0.63
% or 0.84 % of the yeast proteins (Eisenhaber et al., 2001).
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Table 1-1. GPI-anchored proteins in Saccharomyces cerevisiae.
CW and PM indicate cell wall localization and plasma membrane localization, respectively.
Gene name Protein name localization Key references
YAL063c Flo9p CW (Teunissen and Steensma, 1995)
YAR050w Flo1p CW (Teunissen et al., 1993)
YBR067c Tip1p CW (Kondo et al., 1991)
(Van Der Vaart et al., 1995)
(Fujii et al., 1999)
YCR089w Fig2p CW (Van Der Vaart et al., 1997)
(Erdman et al., 1998)
YCR098c Git1p PM (Stratford, 1994)
YDR055w Pst1p CW (Terashima et al., 2000)
YDR077w Sed1p CW (Van Der Vaart et al., 1997)
(Shimoi et al., 1998)
YDR134c CW (Hamada et al., 1999)
YDR144c Mkc7p/Yps2p PM (Komano and Fuller, 1995)
(Komano et al., 1999)
YDR261c Exg2p PM (Cid et al., 1995)
YDR349c Yps7p PM (Olsen et al., 1999)
YDR534c Fit1p CW (Hamada et al., 1999)
YEL040w Utr2p CW (Hamada et al., 1999)
YER011w Tir1p/Srp1p CW (Kowalski et al., 1995)
YER150w Spi1p CW (Hamada et al., 1999)
YGR189c Crh1p CW (Rodriguez-Pena et al., 2000)
(Terashima et al., 2000)
YHR211w Flo5p CW (Bidard et al., 1994)
YIR019c Flo11p/Muc1p CW (Lo and Dranginis, 1996)
YIR039c Yps6p (Olsen et al., 1999)
YJL078c Pry3p CW (Hamada et al., 1999)
YJL171c CW (Hamada et al., 1999)
YJR004c Agα1p/Sag1p CW (Lipke et al., 1989)
(Lu et al., 1994)
YJR150c Dan1p/Ccw13p CW (Mrsa et al., 1999)
YJR151c Dan4p CW (Hamada et al., 1999)
YKL096w Cwp1p CW (Van Der Vaart et al., 1995)
YKL097w Cwp2p CW (Van Der Vaart et al., 1995)
(Skrzypek et al., 1997)
(Skrzypek et al., 2000)
YKR102w Flo10p CW (Teunissen and Steensma, 1995)
(Guo et al., 2000)
YLR040c CW (Hamada et al., 1999)
YLR042c CW (Hamada et al., 1999)
YLR110c Ccw12p CW (Mrsa et al., 1999)
YLR120c Yps1p/Yap3p PM (Ash et al., 1995)
YLR121c Yps3p (Olsen et al., 1999)
YLR194c CW (Hamada et al., 1999)
(Terashima et al., 2000)
YLR391w Ccw14p/Icwp CW (Moukadiri et al., 1997)
(Mrsa et al., 1999)
YMR006c Plb2p PM (Fyrst et al., 1999)
YMR008c Plb1p PM (Lee et al., 1994)
YMR215w Gas3p PM (Popolo and Vai, 1999)
(Hamada et al., 1999)
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Table 1-1 (continued). GPI-anchored proteins in Saccharomyces cerevisiae.
Gene name Protein name localization Key references
YMR307w Gas1p PM (Nuoffer et al., 1991)
(Vai et al., 1991)
(Popolo and Vai, 1999)
YNL190w PM (Hamada et al., 1999)
YNL300w Tos6p CW (Hamada et al., 1999)
YNL322c Kre1p PM (Roemer and Bussey, 1995)
YNL327w Egt2p CW (Hamada et al., 1999)
YNR044w Aga1p CW (Roy et al., 1991)
YOL011w Plb3p PM (Merkel et al., 1999)
YOL030w Gas5p PM (Popolo and Vai, 1999)
(Hamada et al., 1999)
YOL132w Gas4p PM (Popolo and Vai, 1999)
(Hamada et al., 1999)
YOR009w Tir4p CW (Hamada et al., 1999)
YOR010c Tir2p/Srp2p CW (Kowalski et al., 1995)
YOR214c CW (Hamada et al., 1999)
YOR382w CW (Hamada et al., 1999)
YOR383c CW (Hamada et al., 1999)
YPL130w Spo19p CW (Hamada et al., 1999)
Yeast GPI-anchored proteins can be grouped in families with different functions. For
example, the Gas1 family comprises Gas1p and its four homologues, GAS2  to GAS5.
Gas1p, the most abundant GPI-anchored protein in yeast, was identified as a 125 kD GPI-
containing glycoprotein (Conzelmann et al., 1988) and is involved in cell wall construction
(reviewed by Popolo and Vai, 1999). The flocculin family comprises the proteins encoded
by FLO1, FLO5, FLO9, FLO10 and FLO11. These proteins are involved in flocculation, i.e.
the adhesion of yeast cells into clumps which sediment in the medium. The agglutinins
Sag1p and Aga1p promote aggregation of cells of different mating type during mating.
Structure of GPI anchors
Shortly after the elucidation of the GPI-anchor structure of the Trypanosoma brucei VSG
(Ferguson et al., 1988), the structure of the GPI anchor of rat brain Thy-1 (Homans et al.,
1988) and many other proteins have been solved.
These studies have revealed a GPI core structure which is conserved in all eukaryotes, but
is modified by various side chains in different organisms, in a tissue- and species-specific
manner. The conserved core structure consists of ethanolaminephosphate (EthN-P) linked
to the Manα1-2Manα1-6Manα1-4GlcN tetrasaccharide, which in turn is linked to myo-
14
inositol in α1-6 linkage. The carboxy-terminal amino acid of the GPI-anchored protein is
covalently linked to EthN-P.
The structures of Saccharomyces cerevisiae GPI anchors were elucidated in 1993
(Fankhauser et al., 1993). GPI anchors were prepared from crude yeast membrane protein
fractions without purification of individual proteins. Figure 1-2 shows the structures of GPI
anchors found in yeast.
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Figure 1-2. Yeast GPI anchor structures.
Ins, myo-inositol; GlcN, glucosamine; Man, mannose. The abbreviations M1 to M5 indicate
the number of mannoses.
Biosynthesis of GPI glycolipids
Many genes encoding GPI biosynthetic enzymes as well as regulators have recently been
cloned from different organisms. Characterizations of these gene products have revealed
common and also different aspects of GPI biosynthesis in different organsims. GPI
biosynthetic pathways have been extensively reviewed (Englund, 1993; McConville and
Ferguson, 1993; Stevens, 1995; Takeda and Kinoshita, 1995; Kinoshita et al., 1997;
Menon et al., 1997; Tiede et al., 1999; Kinoshita and Inoue, 2000; McConville and Menon,
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2000). The reaction steps required for GPI glycolipid biosynthesis are described below.
The illustration in Figure 1-3 shows a simplified scheme of the GPI biosynthesis in
Saccharomyces cerevisiae. The genes involved in GPI biosynthesis are listed in Table 1-2.
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Figure 1-3. GPI biosynthesis and transfer to proteins.
A linear outline of GPI biosynthesis in Saccharomyces cerevisiae is depicted. However,
some GPI intermediates have EthN-P modifications that suggest the existence of a
branching in the GPI biosynthetic pathway (Taron et al., 2000; Grimme et al., 2001). The
attachment of EthN-P to the α1,6-linked mannose, carried out by Gpi7p, is here shown to
occur in the ER, even though only a small fraction of Gpi7p resides in the ER (Benachour
et al., 1999).
Synthesis of N-acetylglucosaminyl phosphatidylinositol (GlcNAc-PI)
The biosynthesis of GPIs is initiated in the endoplasmic reticulum (ER) by the transfer of N-
acetylglucosamine (GlcNAc) from UDP-GlcNAc to phosphatidylinositol (PI) to yield
GlcNAc-PI (Doering et al., 1989; Masterson et al., 1989). This reaction is carried out by a
complex glycosyltransferase consisting of at least seven proteins in mammalian cells, PIG-
A (Phosphatidylinositol Glycan A), PIG-H, PIG-C, GPI1, PIG-P, DPM2 and a 5 kD protein
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not yet cloned (Watanabe et al., 1998; Watanabe et al., 2000)). In Saccharomyces
cerevisiae, GPI3/SPT14/CWH6, GPI2 and GPI1 have been shown to be required for this
step (Leidich et al., 1995; Schönbächler et al., 1995; Vossen et al., 1995; Leidich and
Orlean, 1996). Sequence comparisons revealed that mammalian PIG-A and
Saccharomyces cerevisiae Gpi3p, as well as mammalian PIG-C and Saccharomyces
cerevisiae Gpi2p are homologous proteins. Mammalian GPI1 was found as homologue of
yeast Gpi1p (Tiede et al., 1998; Watanabe et al., 1998), YDR437w is homologous to PIG-P
(Watanabe et al., 2000), and GPI15/YNL038w has similarity to human PIG-H (Yan et al.,
2001)(data obtained on SGD). However, there is no gene homologous to DPM2 in the
Saccharomyces cerevisiae genome. PIG-A and Gpi3p have homology to a bacterial N-
acetylglucosaminyltransferase (GnT) and to many other glycosyltransferases, suggesting
that PIG-A/Gpi13p most likely is the catalytic subunit of the GPI-N -
acetylglucosaminyltransferase (GPI-GnT) complex (Kinoshita et al., 1997). In support of
this hypothesis, it was recently shown that Gpi3p (but not Gpi2p) is able to bind UDP-
GlcNAc and that Gpi3p therefore probably is the catalytic subunit of GPI-GnT (Kostova et
al., 2000). Insights into the function of GPI1 came from recent studies in mammalian cells
showing that, like in Saccharomyces cerevisiae, disruption of GPI1 causes only an
incomplete defect in the generation of GPI-anchored proteins (Leidich and Orlean, 1996;
Hong et al., 1999b). It was shown that GPI1 is important for the formation of a complex
comprising PIG-A, PIG-H, PIG-C and GPI1 (Hong et al., 1999b).
The functions of PIG-C/Gpi2p, PIG-H and PIG-P have not yet been elucidated. The recent
finding that DPM2, a regulatory subunit of the mammalian Dol-P-Man synthase, specifically
binds to and positively regulates GPI-GnT, provides a first clue to understand the
regulation of the GPI biosynthetic pathway at the initial step (Watanabe et al., 2000).
However, DPM2 is not essential for GPI-GnT activity.
De-N-acetylation of GlcNAc-PI
The second step of GPI biosynthesis is the generation of GlcN-PI from GlcNAc-PI (Doering
et al., 1989). Mammalian class J mutant cells are deficient in GlcNAc-deacetylation, and rat
PIG-L as well as its yeast homologue Gpi12p are able to complement this mutation
(Mohney et al., 1994; Stevens et al., 1996; Nakamura et al., 1997; Watanabe et al., 1999),
suggesting that GlcNAc-PI de-N-acetylase is conserved between mammals and yeast.
Disruption of GPI12 in Saccharomyces cerevisiae is lethal, indicating that the de-N-
acetylation step is indispensable in yeast (Watanabe et al., 1999). The PIG-L gene
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encodes a ER membrane protein, most of it residing on the cytoplasmic side. This
orientation of PIG-L protein is consistent with the notion that de-N-acetylation occurs on the
cytoplasmic side of the ER (Nakamura et al., 1997).
Reversible inositol acylation
Acylation of the position 2 of the myo-inositol represents the third step in GPI biosynthesis
in yeast and mammals (Costello and Orlean, 1992; Urakaze et al., 1992), whereas in
trypanosomes it occurs farther downstream in biosynthesis (Smith et al., 1997). There is
controversy about the precise source of the acyl group. Studies in yeast cell-free systems
suggest that acyl coenzyme A (acyl-CoA) is the acyl donor (Costello and Orlean, 1992),
and similar results have been obtained in CHO cells (Doerrler et al., 1996). However, other
studies have shown that the acyl group was transferred from endogenous membrane lipid
by CoA-dependent transacylation in microsomes derived from murine lymphoma cells
(Stevens and Zhang, 1994). A recent report demonstrated the coexistence of the acyl-CoA-
dependent GlcN-PI acyltransferase and the CoA-dependent acyl-CoA-independent
acyltransferase in rodent microsomes (Doerrler and Lehrman, 2000). The acyl group
attached to the inositol ring is mainly palmitate, but this is not always the case. In vitro
studies in Saccharomyces cerevisiae and the pathogenic fungus Cryptococcus neoformans
have shown that both organisms transfer various fatty acids directly from acyl-CoAs to
inositol (Franzot and Doering, 1999). The acyltransferase has not yet been cloned.
Synthesis of Dol-P-Man
Dolichol-phosphate-mannose (Dol-P-Man), the sugar donor for all three GPI core
mannoses, is formed by transfer of mannose from GDP-Mannose to dolichol phosphate on
the cytoplasmic side of the ER (reviewed by Abeijon, 1992). Dol-P-Man is also the
mannosyl donor for N-glycosylation, and for protein O- and C-mannosylation (Doucey et
al., 1998). In Saccharomyces cerevisiae, the gene encoding Dol-P-Man synthase DPM1
has been cloned and characterized (Orlean et al., 1988; Orlean, 1990).  Mammalian DPM1
encodes a protein with 30% identity to yeast Dpm1p, but the mammalian protein lacks a
stretch of 30 C-terminal hydrophobic amino acids (Tomita et al., 1998). It was then shown
that mammalian Dol-P-Man synthase consists of a complex of Dpm1p and a small
hydrophobic protein encoded by the DPM2 gene (Maeda et al., 1998). Recently, DPM3,
another subunit of the mammalian Dol-P-Man synthase was identified (Maeda et al., 2000).
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The observed differences in Dpm1p proteins from different organisms suggest that Dol-P-
Man synthases can be divided in two classes: class 1 DPM1 proteins containing the
COOH-terminal hydrophobic domain, and class 2 enzymes lacking a hydrophobic COOH-
terminal domain. Class 1 proteins are found in Saccharomyces cerevisiae, Ustilago
maydis, T. brucei (Colussi et al., 1997) and Leishmania mexicana (Ilgoutz et al., 1999b),
and encode single subunit enzymes. Class 2 DPM1 proteins are found in humans, S.
pombe, Caenorhabditis (Colussi et al., 1997) and the filamentous fungus Trichoderma
reesei (Kruszewska et al., 2000), and seem to be part of a multi-component enzyme
(Maeda et al., 2000).
Addition of the first mannose
The first mannose is transferred from Dol-P-Man (Menon et al., 1990) to the position 4 of
GlcN. In yeast and mammalian cells, this mannose is transferred to GlcN-acylPI, whereas
in trypanosomes, the first mannose is transferred to GlcN-PI. Recently, the human
mannosyltransferase required for addition of the first mannose (GPI-MT-I) has been cloned
(Maeda et al., 2001). This gene, PIG-M, encodes a new type of mannosyltransferase
containing a DXD motif characteristic of many glycosyltransferases. The finding that the
lumenally oriented DXD motif is functionally important suggests that the transfer of the first
mannose occur on the lumenal side of the ER. Homologues of PIG-M are found in
Saccharomyces cerevisiae (Gpi14p (Kinoshita and Inoue, 2000)), C. elegans and T. brucei
(Maeda et al., 2001). Characterization of GPI-MT-I is important for two reasons. First, the
orientation of the DXD active site motif allows insights into the topology of GPI
biosynthesis, indicating that the flipping of the intermediate from the cytosolic to the
lumenal leaflet of the ER membrane occurs after mannose addition. Second, because the
substrates of GPI-MT-I are different in mammalian cells and T. brucei, this enzyme might
be a good target for drugs that selectively inhibit GPI biosynthesis in this parasite. Some
synthetic substrates able to inhibit trypanosomal GPI-MT-I have already been described
(Smith et al., 1999; Smith et al., 2000).
Addition of the second mannose
The second mannose is transferred from the donor Dol-P-Man to position 6 of the first
mannose. The α1,6-mannosyltransferase (GPI-MT-II) responsible for this transfer has not
yet been identified. No mutants deficient in this enzyme have been reported.
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The addition of ethanolamine phosphate to the first mannose
In mammalian cells, ethanolamine phosphate (EthN-P) is added to the α1,4-linked
mannose residue (Man1) (Homans et al., 1988; Roberts et al., 1988; Puoti et al., 1991;
Hirose et al., 1992; Kamitani et al., 1992; Puoti and Conzelmann, 1993), probably at
position 2 as found in the GPI anchor of Thy-1 (Homans et al., 1988). In yeast, the
presence of EthN-P attached to Man1 has first been revealed when analyzing the GPI
intermediate that accumulated in the gpi10-1 mutant deficient in addition of the third Man
(Canivenc-Gansel et al., 1998). This finding was unexpected, since previous analysis of the
pool of all GPI anchors in Saccharomyces cerevisiae had failed to reveal EthN-P on Man1
(Fankhauser et al.,  1993). Recent studies in yeast have shown that
phosphatidylethanolamine (PE) is the donor of the EthN-P linked to Man1 (Imhof et al.,
2000).
Yeast MCD4 and its mammalian homologue MCD4/PIG-N are the genes involved in
addition of EthN-P to Man1 (Gaynor et al., 1999; Hong et al., 1999a). MCD4 was initially
identified in a screen for Saccharomyces cerevisiae mutants deficient in bud emergence
(Mondésert et al., 1997). It encodes an essential ER protein containing a large N-terminal
lumenal domain and multiple transmembrane domains. The temperature-sensitive mcd4-
174 mutant is defective in ER to Golgi transport of GPI-anchored proteins, secretion of
proteins into the medium, morphological changes of the endomembrane system, a defect
of inositol incorporation into proteins, and accumulation of multiple GPI precursor lipids
(Gaynor et al., 1999). Recently, its-8+, the fission yeast homologue of MCD4 has been
identified (Yada et al., 2001). Defects in cell wall integrity due to impaired GPI anchor
synthesis in its8-1 mutants caused morphological defects, such as abnormal cytokinesis.
its-8+ is not an essential gene, but disruption resulted in extremely slow growth. In
mammalian cells, it has been shown that modification of the first mannose by EthN-P is not
essential for attachment of GPI anchors to proteins, since the surface expression of GPI-
anchored proteins was only partially affected in Pig-n knockout cells (Hong et al., 1999a).
These cells contained GPI precursors lacking EthN-P on Man1, indicating that PIG-N is
involved in transfer of this side chain (Hong et al., 1999a).
Yeast cells treated with the terpenoid lactone YW3548 accumulate Man2-GlcN-acylPI
(Sütterlin et al., 1997b). YW3548 was isolated in a natural product screen and was initially
thought to inhibit the addition of the third mannose in yeast and animal cells. However, it is
now clear that YW3548 is a specific inhibitor of EthN-P addition to Man1 (Sütterlin et al.,
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1998; Hong et al., 1999a). This compound kills Saccharomyces cerevisiae cells at
micromolar concentrations, but has no effect on GPI biosynthesis in T. brucei and
Plasmodium falciparum (Sütterlin et al., 1997b), where no EthN-P is added to Man1
(McConville and Ferguson, 1993). The studies on the effects of YW3548 in yeast suggest
that the sequence of the GPI biosynthetic reactions in this organism are PI → GlcNAc-PI →
GlcN-PI →  GlcN-acylPI →  Man-GlcN-acylPI → Man-Man-GlcN-acylPI → Man-(EthN-
P)Man-GlcN-acylPI → Man-Man-(EthN-P)Man-GlcN-acylPI. In mammalian cells, EthN-P is
most probably added at the stage of Man-GlcN-acylPI, as indicated by characterization of
putative GPI precursors in mammalian cells (Hirose et al., 1992).
Addition of the third mannose
The third mannose is transferred from Dol-P-Man to position 2 of the second mannose.
Mammalian mutant cell lines of complementation class B have been reported to
accumulate a GPI intermediate containing two mannoses (Puoti et al., 1991; Sugiyama et
al., 1991; Puoti and Conzelmann, 1993), suggesting that GPI-MT-III is deficient. The
corresponding gene was named PIG-B (Takahashi et al., 1996). PIG-B encodes a protein
with a large lumenal domain, suggesting that the functional site of the PIG-B protein reside
on the lumenal side of the ER membrane. In yeast, gpi10-1 mutant cells accumulate the
GPI intermediate Manα1-6(EthN-P)Manα1-4GlcNα1-6(acyl)PI, suggesting that this mutant
is deficient in GPI-MT-III. Interestingly, the gpi10-1 mutant incorporated normal amounts of
inositol into proteins, even though its microsomes were unable to synthesize Man4-GPIs,
suggesting that this mutant was able to make complete GPI precursors in vivo in spite of
the biosynthetic block observed in vitro (Canivenc-Gansel et al., 1998). It was shown that
this mutant is deficient in YGL142c/GPI10, a yeast homologue of mammalian PIG-B
(Canivenc-Gansel et al., 1998; Sütterlin et al., 1998). Gpi10p has three homologues in the
yeast genome: Alg9p and Alg12p, two non-essential proteins involved in mannosyl transfer
in N-glycosylation (Burda et al., 1996; Burda et al., 1999), and Smp3p, which is required for
addition of the fourth mannose in GPI biosynthesis (Grimme et al., 2001).
Addition of the fourth mannose
In yeast, all GPI anchors contain a fourth, α1,2-linked mannose on the α1,2 mannose that
contains the EthN-P moiety through which the GPI anchor becomes linked to protein
(Fankhauser et al., 1993). In mammalian cells, a portion of GPIs might also contain this
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fourth mannose (Hirose et al., 1992; Hong et al., 2000). Consistent with this hypothesis, a
fourth mannose residue has been found on 71% of rat brain Thy-1 GPI anchors, but
interestingly, this extra mannose is unlikely to be present in rat thymocyte Thy-1 (Homans
et al., 1988), suggesting that tissue-specific side chain variation can occur.
The Saccharomyces cerevisiae SMP3 gene encodes a protein which is required for the
addition of the fourth mannose (Grimme et al., 2001). SMP3 is essential for viability, and
temperature-sensitive smp3 mutants accumulate a GPI containing three mannoses.
Characterization of this GPI intermediate showed that it is a mixture of two isoforms, one
with a single EthN-P on Man1, the other bearing EthN-P on Man2, providing evidence that
the GPI assembly pathway in yeast may be branched. However, the most important finding
was that in absence of Smp3p, addition of the bridging EthN-P to Man3 is severely, if not
completely blocked (Grimme et al., 2001). Smp3p-related proteins are found in S. pombe,
C.albicans, D. melanogaster and Homo sapiens (Grimme et al., 2001).
Addition of EthN-P to the third mannose
The addition of EthN-P to position 6 of the third mannose is an essential part of GPI
biosynthesis, since it provides the "bridge" between the glycan and the protein. This EthN-
P is directly transferred from phosphatidylethanolamine (PE) (Menon and Stevens, 1992;
Menon et al., 1993). Class F mutant lymphoma cell lines are unable to express Thy-1 at
the cell surface, and accumulate multiple GPIs with one, two and three mannoses as well
as side chain EthN-Ps, but the most polar GPI in these cells lacks EthN-P on Man3
(Sugiyama et al., 1991; Kamitani et al., 1992; Puoti and Conzelmann, 1993). Thy-1
negative class F mutants are also unable to synthesize ether lipids and make PI and GPIs
that contain diacylglycerol rather than base-resistant ether lipids (Stevens and Raetz, 1990;
Puoti and Conzelmann, 1993). The PIG-F gene restores Thy-1 surface expression and GPI
anchor biosynthesis in class F mutants (Inoue et al., 1993). PIG-F encodes a small, very
hydrophobic protein. Gpi11p, a yeast protein homologous to PIG-F, has recently been
characterized (Taron et al., 2000). The GPI11 gene is essential for viability and required for
GPI anchoring, since yeast cells depleted of Gpi11p are unable to incorporate inositol into
proteins. Depletion of Gpi11p or Pig-Fp in ∆gpi11 cells leads to accumulation of two Man4-
containing GPIs, which differ in the number and positioning of side chains. The more polar
lipid is substituted on Man3, indicating that Gpi11p is not the enzyme required for the
addition of EthN-P to Man3 (Taron et al., 2000). Therefore, another protein is responsible
for adding the bridging EthN-P. Recently, Gpi7p and Mcd4p were identified as candidate
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EthN-P transferases (Benachour et al., 1999; Gaynor et al., 1999). GPI7 and MCD4 belong
to a family of three yeast ORFs, GPI7, MCD4 and YLL031c, and the finding that GPI
intermediates accumulate in YLL031c depleted cells suggested to test YLL031c as a
candidate EthN-P transferase (Benachour et al., 1999). YLL031c encodes a protein of
1017 amino acids with a large N-terminal hydrophilic domain and multiple transmembrane
domains in the C-terminal part. YLL031c as well as MCD4 and GPI7 contain significant
homology to phosphodiesterases, further suggesting that this protein family is involved in
EthN-P transfer (Benachour et al., 1999; Gaynor et al., 1999). YLL031c is an essential
gene, and yeast cells depleted of YLL031c show a reduction of GPI anchor addition to GPI
proteins as well as cell wall fragility (Flury et al., 2000). In addition, they accumulate a GPI
intermediate that contains four mannoses and lacks EthN-P on Man3 (Flury et al., 2000;
Taron et al., 2000). Because of this clear implication of YLL031c in the GPI biosynthetic
pathway, YLL031c was named GPI13 (Taron et al., 2000). A C-terminally tagged version of
Gpi13p is localized in the ER (Flury et al., 2000). Homologues of GPI13 exist in S. pombe,
C. elegans and homo sapiens, and the murine GPI13 homologue PIG-O was recently
identified (Hong et al., 2000). PIG-O is not required for viability of murine embryonic
carcinoma cells, but the expression of the GPI-anchored protein Thy-1 was greatly
reduced, indicating that the PIG-O protein is involved in but not essential for GPI
anchoring. Pig-o knockout cells accumulate the same major GPI intermediate as Pig-f
mutant cells, containing three mannoses and one EthN-P on the first mannose. However,
one of the two minor GPIs that accumulate in Pig-o disrupted cells is not present in class F
cells. This intermediate most likely contains EthN-P on the third Man, and could therefore
explain the residual surface expression of Thy-1 (Hong et al., 2000). PIG-O and PIG-F
proteins associate with each other, and PIG-F is required for the stable expression of PIG-
O (Hong et al., 2000).
Addition of EthN-P to the second mannose
A further EthN-P can be attached to the second mannose. This modification has been first
observed in mammalian cells (Deeg et al., 1992; Kamitani et al., 1992; Ueda et al., 1993).
It has been claimed that EthN-P is added to position 6 of Man2 (Hirose et al., 1992; Ueda
et al., 1993). This additional EthN-P seems to be attached to a GPI precursor which
already contains the bridging EthN-P at Man3 (Hirose et al., 1992). In Saccharomyces
cerevisiae, gpi7 mutants accumulate a GPI intermediate that lacks a HF-sensitive side
chain on Man2, possibly EthN-P (Benachour et al., 1999). GPI7 is a non-essential gene,
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and mutation or disruption of the gene affects transport and remodeling of GPI-anchored
proteins, and cell wall integrity. Depletion of GPI13 in a ∆gpi7 background results in a
synthetic enhancement of the growth retardation caused by Gpi13p depletion (Flury et al.,
2000). GPI7 encodes an integral membrane protein with 9-11 predicted transmembrane
domains in the C-terminal part and a large, hydrophilic domain in the N-terminal part.
Interestingly, the bulk of Gpi7p is localized on the plasma membrane. GPI7 has
homologues in C. elegans and S. pombe (Benachour et al., 1999).
Table 1-2. Genes involved in GPI biosynthesis in yeast and mammalian cells.
Enzyme Gene
S.cerevisiae Mammals
GPI-GlcNAc transferase GPI3/SPT14/CWH6
GPI15/YNL038w
GPI2
GPI1
YDR437w
§
PIG-A
PIG-H
PIG-C
GPI1
PIG-P
DPM2
De-N-acetylase GPI12 PIG-L
Acyltransferase
Flippase
GPI-α1,4mannosyltransferase (GPI-MT-I) GPI14 PIG-M
GPI-α1,6mannosyltransferase (GPI-MT-II)
Ethanolamine phosphate transferase on M1 MCD4 PIG-N
GPI-α1,2mannosyltransferase (GPI-MT-III) GPI10 PIG-B
GPI-α1,2mannosyltransferase (GPI-MT-IV) SMP3
Ethanolamine phosphate transferase on M3 GPI13
GPI11
PIG-O
PIG-F
Ethanolamine phosphate transferase on M2 GPI7 hGPI7
Transamidase GPI8
GAA1
GPI16
GPI17
GPI8 (PIG-K)
GAA1
PIG-T
PIG-S
Dol-P-Man synthase DPM1
§
§
§
DPM1
DMP2
DPM3
(SL15)
§ genes homologous to mammalian counterpart are not found in the Saccharomyces
cerevisiae genome. For key references, see text.
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Transfer of the GPI to proteins
Upon completion of its biosynthesis, the GPI is transferred to the carboxy-terminus of a
pre-synthesized protein. The anchor attachment is known to occur in the ER, since GPI
anchoring is still observed when vesicular traffic between the ER and the Golgi apparatus
is blocked (Conzelmann et al., 1988). Proteins to be GPI-anchored need to have the
following features:
1) A hydrophobic N-terminal signal peptide required for entering the ER lumen.
2) A hydrophobic C-terminal GPI-attachment signal peptide which serves to transiently
attach the protein in the ER membrane. During anchor addition, this signal peptide is
cleaved off.
3) A suitable triplet of amino acids containing the GPI attachment site (termed "ω" site)
The transfer of the GPI to the protein occurs by a transamidation reaction, in which a
putative transamidase removes the C-terminal GPI signal peptide and attaches the
truncated protein to the amino group of the bridging EthN-P on the preformed GPI
(Udenfriend and Kodukula, 1995). Cells deficient in transamidase activity are expected to
accumulate complete GPI lipids as well GPI precursor proteins. The Saccharomyces
cerevisiae mutants gpi8 and gaa1 as well as the mammalian class K mutant cell line all
exhibit the transamidase deficient phenotype (Mohney et al., 1994; Benghezal et al., 1995;
Hamburger et al., 1995; Benghezal et al., 1996; Chen et al., 1996; Yu et al., 1997). The
yeast genes GPI8 and GAA1 were cloned and it was shown that both genes encode
essential ER proteins with the bulk of the protein residing in the lumen of the ER
(Hamburger et al., 1995; Benghezal et al., 1996). Gpi8p belongs to a novel cysteine
protease family (Benghezal et al., 1996; Meyer et al., 2000; Ohishi et al., 2000). Homology
searches have shown that GPI8 homologues exist in man, C. elegans, D. melanogaster
and A. thaliana, and the homology of GPI8 with proteases suggests that Gpi8p is directly
involved in the proteolytic removal of the GPI signal sequence (Meyer et al., 2000). Human
homologues of Gpi8p and Gaa1p have been cloned and shown to be required for GPI
anchoring (Yu et al., 1997; Hiroi et al., 1998). Recently, homologues of Gpi8p from
trypanosomes, Leishmania and S. pombe have been cloned (Hilley et al., 2000; Sharma et
al., 2000; Shams-Eldin et al., 2001). Studies with non-functional and partially functional
alleles of GPI8 suggest that Gpi8p is present in homo- or heteropolymeric complex (Meyer
et al., 2000). Indeed, Gaa1p and Gpi8p are found to form a complex, and Gaa1p is
required for the generation of a carbonyl intermediate between the transamidase and a
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precursor protein (Ohishi et al., 2000). Recent in vitro studies provide direct evidence for an
interaction between a proprotein and a transamidase subunit, and suggest that additional
proteins might be part of the mammalian transamidase complex (Vidugiriene et al., 2001).
Indeed, two studies have identified additional subunits of the transamidase complex by
affinity purification (Fraering et al., 2001; Ohishi et al., 2001). In the study of Fraering et al.
(2001), digitonin-solubilized GPI transamidase complex was isolated by affinity purification
from Saccharomyces cerevisiae membranes, and proteins contained in the complex were
identified by mass spectometry. In addition to Gpi8p and Gaa1p, the complex contained
Gpi16p (encoded by YHR188c). Gpi16p is an essential transmembrane glycoprotein. Cells
depleted of Gpi16p accumulate complete GPI lipids as well GPI precursor proteins. Ohishi
et al. (2001) identified two new components of the mammalian GPI transamidase, PIG-S
and PIG-T. PIG-T is the mammalian homologue of Saccharomyces cerevisiae Gpi16p, and
PIG-S has homology to yeast YDR434w (GPI17). PIG-S and PIG-T mouse knockout cells
do not express the GPI-anchored protein Thy-1 at the cell surface and accumulate mature
GPI lipids. By immunoprecipitation experiments, it was shown that PIG-T has a central role
in maintenance of the transamidase complex, and Figure 1-4 shows a model based on
these results.
Figure 1-4. The mammalian GPI transamidase.
Model from Ohishi et al. (2001).
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Localization and topology of GPI biosynthesis
In mammalian cells, GPI biosynthesis is initiated on the cytoplasmic leaflet of the ER
(Vidugiriene and Menon, 1993). The early GPI intermediates GlcNAc-PI and GlcN-PI could
be quantitatively hydrolyzed by PI-PLC in intact mammalian microsomes, indicating that
they are located on the cytoplasmic leaflet of the ER (Vidugiriene and Menon, 1993), and
characterization of the GlcNAc-transferase complex demonstrated that the functional
transferase enzyme is cytoplasmically oriented (Watanabe et al., 1996; Watanabe et al.,
1998; Hong et al., 1999b). The topologies of subsequent biosynthetic steps are less clear.
In trypanosomes and Leishmania, mannosylated GPI intermediates are located on the
cytoplasmic side of the ER (Mensa-Wilmot et al., 1994; Vidugiriene and Menon, 1994).
Two interpretations of this data are possible: a) the biosynthesis of these intermediates is
cytoplasmically oriented, or b) these reactions occur in the lumen of the ER, and the lipid
intermediates can flip out to the cytoplasmic side. Consistent with the latter possibility, the
membrane orientation of the mammalian GPI-mannosyltransferases PIG-B and PIG-M
suggest that mannosylation of GPI occurs in the lumen of the ER (Takahashi et al., 1996;
Maeda et al., 2001). This requires however a flipping step of GlcN-acylPI across the ER
membrane. The transamidase components Gpi8p and Gaa1p have membrane topologies
in which the bulk of the protein is lumenally oriented, supporting the idea that the mature
GPI anchor is transferred to proteins in the lumen of the ER (Hamburger et al., 1995;
Benghezal et al., 1996).
Recent data suggests that the GPI biosynthetic pathway is spatially restricted in the ER
(Ilgoutz et al., 1999a; Stevens et al., 1999; Vidugiriene et al., 1999). Attempts to reproduce
GPI biosynthesis in vitro using highly enriched ER preparations from thymoma cells and
CHO cells were less successful than when using cell lysates (Vidugiriene et al., 1999). It
was shown that de-N-acetylation of GlcNAc-PI and subsequent reaction steps up to the
singly mannosylated GPI structure containing one EthN-P side chain (intermediate H5) are
largely confined to an ER subcompartment that co-fractionates with mitochondria and
probably corresponds to a previously described ER fraction involved in phospholipid
synthesis (Vidugiriene et al., 1999). The observation that GlcNAc-PI synthase and
deacylase are spatially segregated in the ER provides additional evidence for
compartmentalization of GPI biosynthesis within the ER (Stevens et al., 1999). In
Leishmania mexicana, GPI biosynthetic enzymes colocalize with Dol-P-Man synthase in a
stable tubular subdomain of the ER (Ilgoutz et al., 1999a).
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Events after attachment of the GPI to protein
Remodeling of the lipid
Studies in trypanosomes have revealed the existence of lipid remodeling, a process in
which the longer fatty acid moieties of PI are sequentially removed and replaced by
myristate (Masterson et al., 1990). In Saccharomyces cerevisiae, GPI precursors contain
diacylglycerol probably with C16 or C18 fatty acids, whereas the majority of protein-bound
GPI anchors contain ceramide (C18:0 phytosphingosine with a C26:0 fatty acid), and a
smaller fraction of proteins contain diacylglycerol with a C26:0 fatty acid (Conzelmann et
al., 1992; Fankhauser et al., 1993; Sipos et al., 1994). These findings strongly argue for a
remodeling step that occurs after addition of the GPI to proteins. It was shown that at least
three different remodeling pathways can lead to the observed lipid exchange: 1)
remodeling from diacylglycerol to ceramide in the ER (Reggiori et al., 1997); 2) remodeling
from diacylglycerol to a more hydrophobic diacylglycerol probably by replacing only the
acyl chains (and not by replacing the entire DAG by a different DAG) (Sipos et al., 1997);
and 3) remodeling to a more polar ceramide in the Golgi apparatus or on the plasma
membrane (Sipos et al., 1997).
Addition of the fifth mannose residue
Structural analysis of the GPI anchors found on Saccharomyces cerevisiae proteins has
revealed the presence of a fifth mannose residue in 20% of the anchors (Fankhauser et al.,
1993). This side chain is linked to Man4 in α1,2 linkage or in α1,3 linkage. Whereas the
fourth mannose residue is added to all yeast GPI precursors in the ER, the fifth mannose is
transferred only upon arrival in the Golgi apparatus (Sipos et al., 1995). Studies using
secretion mutants have shown that the α1,3-mannosyltransferase is localized in the cis-
Golgi compartment, whereas the α 1,2-mannosyltransferase resides in later Golgi
compartments (beyond the sec7 block between cis- and mid-Golgi) (Sipos et al., 1995).
The genes that encode these mannosyltransferases have not yet been identified. So far,
the presence of a fifth mannose has been described only in Saccharomyces cerevisiae.
Inositol deacylation
Acylation on inositol renders GPIs resistant to PI-specific phospholipase C (PI-PLC).
However, most GPI-anchored proteins in mammals and other eukaryotes are sensitive to
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PI-PLC, due to inositol-deacylation. This deacylation occurs in the ER, shortly after the
transfer of the GPI to the protein (Chen et al., 1998). In trypanosomes, the acyltransferase
can be blocked by phenylmethylsulfonyl fluoride (PMSF) (Güther et al., 1994), whereas the
deacylase that removes the acyl chain on the inositol can be blocked by
diisopropylfluorophosphate (DFP) (Güther and Ferguson, 1995), indicating that different
enzymes are involved in acylation and deacylation. By exploiting the sensitivity of the
trypanosome GPI inositol deacylase (GPIdeAc) to DFP, this enzyme was affinity-labeled
and purified (Güther et al., 2001). The affinity-purified HA-tagged DFP-binding protein was
shown to have inositol deacylase activity. However, GPIdeAc-/- trypanosomes showed only
reduced inositol deacylase activity, suggesting that there is another GPIdeAc i n
trypanosomes. GPIdeAc shows homology to acyloxyacyl hydrolase, a mammalian lipase.
Interestingly, there are no other obvious GPIdeAc homologues in the database, suggesting
that this enzyme is unique to trypanosomes and that the other inositol deacylase(s) will be
common to other organisms (Güther et al., 2001).
Intracellular transport of GPI-anchored proteins
The intracellular transport of GPI-anchored proteins has recently been reviewed (Muniz
and Riezman, 2000). The GPI anchor is added to newly synthesized proteins in the lumen
of the ER, and GPI-anchored proteins are then transported along the secretory pathway to
the cell surface. Like other secretory proteins, the ER to Golgi transport of the GPI-
anchored protein Gas1p is dependent on genes specifically required for vesicular transport
(Conzelmann et al., 1990). Protein transport from the ER to the Golgi is mediated by COPII
vesicles (reviewed in Barlowe, 1998), but COPI-coated vesicles might also me involved in
forward transport from the ER to the Golgi apparatus (reviewed in Cosson and Letourneur,
1997). Components of the COPII coat assemble at the site of vesicle formation and induce
the membrane to form a bud. Selective incorporation of cargo proteins into vesicles is
driven by the interaction between the cargo receptors and COPII components. GPI-
anchored proteins are lumenal, having the lipid part inserted in the lumenal leaflet of the
ER membrane, and therefore unable to directly interact with the COPII coat on the
cytosolic face of the ER membrane. p24 proteins are a large family of type I
transmembrane proteins that are conserved from yeast to mammals and are found in COPI
and COPII vesicles in addition to ER and Golgi membranes (Schimmöller et al., 1995;
Stamnes et al., 1995; Belden and Barlowe, 1996; Sohn et al., 1996; Dominguez et al.,
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1998). The exact role of the p24 family proteins is not clear, but because of their
conservation through evolution, their abundance and the fact that they shuttle in transport
vesicles between the ER and the Golgi compartments, these proteins might act as cargo
receptors (Muniz et al., 2000). Saccharomyces cerevisiae has eight p24 homologs,
EMP24, ERV25 and ERP1 to ERP6 (Schimmöller et al., 1995; Belden and Barlowe, 1996;
Marzioch et al., 1999). Deletion of EMP24 or ERV25 leads to a delay in the ER to Golgi
transport of the GPI-anchored protein Gas1p and of the soluble, secreted protein invertase.
In contrast, carboxypeptidase Y (CPY) and pro-alpha factor are secreted at wild-type rates,
suggesting that Emp24p and Erv25p are candidate receptors or adaptors for Gas1p and
invertase (Schimmöller et al., 1995; Belden and Barlowe, 1996), providing evidence for the
existence of transmembrane adaptors that connect the lumenal GPI-anchored proteins with
the cytosolic COPII coat components. Recently, it was shown that Emp24p is directly
required for efficient incorporation of Gas1p into ER-derived vesicles in vitro, providing
further evidence that Emp24p acts as a cargo receptor (Muniz et al., 2000). In this study,
Emp24p and Erv25p could be directly crosslinked to Gas1p in ER-derived vesicles.
However, another recent study has shown that Gas1p does not depend exclusively on p24
proteins for its exit from the ER (Springer et al., 2000). According to this study, the p24
proteins are not essential cargo receptors in Saccharomyces cerevisiae, since a strain
deleted for all eight p24 proteins (p24∆8) is viable. This result suggests that if p24 proteins
are cargo receptors, transport of their cognate cargo can be achieved by different means,
e.g. by using other receptors or by bulk flow.
It was recently shown that GPI-anchored proteins are segregated from other cargo proteins
during ER export (Muniz et al., 2001). Primary ER-derived vesicles were either
immunoisolated or separated by centrifugation on sucrose gradients, and contents were
analyzed. The GPI-anchored proteins Gas1p and Yps1p/Yap3p were largely excluded from
vesicles that contained other secretory proteins such as the vacuolar alkaline phosphatase
(ALP) and the plasma-membrane resident amino acid permease Gap1p, suggesting that
GPI-anchored proteins are sorted from other proteins at the exit from the ER. This finding
could explain previous observations concerning specific requirements for the transport of
GPI-anchored proteins, described below.
An interesting feature of the ER to Golgi transport of GPI-anchored proteins is the
requirement for Ret1p, the alpha-subunit of the COPI coat (Sütterlin et al., 1997a). In ret1-1
mutant cells, GPI anchoring is normal, but the ER to Golgi transport of the GPI-anchored
proteins Gas1p and Yap3p/Yps1p is defective, whereas other secretory proteins are
transported with wild-type kinetics. Incorporation of ceramide into proteins was normal in
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ret1-1 mutant cells, but the authors have not specifically tested at which stage this lipid
remodeling occurred. COPI is involved in retrieval of proteins from the Golgi apparatus to
the ER (Letourneur et al., 1994), and might thus be required for recycling of a protein that
is required for sorting, budding or fusion of vesicles containing GPI-anchored proteins.
However, since COPI vesicles can bud from the ER (Bednarek et al., 1995), the
requirement for COPI could also mean that GPI-anchored proteins are transported to the
Golgi in COPI vesicles, whereas other secretory proteins use COPII vesicles (discussed in
Muniz et al. (2001).
Sphingolipids are specifically required for the transport of GPI-anchored proteins from the
ER to the Golgi (Horvath et al., 1994; Skrzypek et al., 1997; Sütterlin et al., 1997a),
reviewed by Dickson, (1998). When sphingolipid biosynthesis is reduced either
pharmacologically or genetically, the transport of Gas1p from the ER to the Golgi is
delayed. A screen for compounds that inhibit GPI anchoring or transport of GPI-anchored
proteins was performed based on the different electrophoretic mobilities of the immature
and the mature forms of Gas1p, and identified a fungal metabolite, myriocin (Horvath et al.,
1994). Myriocin inhibits serine:palmitoyl CoA transferase, the key enzyme in ceramide
biosynthesis. Gas1p is GPI-anchored in yeast cells treated with myriocin, but its maturation
from the 105 kD to the 125 kD form is slowed down. The same delay in Gas1p transport is
also observed in lcb1-100 mutant cells that are defective in ceramide biosynthesis
(Sütterlin et al., 1997a), strenghtening the importance of ceramide synthesis for transport of
GPI-anchored proteins to the Golgi. The two structurally related proteins Lag1p and
Lac1p/Dgt1p have recently been shown to be involved in the transport of GPI-anchored
proteins, since cells disrupted for both LAG1 and LAC1/DGT1 show a delay in Gas1p ans
Yap3p maturation (Barz and Walter, 1999). A subsequent study has shown that cells
disrupted for both LAG1 and LAC1 lack ceramide synthase activity, suggesting that Lag1p
and Lac1p either encode the catalytic subunit of ceramide synthase or are obligatory
activators for the ceramide synthase in Saccharomyces cerevisiae (Guillas et al., 2001).
The observed delay in ER to Golgi transport of Gas1p and Yap3p is therefore likely to be a
consequence of the defect in ceramide biosynthesis in lag1∆lac1∆ cells.
Lipids and proteins are organized into distinct domains within the plasma membrane.
Sphingolipids and cholesterol form lateral assemblies and associate with specific proteins
while excluding others (reviewed in Simons and Ikonen, 1997; Hooper, 1999; Kurzchalia
and Parton, 1999; Brown and London, 2000). These domains, known as rafts, can be
isolated from most mammalian cells as membrane fragments that are insoluble in non-ionic
detergents (DRMs (detergent-resistant membranes); also termed DIGs (detergent-
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insoluble glycolipid-enriched membranes), GEMs (glycolipid-enriched membranes), and
TIFF (Triton-insoluble floating fraction)) (Brown and Rose, 1992). Multiple GPI-anchored
proteins are insoluble in certain non-ionic detergents such as Triton X-100 (Hooper and
Turner, 1988), and it was shown that in Madin-Darby canine kidney (MDCK) cells, the GPI-
anchored protein alkaline phosphatase became detergent-insoluble only after its transport
to the Golgi apparatus (Brown and Rose, 1992). This finding provided support for the
formation of lipid rafts in the Golgi apparatus in mammalian cells, where sphingolipids are
synthesized (Simons and Ikonen, 1997). Figure 1-5 shows a model for lipid rafts.
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GPI-anchored protein non-raft lipid non-raft 
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Figure 1-5. Lipid raft.
Adapted from Brown and London (2000).
A possible explanation for the ceramide requirement for the ER to Golgi transport of GPI-
anchored proteins could be that ceramide microdomains form in the ER and recruit
specifically GPI-anchored proteins. The physical properties of the GPI anchor could act as
a signal for GPI-anchored proteins to enter the ceramide microdomains. Consistent with
this idea, GPI anchor attachment was shown to be necessary for the exit of Gas1p from the
ER in COPII vesicles (Doering and Schekman, 1996), and recently, detergent-insoluble
glycolipid-enriched complexes (DIGs) have been detected in the yeast ER (Bagnat et al.,
2000). The presence of these DIGs in the ER suggests that in contrast to what has been
shown for mammalian cells, lipid rafts can be formed already in the ER in yeast. Therefore,
partitioning of GPI-anchored proteins into lipid rafts might be required for packaging into
COPII vesicles. COPII vesicles could thus incorporate either a patch of non-raft ER
membrane containing standard cargo proteins, or a raft subdomain containing GPI-
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anchored proteins, allowing the production of distinct vesicles from a single COPII
machinery, as shown in Figure 1-6 (discussed in Glick, 2001). In this scenario, COPI
vesicles might be required for transport of sphingolipids from their site of synthesis, the
Golgi apparatus, to the ER.
ER lumen
cytosol
COPII coat
non-raft membrane
 lipid raft 
cargo 
receptor
transmembrane
protein
soluble
cargo
GPI-anchored
protein
Figure 1-6. Transport of GPI-anchored proteins from the ER.
Adapted from Glick (2001).
Fate of GPI-anchored proteins
In yeast, GPI-anchored proteins are also transported to the external leaflet of the plasma
membrane, but some of them are further processed and become incorporated into the cell
wall (Lu et al., 1994; Lu et al., 1995), reviewed in Lipke and Ovalle (1998) and Kapteyn et
al. (1999). GPI-anchored proteins that remain on the plasma membrane have a dibasic
motif just N-terminal to the GPI-attachment site (ω), whereas proteins destined for the cell
wall have valine, isoleucine or leucine at ω-4 or ω-5 positions, and tyrosine or asparagine
at position ω-2 (Hamada et al., 1999). For incorporation into the cell wall, the GPI anchor is
trimmed, and lacks at least the phospholipid moietey. The glycan part of the GPI-remnant
was shown to be bound to cell wall β1,6-glucans (Kapteyn et al., 1996; Van Der Vaart et
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al., 1996). Analysis of the glucan-binding sugar chain of Tip1p, a GPI-protein that gets
incorporated into the cell wall, suggests that a mannose reducing end of the GPI moiety is
used for binding to cell wall glucan (Fujii et al., 1999), consistent with previous findings that
the GPI anchor of cell wall proteins is cleaved between mannose and glucosamine
(Kapteyn et al., 1996; Kollar et al., 1997). However, the nature of the linkage between the
GPI remnant and the glucan, as well as the number of mannose residues present in the
GPI remnant of Tip1p, have not been established (Fujii et al., 1999). The data of Kollar et
al. (1997) indicate that the GPI remnant consists of ethanolaminephosphate-Man5. Another
study however has found some N-acetylglucosamine bound to cell wall proteins,
suggesting that the cleavage is between glucosamine and inositol (Montijn et al., 1994).
Additional studies will be required to identify the precise structure of the glucan-binding
sugar chain. Figure 1-7 shows the structure of the yeast cell wall.
protein PO4-
GPI remnant
β1,6-glucan
β1,3-glucan
chitin
A                                                  B
N-glycans
O-glycans
β1,6-glucan
β1,3-glucanchitin
GPI remnant
Figure 1-7. Cell wall.
A) How GPI-anchored proteins are bound to the cell wall. B) Cell wall lattice. From Lipke
and Ovalle (1998).
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In mammalian cells, GPI-anchored proteins attached to the cell surface can undergo
internalization by endocytosis or enzymatically be released to the extracellular medium
(reviewed by Nosjean, 1997). In yeast, the GPI-anchored plasma membrane protein Gce1p
can be released by a endogenous (G)PI-specific phospholipase C when cells are
transferred from media containing a non-fermentable carbon source to glucose medium
(Müller and Bandlow, 1993). Gce1p is subsequently further processed and gets
incorporated into the cell wall (Müller et al., 1996). This high-molecular-weight form of
Gce1p lacks inositol and ethanolamine, suggesting that this protein is linked to the cell wall
differently from other GPI-anchored proteins.
Deficiencies in GPI anchoring
Saccharomyces cerevisiae mutants deficient in the GPI biosynthetic pathway are a
convenient tool to identify genes involved in GPI anchoring (Leidich et al., 1994; Benghezal
et al., 1995). GPI anchoring is essential for yeast viability, since mutations in genes
required for biosynthesis of the GPI core or transfer to the protein are lethal. Restriction of
GPI synthesis causes hypersensitivity to calcofluor white, a cell wall perturbing agent, and
aberrant cell wall biogenesis (Vossen et al., 1997).
In mammalian cells, mutation of the P I G - A gene causes paroxysmal nocturnal
haemoglobinuria (PNH), an acquired clonal blood disease (Kinoshita et al., 1997, and
references therein). Intravascular hemolysis caused by the patients own complement is a
major clinical symptom of PNH. Somatic mutation of PIG-A in a hematopoietic stem cell
leads to a lack of GPI-anchored proteins. PIG-A is an X-linked gene (Takeda et al., 1993),
and since there is only a single functional X-chromosome in both male and female somatic
cells, mutations affecting GPI biosynthesis are more likely found in PIG-A than in any
autosomal GPI biosynthetic gene. In mice, targeted disruption of PIG-A is lethal during
embryonic development, indicating that the total absence of GPI-anchored proteins causes
a lethal effect (Kawagoe et al., 1996).
In parasitic protozoa, GPI-anchored glycoproteins and glycosylated PIs are abundant cell
surface constituents (reviewed by Tiede et al., 1999). In humans, such parasites can cause
important diseases, such as sleeping sickness and malaria. GPI-anchored cell surface
molecules play a major role in parasite infectivity and survival, and therefore the inhibition
of GPI pathways might attenuate pathogenicity and viability of these organisms. It is hoped
that differences in properties of GPI biosynthetic enzymes in different species can be
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exploited for drug design. Indeed, a GlcNAc-PI analogue containing 2-O-octyl-D-myo-
inositol or the GlcNAc-PI diastereoisomer containing L-myo-inositol (GlcNAc-P(L)I) are
substrates for the trypanosomal De-N-acetylase, but not for the HeLa enzyme, suggesting
that selective inhibition of the trypanosomal de-N-acetylase may be possible and that this
enzyme should therefore be considered as a possible therapeutic target (Sharma et al.,
1999).
Aim of the Thesis Work
Side chain modification of GPI anchors with EthN-P has been described for several years
in mammalian cells, but not in parasites. In Saccharomyces cerevisiae, similar side chain
modifications were only recently found to occur (Canivenc-Gansel et al., 1998; Sütterlin et
al., 1998; Benachour et al., 1999). In 1998, at the beginning of this thesis, there were no
reports on the genes involved in the transfer of EthN-P in the literature. In our laboratory,
studies with the gpi7 mutant have shown that the corresponding protein, Gpi7p, might be
involved in the addition of a HF-sensitive side-chain to Man2 of the GPI core, since this
mutant lacked a HF-sensitive side chain on Man2 in comparison to the complete precursor
glycolipid CP2. It was tempting to speculate that the proteins encoded by GPI7 and its two
yeast homologues, YLL031c and MCD4, might play a role in the transfer of EthN-P to the
GPI core.
The work reported in this thesis is a characterization of the enzymes involved in EthN-P
transfer to the GPI precursor in Saccharomyces cerevisiae.
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2. Role of GPI13/YLL031c in GPI biosynthesis
Summary
GPI anchors serve to attach certain secretory proteins to the outer leaflet of the plasma
membrane. The biosynthesis of the GPI anchor and its transfer to proteins is highly
conserved in eukaryotes. In the yeast Saccharomyces cerevisiae, the genes GPI7 and
MCD4 have been shown to be involved in GPI anchor biosynthesis. This thesis work had
as main objective the characterization of YLL031c/GPI13, a yeast open reading frame
predicting a further homologue of GPI7 and MCD4. During this work, we have shown that
YLL031c/GPI13 encodes an essential membrane protein that is involved in GPI anchoring.
Cells depleted of Yll031c-protein (Gpi13p) accumulated two GPI intermediates, both
lacking EthN-P on Man3, suggesting that Gpi13p transfers the bridging EthN-P onto the
GPI core. Consistent with a role for Gpi13p in GPI anchoring, a reduction of GPI anchor
addition to proteins and cell wall fragility was observed in yeast cells depleted of Gpi13p. A
tagged form of Gpi13p was functional and shown to be localized in the ER.
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MCD4 and GPI7 are important for the addition of gly-
cosylphosphatidylinositol (GPI) anchors to proteins in
the yeast Saccharomyces cerevisiae. Mutations in these
genes lead to a reduction of GPI anchoring and cell wall
fragility. Gpi7 mutants accumulate a GPI lipid interme-
diate of the structure Mana1–2[NH2-(CH2)2-PO43]Man-
a1–2Mana1– 6[NH2-(CH2)2-PO43]Mana1– 4GlcNa1– 6
[acyl3]inositol-PO4-lipid, which, in comparison with
the complete GPI precursor lipid CP2, lacks an HF-sen-
sitive side chain on the a1–6-linked mannose. In con-
trast, mcd4–174 accumulates only minor amounts of ab-
normal GPI intermediates. Here we investigate whether
YLL031c, an open reading frame predicting a further
homologue of GPI7 and MCD4, plays any role in GPI
anchoring. YLL031c is an essential gene. Its depletion
results in a reduction of GPI anchor addition to GPI
proteins as well as to cell wall fragility. YLL031c-de-
pleted cells accumulate GPI intermediates with the
structures Mana1–2Mana1–2Mana1– 6[NH2-(CH2)2-
PO43]Mana1–4GlcNa1–6[acyl3]inositol-PO4-lipid and
Mana1–2Mana1–2Mana1– 6Mana1– 4GlcNa1– 6[acyl3]
inositol-PO4-lipid. Subcellular localization studies of a
tagged version of YLL031c suggest that this protein is
mainly in the ER, in contrast to Gpi7p, which is found at
the cell surface. The data are compatible with the idea
that YLL031c transfers the ethanolaminephosphate to the
inner a1–2-linked mannose, i.e. the group that links the
GPI lipid anchor to proteins, whereas Mcd4p and Gpi7p
transfer ethanolaminephosphate onto the a1–4- and a1–
6-linked mannoses of the GPI anchor, respectively.
The structural analysis of GPI1 anchors revealed that differ-
ent organisms add different side chains to the universally
conserved Mana1–2[NH2-(CH2)2-PO43]Mana1–2Mana1–
6Mana1–4GlcNa1–6inositol-PO4-lipid core structure (Fig. 1)
(1). In particular, human and all other mammalian cells invari-
ably add an EtN-P group onto Man1 (Fig. 1), and in a few cases
they also add an EtN-P group to Man2 (for a review, see Ref. 2).
Although no EtN-P side chains had been found in a study of a
pool of protein-derived GPI anchors of Saccharomyces cerevi-
siae (3), it recently was shown that the GPI intermediate M2*
accumulating in a gpi10 mutant has the structure Mana1–
6[NH2-(CH2)2-PO43]Mana1–4GlcNa1–6[acyl3]inositol-PO4-
lipid (4). Moreover, the complete GPI anchor precursor lipid
CP2 that can be observed in mutants such as pmi40 or in
transamidase mutants (5–7) contains phosphodiester-linked
side chains on both Man1 and Man2 (4, 8). This suggests that
the side chains on Man1 and Man2 may have been invented
before the separation of the lineages leading to present day
yeast and mammals. Recent studies have implicated MCD4
and GPI7 in the transfer of EtN-P groups onto GPI structures
in yeast. MCD4 is essential, and mcd4–174 cells show an
almost complete defect in GPI anchor addition to proteins at
the restrictive temperature (9, 10). Deletion of PIG-N, a mam-
malian homologue of MCD4, leads to a reduced surface expres-
sion of GPI proteins and loss of an enzyme activity that adds
EtN-P to Man1 (11). GPI7 is not essential, but its deletion
slows the GPI anchor addition to newly synthesized proteins,
produces cell wall fragility, and blocks biosynthesis of GPI
lipids at a premature stage. Of the several abnormal GPI lipids
accumulating in Dgpi7 cells, even the most complete one lacks
the phosphodiester-linked substituent on Man2, a finding that
relates GPI7 to the addition of a side chain to Man2 (8). The
idea that MCD4, GPI7, and their homologue YLL031c may all
be involved in the transfer of EtN-P groups has been fostered
by their pronounced homology with bacterial, viral, plant, and
mammalian phosphodiesterases, phosphatases, and pyrophos-
phatases (8, 10).
Here we investigate whether YLL031c plays any role in GPI
biosynthesis and, specifically, in the addition of EtN-P- groups
to GPI structures.
EXPERIMENTAL PROCEDURES
Strains, Growth Conditions, and Materials—S. cerevisiae strains
were FBY413 (MATa ura3–52 leu2-D1 trp1-D63 his3-D200), FBY1102
(MATa ura3–52 leu2-D1 trp1-D63 his3-D200 yll031c::HIS3-pGAL1,
10-YLL031c), FCEN010a (MATa ura3–52 trp1-D63 his3-D200
YNR019w::KanMX4), FBY1103 (MATa ura3–52 trp1-D63 his3-D200
yll031c::HIS3-pGAL1,10-YLL031c YNR019w::KanMX4), FBY1104
(MATa ura3–52 trp1-D63 his3-D200 mcd4::HIS3-pGAL1,10-MCD4
YNR019w::KanMX4), FBY182 (MATa ade2–1 ura3–1 leu2–3,112
his3–11,15 gpi7::KanMX4), FBY1106 (MATa yll031c::HIS3-pGAL1,
10-YLL031c gpi7::KanMX4 leu2 ura3 his3), FY1679 (MATa/a ura3–
52/ura3–52 leu2-D1/1 trp1-D63/1 his3-D200/1), FBY1105
(MATa/a ura3–52/ura3–52 leu2-D1/1 trp1-D63/1 his3-D200/1
YLL031c::KanMX4/YLL031c), FBY1107 (MATa ura3–52 leu2-D1 trp1-
D63 his3-D200 yll031c::YLL031c-13Myc-KanMX6), FBY122 (MATa
ade2–1 ura3–1 leu2–3,112 his3–11,15 trp1–1 gpi8–1 gpi7–1), FBY169
(MATa ade2–1 can1–100 ura3–1 leu2–3,112 his3–11,15 trp1–1 gpi10–
1), and HMSF176 (MATa sec18–1). Maintenance and growth conditions
have been described (7). CFW-containing plates were made as described
(12), with the exception that a 100 mg/ml filter-sterilized CFW stock
solution was used.
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Materials were obtained from the sources described recently (4).
Oligonucleotides were from Microsynth GmBH (Balgach, Switzerland),
Quantazyme ylg from Quantum Biotechnologies Inc. (Montreal, Cana-
da), Calcofluor White (CFW) from Sigma, and antibodies to carboxypep-
tidase Y from Molecular Probes, Inc. (Eugene, OR). Rabbit antibodies to
Yap3p and Cwp1p were kindly donated by Dr. Y. Bourbonnais (Univer-
site´ Laval, Que´bec, Canada) and Dr. H. Shimoi (National Institute of
Brewing, Higashihiroshima, Japan), respectively. Rabbit antibodies to
Och1p and Wbp1p were gifts from Dr. Y. Jigami (National Institute of
Bioscience and Human Technology, Ibarasaki, Japan) and Dr. M. Aebi
(Mikrobiologisches Institut, ETH Zu¨rich, Switzerland), respectively. A
mouse monoclonal anti-Myc antibody, clone 9E10, was obtained from
Babco (Richmond, CA), and goat anti-mouse IgG-peroxidase conjugate
was from Sigma.
Conditional Expression of YLL031c and MCD4—Conditional expres-
sion of YLL031c was achieved by the insertion of the GAL1,10 promoter
in front of the chromosomal YLL031c gene as described (13). Briefly, the
HIS3 marker flanked by the GAL1,10 promoter was PCR-amplified
using pTL26 as template and the following two adapter primers:
031GalFor (59-AAGATCAAAAAAGGAATAGAAGCATATGTTTTAAG-
GGCAACGCCGctcttggcctcctctag-39) with 17 nt of homology to the
pTL26 vector (lowercase) and 45 nt of homology to a 59-flanking sequ-
ence of YLL031c (uppercase) and oligonucleotide 031GalRev (59-AAG-
AATCGACTTTTTAATTGTCTTTTCATCCATATTACGGGAGCTcgaat-
tccttgaattttcaaa-39) with 45 nt of homology to the 59-end of YLL031c
ending 12 nt upstream of the start codon (boldface type) and 21 nt of
homology to the pTL26 vector (lowercase type). This PCR-generated
DNA fragment was used to transform the strains FCEN010a and
FBY413, yielding FBY1103 and FBY1102, respectively. Correct target-
ing of the inserted promoter was verified by whole yeast cell PCR (14),
using primers A3Gal (59-gagcagttaagcgtattactg-39) and 031A4 (59-cat-
caatgaaagtcggtaagg-39) yielding a 0.7-kilobase pair DNA fragment.
The genomic MCD4 was placed under the control of the GAL1,10
promoter by the same strategy as described above for YLL031c, using
the following two adapter primers for PCR amplification from the
pTL26 as the template: 165GalFor (59-GAACCGTTCTTTACTATATAT-
TCAACAACCCATCTTCGACCAAAGctcttggcctcctctag-39) with 17 nt of
homology to the pTL26 vector (lowercase type) and 45 nt of homology to
the MCD4 flanking sequence (uppercase type) and oligonucleotide
165GalRev (59-GACACCAACAGCCAGAAGCGTCGTTCTGGTTTTGT-
TCCACATTTTcgaattccttgaattttcaaa-39) with 45 nt of homology to
MCD4 ending 3 nt upstream of the start codon (boldface type) and 21 nt
of homology to the pTL26 vector (lowercase type). This PCR-generated
DNA fragment was used to transform the strain FCEN010a. Correct
targeting of the HIS3-marked GAL1,10 promoter was verified by whole
yeast cell PCR using primers A3Gal (59-gagcagttaagcgtattactg-39) and
165A4 (59-agcaatcatagcaacatgacc-39) yielding a 0.5-kilobase pair DNA
fragment.
Disruption of YLL031c—For deletion of YLL031c, a short flanking
homology (SFH) replacement cassette was synthesized by PCR ampli-
fication of the KanMX4 module of pFA6a-KanMX4 (15) with the follow-
ing primers: primer 031-S1 (59-GATGAAAAAATAATATACAAATCGC-
GAATAAAGAAATTTCAAcgtacgctgcaggtcgac-39) with 42-nt homology
to amino acids 16–29 of YLL031c and 18-nt homology to the KanMX4
module (lowercase type) and primer 031-S2 (59- TATAGTATATTTGT-
AAGTAAAGAGTGGAAATGAAGTTCGTCATTatcgatgaattcgagctcg-39)
with 19 nt of homology to the KanMX4 module (lowercase type) and 44
nt of homology to a sequence near the 39 end of YLL031c (uppercase
type) comprising the stop codon (boldface type). Since gene replacement
with this SFH cassette proved to be difficult, the SFH cassette was used
as a template to construct a long flanking homology cassette. This long
flanking homology replacement cassette was synthesized as described
(16). In a first step, the primer pair K1 (59-CATGGTACAATTGCAAA-
GT-39) and L2 (59-TTGAAATTTCTTTATTCGCGATTTGTATATTAT-39)
as well as the primer pair L3 (59- AATGACGAACTTCATTTCCACTC-
TTTACTTACAAATATAC-39) and A4 (59-GCTGCAGAAAAGAGATGC-
39) were used to amplify two fragments of genomic DNA corresponding
to the promoter region including the first 29 codons of the open reading
frame and the terminator region, respectively. The 59-parts of primers
L2 and L3 were designed to anneal, respectively, to the 59- and 39-ends
of the SFH replacement cassette, which are homologous to YLL031c. In
the second step, a PCR was performed using the SFH cassette as
template and the two PCR-generated fragments from the first step as
primers, yielding a replacement cassette with long flanking regions
having homology to the YLL031c gene. The long flanking homology
cassette was used to transform the diploid WT strain FY1679, homozy-
gous for YLL031c. The correct targeting of the KanMX4 replacement
cassette to the YLL031c locus was verified by whole yeast cell PCR
using primer K1, primer 031-A5 (59-catcaatgaaagtcggtaagg-39) anneal-
ing inside the YLL031c coding sequence, and the K2 primer of the
KanMX4 module (59-gtcgcacctgattgcccg-39), yielding a 900-bp DNA
fragment for the disrupted gene and a 748-bp DNA fragment for the WT
YLL031c gene.
Tagging of YLL031c—A Myc tag was inserted at the C terminus of
the genomic copy of YLL031c by homologous recombination with an
insertion cassette containing the Myc tag and the selectable KanMX6
marker as described (17). The insertion cassette was obtained by using
plasmid pFA6a-13Myc-kanMX6 (17) as template and the oligonucleo-
tides F2 and R1 as target gene-specific primers (F2, 59-AGTGGGAGA-
TTGATTAAGCACATAAATGACATTTTTTGGAAAcggatccccgggttaatt-
aa-39, with 20-nt homology to the pFA6a-13Myc-kanMX6 sequence
(lowercase type) and 42-nt homology to the sequence of YLL031c im-
mediately upstream of the stop codon (uppercase type), including the
codon of the last amino acid (boldface type); R1, 59-ATATATAGTATA-
TTTGTAAGTAAAGAGTGGAAATGAAGTTCGgaattcgagctcgtttaaac-39
with 42-nt homology to the genomic sequence of YLL031c immediately
downstream of the stop codon (uppercase) and 20-nt homology to the
pFA6a-13Myc-kanMX6 plasmid sequence). This PCR fragment was
used to transform the WT strain FBY413, yielding FBY1107. The cor-
rect targeting of the PCR-made module was verified by whole yeast cell
PCR using the primer K2 of the kanMX module and oligonucleotide
C1-Myc (59-CTGACACTGTGGTCACAGCC-39), producing a 1577-nt
fragment.
Cellular Localization and Protease Sensitivity of YLL031c-Myc Pro-
tein—The subcellular localization of YLL031c-Myc was determined es-
sentially as described (18). Briefly, 100 optical density units of expo-
nentially growing FBY1107 cells were washed with 10 mM NaN3 and
converted to spheroplasts by incubation for 1 h at 30 °C with Quan-
tazyme in 1.4 M sorbitol, 10 mM NaN3, 50 mM K2HPO4, pH 7.5, 40 mM
2-mercaptoethanol. Spheroplasts were resuspended in lysis buffer (20
mM HEPES-KOH, pH 6.8, 150 mM potassium acetate, 250 mM sorbitol,
1 mM magnesium acetate, 20 mg/ml phenylmethylsulfonyl fluoride, 5
mg/ml antipain, 0.5 mg/ml leupeptin, 0.7 mg/ml pepstatin) and homoge-
nized by 20 strokes in a Dounce homogenizer. The crude lysate was
centrifuged twice at 1000 3 g for 5 min to remove unlysed spheroplasts.
The cleared supernatant was then centrifuged at 13,000 3 g for 15 min
to generate pellet P13 and supernatant S13. S13 was centrifuged at
100,000 3 g for 60 min in a Sorvall AH-650 swing out rotor to generate
pellet P100 and supernatant S100. Pellet fractions were dissolved and
denatured in high urea buffer (8 M urea, 5% SDS, 200 mM Tris-HCl, pH
6.8, 20 mM EDTA, bromphenol blue, 15 mg/ml dithiothreitol) by soni-
cation and incubation at 95 °C for 5 min. The S100 fraction was trichlo-
roacetic acid-precipitated before denaturation in high urea buffer.
For probing the surface exposure of YLL031c-Myc, exponentially
growing FBY1107 cells were converted to spheroplasts as described
above but using zymolyase-20T. Spheroplasts were either mock-treated
or treated with proteinase K in the presence or absence of 0.5% Triton
X-100 for 30 min on ice. Phenylmethylsulfonyl fluoride was then added
to a final concentration of 4 mM, and samples were kept on ice for 15
min. Finally, spheroplasts were placed on a cushion of 1.5 M sorbitol, 50
mM K2HPO4, pH 7.5, 20 mM EDTA, 10 mM NaN3, 10 mM NaF and were
centrifuged. YLL031c protease sensitivity in microsomes was examined
by protease K digestion essentially as described (8), except that the
membrane pellet was resuspended in 600 ml of lysis buffer before
protease digestions. All samples were denatured during 5 min at 95 °C
in reducing sample buffer containing 20 mM EDTA and analyzed by
SDS-polyacrylamide gel electrophoresis in 6–10% gels (19) followed by
Western blotting.
Miscellaneous Methods—Western blots were revealed using the
chemiluminescence ECL kit from Amersham Pharmacia Biotech.
FIG. 1. Presumed structure of the complete yeast precursor
glycolipid CP2. Relevant cleavage procedures are indicated. Man1,
Man2, Man3, and Man4 are used here to designate the a1–4-linked,
a1–6-linked, and a1–2-linked mannoses, respectively. X indicates an
HF-sensitive group that is not yet defined chemically. R, alkyl; P,
phosphate.
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Previously described procedures were used to label cells with
[2-3H]Ins and for lipid extraction (20).
In vitro biosynthesis of GPIs with microsomes was performed as
described previously (4), with the exception that spheroplasts were
sometimes prepared using Quantazyme ylg instead of zymolyase-20T.
Desalted lipid extracts were analyzed by ascending TLC using solvent
1 (CHCl3/CH3OH/H2O, 10:10:3, v/v/v) or solvent 2 (chloroform/metha-
nol/0.25% KCl, v/v/v). Radioactivity was detected and quantitated by
two-dimensional radioscanning (LB 2842; Berthold AG, Regensdorf,
Switzerland). Thereafter, TLC plates were sprayed with EN3HANCE
and exposed to film (X-Omat; Eastman Kodak Co.) at 280 °C.
Soluble head groups were obtained from purified radiolabeled glyco-
lipids through limiting methanolic NH3 deacylation (21) followed by
PI-PLC treatment, for which the lipid extracts were dissolved in 20 mM
Tris-HCl, pH 7.5, 0.2 mM EDTA, 20% 1-propanol. Incubations with
PI-PLC were for 16 h at 37 °C. Nonhydrolyzed GPIs were removed by
butanol extraction. The water-soluble head groups were treated with
JBAM (0.5 units) or A. satoi a-mannosidase (5 microunits) as described
(22). HF dephosphorylation was done as described (23). The generated
fragments were analyzed by paper chromatography in methylethylk-
etone/pyridine/H2O (20:12:11) as described (23). Before paper chroma-
tography the products were N-acetylated and desalted over mixed bed
ion exchange resin AG-501-X8 (Bio-Rad). Radiolabeled chromatography
standards were obtained as described (8).
RESULTS
Characterization of YLL031c—YLL031c was disrupted in a
diploid strain by the replacement of most of the open reading
frame by the KanMX4 kanamycin resistance gene. This dele-
tion strain was constructed because in the YLL031c deletion
strain produced in the EUROFAN project, part of YLL030c has
been deleted along with YLL031c (24). Sporulation and dissec-
tion of tetrads yielded in all cases two growing colonies per
tetrad. None of these colonies were kanamycin-resistant, indi-
cating that YLL031 is essential. A partial depletion of YLL031
was achieved by the insertion of the glucose-repressible
GAL1,10 promoter immediately upstream of the genomic
YLL031c. When such cells, growing in liquid culture, were
shifted from galactose to glucose, thus allowing for the partial
depletion of the YLL031c protein, their doubling time in-
creased, after 24 h, to 3.5 h, and cells thereafter continued to
grow at this rate, whereas WT cells grew on glucose with a
doubling time of 1.3 h. When the same experiment was done in
a Dgpi7 background, the doubling time of YLL031c-depleted
cells, after 24 h on glucose, had risen to 7.7 h, while Dgpi7
mutants grew as fast as WT cells. Thus, the deletion of GPI7
synthetically enhances the growth retardation caused by de-
pletion of YLL031c. The reduced growth rate of YLL031c-de-
pleted cells could also be observed on YPD plates, and this
effect was significantly enhanced by the presence of CFW at a
concentration that did not affect growth of WT cells but totally
blocked the growth of Dgpi7 cells (Fig. 2). This result indicates
that partial depletion of YLL031c leads to cell wall fragility, a
phenotype that is commonly observed in mutants affected in
the GPI biosynthesis pathway.
Depletion of YLL031c Leads to the Accumulation of Imma-
ture GPI Proteins—If Gas1p does not receive a GPI anchor in
the ER, it fails to be transported to the Golgi (25), because, as
shown by in vitro experiments using a vesicle budding assay,
nonanchored Gas1p is not packaged into COPII-coated trans-
port vesicles budding off the ER (26). Therefore, the character-
istic mass increase due to elongation of N- and O-glycans in the
Golgi does not take place, and the maturation of the immature
105-kDa ER form into the mature 125-kDa form is delayed.
GPI anchoring deficiencies also can lead to the relative deple-
tion of the mature forms of Gas1p and other GPI proteins (27).
Using Western blotting and antibodies to detect well charac-
terized GPI proteins, we could observe a significant depletion of
mature GPI proteins upon depletion of YLL031c. As can be
seen in Fig. 3, while in WT cells the carbon source affects the
amount of Gas1p only moderately, cells partially depleted of
YLL031c by growth on glucose contain much less of the mature
125-kDa form of Gas1p than cells grown on galactose. This
phenomenon is even more drastic when YLL031c depletion
occurs in a Dgpi7 background. Other GPI proteins such as
Yap3p and Cwp1p are also affected. Although the details of the
FIG. 2. Characterization of YLL031c. From cell suspensions con-
taining 2.5 3 107 cells/ml, we prepared sequential 1:10 dilutions. 3-ml
aliquots of the various dilutions were spotted on agar plates containing
either YPD medium (A) or YPD with 1.5 mg/ml of CFW (B). Plates were
photographed after 3 days at 30 °C. The amounts of YLL031c protein
and Gpi7p in the various strains are indicated on the right. 1, normal
or elevated due to induction of GAL1,10 promoter; 2, depleted due to
repression of GAL1,10 promoter; ø 5 non existent due to deletion of the
gene.
FIG. 3. Depletion of YLL031c leads to a depletion of mature
and accumulation or depletion of immature forms of GPI pro-
teins. Cells indicated at the top were grown for at least four generations
at 30 °C on either Gal or Glc except for sec18 cells, which were grown at
24 °C but were shifted to 37 °C 2 h before extraction. Exponentially
growing cells were lysed by boiling for 5 min in reducing sample buffer
and processed for SDS-polyacrylamide gel electrophoresis on 7.5 or 10%
gels (19) followed by Western blotting with antibodies against Gas1p,
Yap3p, Cwp1p, or carboxypeptidase Y (CPY). The expected amounts of
Gpi7p and YLL031c protein in these cells are indicated as in Fig. 2.
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biosynthesis of these proteins have not been reported and part
of their mature forms gets covalently attached to the cell wall,
the mass of their ER forms can be inferred form the peptides
accumulating in sec18, a mutant that blocks the protein traffic
from ER to Golgi at 37 °C (28, 29). YAP3 predicts a 60-kDa
translation product, but upon shift to 37 °C, sec18 cells rapidly
accumulate lower molecular weight forms (Fig. 3). Similar
forms also accumulate upon depletion of YLL031c, suggesting a
maturation defect of these proteins due to a delay in GPI
anchor addition. Cwp1p is a cell wall protein that can be
released as soluble 55–60-kDa protein by b-glucanase (30, 31).
There are also intracellular, detergent-soluble forms of Cwp1p
of 48 and 58 kDa, and these forms are drastically increased
when the secretory pathway is blocked for 2 h at 37 °C in sec18
(Fig. 3). In YLL031c-depleted cells, these detergent-soluble
forms are severely diminished. This also can be taken as evi-
dence for some disturbance of GPI protein maturation, al-
though in this case the protein does not seem to accumulate but
may be rapidly degraded. In contrast, YLL031c-depleted cells
do not accumulate the typical ER proform p1 of carboxypepti-
dase Y, a vacuolar hydrolase, nor do they show a thinning of
mature carboxypeptidase Y (Fig. 3). This suggests that the
maturation defect of YLL031c-depleted cells affects only GPI
proteins.
Depletion of YLL031c Leads to the Accumulation of Abnor-
mal GPI Lipids—When WT cells are metabolically labeled with
myo-[3H]inositol ([3H]Ins), their lipid extracts contain various
forms of labeled phosphatidylinositol and inositolphosphoryl-
ceramide, but the GPI intermediates remain undetectable. GPI
intermediates have, however, been found to accumulate in
several gpi mutants. As can be seen in Fig. 4, A and B,
YLL031c-depleted cells accumulate the abnormal lipids 031a
and 031b, which are present neither in WT nor in previously
described gpi mutants. Lipid 031a migrates quite differently
from M2*, the most polar lipid accumulating in gpi10–1, which
has the structure Mana1–6[NH2-(CH2)2-PO43]Mana1–
4GlcNa1–6[acyl3]Ins-PO4-lipid (Fig. 4B, lanes 3 and 4) (4).
The more polar lipid 031b has a lower RF than M2* but a higher
RF than M4, the GPI lipid that accumulates in Dgpi7 cells and
has the structure Mana1–2[NH2-(CH2)2-PO43]Mana1–2-
Mana1–6[NH2-(CH2)2-PO43]Mana1–4GlcNa1–6[acyl3]Ins-
PO4-lipid (Fig. 4A, lanes 3 and 4) (8). A block of GPI biosyn-
thesis can also be observed in vitro with YLL031c-depleted
microsomes. WT microsomes make the complete GPI precursor
CP2 irrespective of the carbon source on which cells have been
grown (Fig. 4C, lanes 8 and 9). In contrast, YLL031c-depleted
microsomes make considerably less CP2 but instead accumu-
late a less polar lipid that also has a higher RF than the M4
made by Dgpi7 microsomes (Fig. 4C, lanes 3, 4, 10, and 11).
This in vitro generated lipid comigrates with in vivo made 031b
(Fig. 4C, lanes 2 and 4).
031a and 031b are less polar than M4, suggesting that they
have smaller head groups and are earlier intermediates of GPI
biosynthesis than M4. It therefore is not unexpected that the
accumulation of 031b is epistatic to the accumulation of M4
both in vitro and in vivo. Indeed, the combination of Dgpi7 with
YLL031c depletion strongly reduces the accumulation of M4
and increases the accumulation of 031b (Fig. 4, A, lane 6, and
C, lanes 5 and 6). Since the depletion of YLL031c is only partial,
it is understandable that in vitro there still is residual biosyn-
thesis of CP2 or M4 in single or double mutants, respectively
(Fig. 4C, lanes 4, 6, and 11). The severely affected mcd4–174
mutant has been reported to accumulate only trace amounts of
abnormal [3H]Ins-labeled lipids (10). We find the same if
Mcd4p is depleted using the repressible GAL1,10 promoter
(Fig. 4A, lane 5).
Structural Characterization of Lipids 031a and 031b—
YLL031c-depleted cells were labeled with [3H]Ins, and lipids
031a and 031b were purified by preparative TLC. Their struc-
tural analysis yielded the following information. Both lipids are
effectively cleaved by GPI-specific phospholipase D, indicating
that they are GPIs. They are totally resistant to bacterial,
phosphatidylinositol-specific phospholipase C, suggesting that
they contain a protecting acyl group on the Ins. Their label
becomes entirely hydrophilic upon deacylation by mild alkaline
hydrolysis.
Analysis of the hydrophilic head group of lipid 031b indicates
that it contains a Man4-GlcN-Ins core structure (Fig. 5A), that
two or three of its mannoses can be removed by JBAM (Fig.
5C), whereas the same enzyme removes all four mannoses from
the HF dephosphorylated head group (Fig. 5D). If the HF-
treated core structure is treated with Aspergillus satoi a-man-
nosidase, a linkage-specific exo-a-mannosidase cleaving a1–2
bonds, one obtains Man2-GlcN-Ins (Fig. 5B). These data
strongly suggest that the bulk of lipid 031b has the structure
Mana1–2Mana1–2Mana1–6[NH2-(CH2)2-PO43]Mana1–4G-
lcNa1–6[acyl3]Ins-PO4-lipid. We infer that the substituent on
Man1 consists of EtN-P, because this substituent has been
demonstrated to be present on Man1 of M2* of the gpi10–1
mutant (4). The sensitivity of the in vitro made lipid 031b to
JBAM (Fig. 4C, lanes 11 and 12) is in agreement with the
FIG. 4. YLL031c-depleted cells accumulate at least two abnor-
mal GPI lipids. A and B, exponentially growing cells were radiolabeled
with [3H]Ins at 37 °C (4 mCi/1–2 3 107 cells), and desalted lipid extracts
were analyzed by TLC using solvent 1 (A) or solvent 2 (B) and fluorog-
raphy. C, for lanes 1 and 2, cells were labeled with [3H]Ins (I) and
processed as described for A. Lanes 3–14, microsomes were prepared
from exponentially growing cells and were incubated with 3 or 6 mCi of
UDP-[3H]GlcNAc (GN), GDP-Man, tunicamycin, CoA, and ATP for 1 h
at 30 °C (lanes 3–7) or 2 h at 30 °C (lanes 8–14) as described (4), and
lipid extracts were analyzed by TLC using solvent 1 and fluorography.
Extracts in lanes 12 and 14 were first treated with JBAM. FBY1102 and
FBY1106 were grown in medium containing either galactose (G) or
glucose (D). M(IP)2C, mannosyldiinositolphosphorylceramide. The
amounts of YLL031c activity and Gpi7p, Mcd4p, and gpi10 activity are
indicated as in Fig. 2.
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structure proposed above. A second, less prominent Man2-Glc-
NAc-Ins peak in Fig. 5C could not be reduced by increasing the
concentration of JBAM. This suggests the presence of a lipid
having the structure Mana1–2Mana1–2[NH2-(CH2)2-PO43]
Mana1–6Mana1–4GlcNa1–6[acyl3]Ins-PO4-lipid, which we
call 031b9 in the following. Based on its comigration with 031b
on TLC we assume that 031b9 also carries no more than one
EtN-P group.
Analysis of the hydrophilic head group of lipid 031a indicates
that it contains a Man4-GlcN-Ins core structure (Fig. 6A) and
that all of its four mannoses can be removed by JBAM not only
after but also before HF dephosphorylation (Fig. 6, C and B).
These data strongly suggest that lipid 031a has the structure
Mana1–2Mana1–2Mana1–6Mana1–4GlcNa1–
6[acyl3]inositol-PO4-lipid. Thus, the GPI structures accumu-
lating upon YLL031c depletion contain four mannoses and may
contain HF-sensitive side chains on Man1 or Man2 but lack
EtN-P on Man3 (Fig. 1).
Subcellular Localization of YLL031c—YLL031c predicts a
translation product of 116 kDa. To localize the YLL031c pro-
tein, the endogenous, chromosomally encoded gene was modi-
fied by the insertion of a Myc tag at its C terminus. This
YLL031c-Myc translation product (including the N-terminal
signal sequence) has a predicted molecular mass of 136 kDa.
The corresponding protein was detected in Western blots as a
major band at about 136 kDa plus a heterogeneously glycosy-
lated smear with another distinct band at about 300 kDa. The
cells containing the tagged YLL031c grew at the same rate as
WT cells and were completely resistant to CFW, indicating that
the tagged version of the protein is functional. As shown in Fig.
7B, when intact spheroplasts were treated with variable
amounts of zymolyase and proteinase K, YLL031c-Myc as well
as ER proteins such as Wbp1p and Gpi8p remained intact,
whereas Gas1p was strongly diminished, as expected for a
surface protein and as described before (8). Gpi7p could not be
detected on any blot in this experiment (not shown) because of
its previously reported susceptibility to zymolyase (8). When
spheroplasts were prepared with Quantazyme, both YLL031c
and Gpi7p were preserved, but Gpi7p was readily destroyed by
proteinase K, whereas YLL031c-Myc was completely resistant
(not shown). Thus, unlike Gpi7p, YLL031c-Myc does not reside
at the cell surface. Differential centrifugation of microsomes
indicated that YLL031c-Myc cofractions with ER markers
Wbp1p and Gpi8p, since it could be found mainly in P13, which
is enriched in ER and plasma membrane (Fig. 7A). Minor
amounts were present in P100, a fraction that is enriched in
FIG. 5. Analysis of the head group of lipid 031b using HF,
JBAM, and A. satoi a-mannosidase (ASAM). FBY1102 was labeled
with [3H]Ins at 30 °C, and lipid 031b was purified by two rounds of
preparative TLC and used to prepare head groups. Head groups were
subjected to the following sequential treatments. A, HF followed by
N-acetylation; B, HF followed by N-acetylation, desalting, and then A.
satoi a-mannosidase; C, JBAM followed by HF and then N-acetylation;
D, HF followed by desalting, then JBAM, and then N-acetylation. The
thus generated fragments were separated by paper chromatography,
and radioactivity contained in 1-cm-wide strips was determined
through scintillation counting. Standards 0–4 run on the same paper
are Manx-GlcNAc-Ins with x 5 0, 1, 2, 4.
FIG. 6. Analysis of the head group of lipid 031a using HF and
JBAM. FBY1102 cells were labeled with [3H]Ins at 30 °C, lipid 031a
was purified by two rounds of preparative TLC, and head groups were
prepared. Head groups were subjected to the following treatments. A,
HF followed by N-acetylation; B, JBAM followed by HF and then
N-acetylation; C, HF followed by desalting, JBAM, and then N-acety-
lation. The thus generated fragments were separated as in Fig. 5.
FIG. 7. Subcellular localization of YLL031c. A, FBY1107 cell ly-
sates were subjected to differential centrifugations at 13,000 and
100,000 3 g. These centrifugations generated pellet P13, which con-
tains ER, plasma, and vacuolar membranes, and pellet P100, which
contains Golgi membranes. The 100,000 3 g supernatant (S100) was
precipitated with trichloroacetic acid. B, FBY1107 cells were converted
to spheroplasts using various concentrations of zymolyase-20T and
then digested with proteinase K at the indicated concentrations. Lane 6
shows the reactivity of the anti-Myc antibody and secondary antibody
with an extract from FBY413 WT cells not harboring any Myc-tagged
proteins. This control extract was prepared as described in the legend to
Fig. 3. C, FBY1107 microsomes were sedimented at 13,000 3 g for 15
min, and the membrane pellet was thoroughly resuspended and di-
gested with the indicated amounts of proteinase K at 0 °C on ice for 20
min in the presence or absence of 0.5% Triton X-100. Samples were
processed for SDS-polyacrylamide gel electrophoresis and Western
blotting.
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the Golgi marker Och1p and is largely free of Gpi8p and Wbp1p
(Fig. 7). The existence of the 300-kDa form is indicative of
massive glycan elongation in the Golgi on part of YLL031c-
Myc. Since only little YLL031c-Myc is found in this organelle at
steady state, it may be that the protein is recirculating between
Golgi and ER as has been reported for other proteins such as
Emp47p, Sec12p, and Sed5p. When microsomes were incu-
bated with proteinase K, even low concentrations of protease
(10 mg/ml) readily destroyed the immunoreactivity of YLL031c-
Myc (Fig. 7C). In contrast, Gpi8p, which has a large N-terminal
luminal and a small C-terminal cytosolic domain of about 14
amino acids was slightly reduced in size but not destroyed by
proteinase K. In view of the massive glycosylation of part of
YLL031c-Myc and the presence of an N-terminal hydrophobic
domain that qualifies as potential signal sequence, we inter-
pret these findings in the sense that the N-terminal part of
YLL031c containing six N-glycosylation sites is oriented lumi-
nally. The fact that proteinase K treatment of microsomes does
not generate any immunoreactive low molecular weight prod-
uct suggests that the C-terminal Myc tag is exposed cytosoli-
cally or that YLL031c-Myc contains a proteinase K-sensitive
site close to its C terminus. The membrane topology of YLL031c
thus appears to be the same as in the homologous Gpi7p (8).
DISCUSSION
In this study, we investigate the potential function of
YLL031c in GPI anchoring. As shown in Fig. 8, YLL031c pre-
dicts a membrane glycoprotein of 1017 amino acids with an
N-terminal hydrophilic domain and a C-terminal hydrophobic
sequence containing numerous potential transmembrane do-
mains, a feature that initially led to its classification as poten-
tial facilitator of membrane permeation (32).
YLL031c is homologous to GPI7 and MCD4 of S. cerevisiae,
but closer homologues can be found in other species such as
Homo sapiens, Drosophila melanogaster, Caenorhabditis el-
egans or Schizosaccharomyces pombe. The GPI7/MCD4/
YLL031c gene family can be subdivided into three subfamilies
of more closely related genes. MCD4, GPI7, and YLL031c each
belong to a different subfamily. All genes in this family predict
proteins that have the same general structural attributes; i.e.
they have an N-terminal signal sequence followed by a large
hydrophilic domain and a C-terminal hydrophobic sequence
containing numerous potential transmembrane domains. The
hydrophilic domains of YLL031c, GPI7, and MCD4 have a
distinct homology with mammalian enzymes classified as phos-
phodiesterases, phosphatases, or nucleotide pyrophosphatases.
This homology extends over 240 amino acids. YLL031c and
GPI7 also contain the distinct, universally conserved motif
PTXTX8TGX2P (double bar above the sequence in Fig. 8A; stip-
pled in Fig. 8B), which is found in mammalian but also some
plant and bacterial enzymes. The homology among the mem-
bers of the GPI7/MCD4/YLL031c gene family encompasses
400 amino acids at the N terminus of these proteins. The family
contains several motifs that are not present or are only par-
tially conserved in phosphatases (e.g. HXLGXDXXGH and DH-
GMXXXGXHG (single bar above the sequence in Fig. 8A;
hatched in Fig. 8B). These motifs fall into regions in which also
FIG. 8. Homology of YLL031c with
GPI7 and MCD4. A, the first 395 amino
acids of YLL031c are shown. Potential N-
glycosylation sites and the N-terminal hy-
drophobic sequence for translocation of
the protein into the ER are underlined.
Homologies with the other S. cerevisiae
(OSC) genes GPI7 and MCD4 were iden-
tified using the Clustal W (version 1.8)
program at EBI. This introduced a few
gaps into the YLL031c sequence (dashes).
In parallel, each of these three genes was
aligned with its nearest neighbors in
other species, namely humans, mice, C.
elegans, and S. pombe. GenBankTM acces-
sion numbers and Geninfo identifiers of
sequences aligned with YLL031c were
T02245 GI:7513075, AAB93646
GI:2734088, and T40030 GI:7491546;
aligned with GPI 7 were Q09782
GI:1175452 and T21487 GI:7500059, and
aligned with MCD4 were NP_036459 GI:
6912500, NP_038812 GI:7305383, and
T40715 GI:7491747. These alignments re-
veal homologies for the YLL031c (C31)
subfamily, the GPI7 (equivalent to
YJL062w) (C62) and the MCD4 (equiva-
lent to YKL165c) (C65). Asterisks, colons,
and periods indicate identity, strong sim-
ilarity, and weak similarity, respectively.
B, in the Kyte-Doolittle plot of YLL031
are integrated the positions of the nine
potential N-glycosylation sites (vertical
lines). The phosphatase motif (double
bar), and two motifs conserved between
the YLL031c, GPI7, and MCD4 subfami-
lies (single bars) are also indicated.
GPI Anchor Biosynthesis in Yeast 24463
the highest degree of homology is observed within each sub-
family. As shown in Fig. 8A, the degree of consensus within
each subfamily is significantly higher than between YLL031c,
GPI7, and MCD4 (compare lines OSC, C31, C62, and C65).
Assuming that all of these genes evolved from a common an-
cestor, this suggests that the divergence and functional diver-
sification of these three subfamilies occurred prior to the sep-
aration of the lineages leading to S. cerevisiae, S. pombe, C.
elegans, and humans.
The phenotype of YLL031c-depleted cells strongly suggests
that YLL031c indeed is involved in GPI anchoring. The cell
wall fragility of YLL031c-depleted cells as revealed by CFW
hypersensitivity is a common feature of all gpi mutants (33–
36). Indeed, many GPI proteins of yeast are cell wall proteins or
plasma membrane proteins participating in the building of the
cell wall (37, 38). The appearance of abnormal GPI lipid inter-
mediates and the specific accumulation or disappearance of
mature and immature forms of GPI proteins equally point to a
GPI anchoring defect.
This defect seems to be due to a defect in making GPI lipids
but not in the attachment process itself. This can be concluded,
since YLL031c-depleted microsomes still make some CP2 in
vitro, but YLL031c-depleted cells do not accumulate CP2 in
vivo as is observed in mutants that are deficient in the GPI
attachment process itself (6, 7). The difficulty of YLL031c-
depleted cells seems to reside in the attachment of the strate-
gically important EtN-P to Man3, the EtN-P that will have to
make the link to the protein moiety (Fig. 1). Earlier studies
indicated that GPI7 is required for the addition of an HF-
sensitive substituent onto Man2, but not Man1 and Man3, and
that PIG-N, the human homologue of MCD4, is required for the
addition of EtN-P onto Man1 but not Man3. Together with the
data presented here, it therefore appears reasonable to as-
sume, as a working hypothesis, that MCD4, GPI7, and
YLL031c are required for the addition of EtN-P to Man1, Man2,
and Man3, respectively. Moreover, their homology with phos-
phodiesterases suggests that these three genes encode the cor-
responding EtN-P-transferases. (These transferases may be
expected to bear homology with phosphodiesterases, since pre-
vious studies by the group of Anant Menon (39, 40) demon-
strate that the attachment of the EtN-P to Man3 occurs by
transesterification of EtN-P from phosphatidylethanolamine
onto Man). A protein such as YLL031c would seem to be well
suited to carry out this transfer inasmuch as its hydrophobic
C-terminal domain may bind or even flip phosphatidylethano-
lamine, and the hydrophilic phosphodiesterase domain could
operate the actual transfer reaction. Also, the subcellular lo-
calization of YLL031c in the ER is compatible with its func-
tioning as an EtN-P-transferase, since it has been reported
recently that, at least up to the stage of [NH2-(CH2)2-PO43]
Mana1–4GlcNa1–6[acyl3]Ins-PO4-lipid, GPI lipids are made
in the ER (41).
The structure of the abnormal GPI lipids accumulating in
various gpi mutant cells may not tell us in what order these
transfer reactions take place in WT cells, but, if we assume that
the observed GPI structures represent biosynthetic intermedi-
ates, they may tell us in what order the physiological pathway
does not work. The six theoretical possibilities for the order of
EtN-P additions to Man1, Man2, and Man3 starting from a
Man4-GlcN-Ins core structure are represented in Fig. 9. Path-
ways starting with reaction 1 (i.e. the addition of EtN-P by
YLL031c) may not be possible, since we then would expect that
MCD4-depleted cells or mcd4 mutants would accumulate the
theoretical structure H1 or M4*, which is not the case (Fig. 4A,
lane 6) (10). Pathways using reaction 30, leading from 031b to
H2, may also be impracticable, since YLL031c-depleted cells
accumulate the substrate for reaction 30, but H2 is not ob-
served. On the other hand, the appearance of 031b9 in these
cells suggests that reaction 3 is possible albeit not favored.
Since reactions 1 and 30 seem unfeasible and 3 is not favored,
we may predict that the physiological pathway in normal cells
proceeds mainly via the only remaining way, which is 2–10-3-.
Thus, the addition of EtN-P to Man1 may represent a prereq-
uisite for the addition of further EtN-P residues. The fact that
MCD4 is essential is in accordance with a pivotal role of the
EtN-P transfer to Man1. EtN-P is already present on M2* of
gpi10–1 having the structure Mana1–6[NH2-(CH2)2-PO43]
Mana1–4GlcNa1–6[acyl3]Ins-PO4-lipid. Also, several studies
in mammalian cells document that EtN-P may be added before
any other residues are attached to Man1 (11, 23, 42, 43).
Nevertheless, the abundance of 031a in YLL031c-depleted cells
argues that the addition of EtN-P to Man1 is not a prerequisite
for the addition of mannoses (Man2, Man3, and Man4, Fig. 1).
Since YLL031c is an essential gene, we may conclude that
lipid 031b cannot be used as an anchor device (i.e. that at least
some essential GPI proteins cannot be attached to the EtN-P on
Man1 or that this process, if it occurs, does not yield a func-
tional GPI protein). A similar conclusion has been reached
previously in that the gpi10–1 mutant does not seem to add the
accumulating Mana1–6[NH2-(CH2)2-PO43]Mana1–4GlcNa1–
6[acyl3]Ins-PO4-lipid to proteins (4).
Genes other than YLL031c may be required for the transfer
of EtN-P onto Man3. In mammals this step is dependent on
PIG-F, a gene encoding a very hydrophobic protein. Its exact
function has not yet been elaborated (44).
Further studies will be required to prove the validity of the
model proposed in Fig. 9 and to show that the MCD4/GPI7/
YLL031c gene family indeed encodes EtN-P-transferases.
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FIG. 9. Biosynthesis of CP2: Are ethanolaminephosphates
added in random order? All theoretically possible intermediates in
the biosynthesis of CP2 from 031a are placed at the corners of a cube.
The six nearest pathways along the edges leading from 031a to CP2
represent all of the possible orders of the EtN-P side chain addition to
the carbohydrate core. GPI structures that have actually been identi-
fied are filled: 031a, 031b, and 031b9 in this report; M2*, M4*, M4, and
CP2 in previous publications (4, 5, 8). H1 and H2 indicate hypothetical
structures, which have not been identified. Reactions 1, 2, and 3 are
proposed to be carried out by YLL031c, Mcd4p, and Gpi7p, respectively.
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Additional results
Incorporation of [3H]inositol into proteins
GPI-anchored proteins are the only proteins known to be covalently linked to inositol. Thus,
when GPI synthesis or attachment is impaired, moderate to severe defects in inositol
incorporation into proteins are observed. We therefore tested if newly synthesized proteins
in cells depleted of Gpi13p could be labeled with [3H]inositol. Wild-type cells efficiently
incorporated inositol into proteins (Figure 2-1, lane 4). In contrast, gpi7∆ cells had a partial
defect in inositol incorporation (Figure 2-1, lane 1, and Benachour et al., 1999), and cells
depleted of Gpi13p showed a similar pattern of labeled proteins as gpi7∆ cells (Figure 2-1,
lane 2). When Gpi13p was depleted in a gpi7∆ background, inositol incorporation into
proteins was severely diminished (Figure 2-1, lane 3).
Figure 2-1. Cells depleted of Gpi13p incorporate reduced amounts of inositol into
proteins.
Cells were grown overnight in SDCUA medium at 30 °C. 10 OD600 units of wild-type
(FBY413), ∆gpi7 (FBY182), GPI13-depleted (FBY1102), and ∆gpi7 GPI13-depleted
(FBY1106) cells were labeled with 40 µCi myo-[2-[3H]]inositol. Proteins were extracted and
delipidated as described (Guillas et al., 2000), and analyzed by SDS-PAGE/fluorography.
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Myc-tagged Gpi13p is functional
As described in Flury et al. (2000), a 13myc tag was inserted in a wild-type yeast strain at
the 3' end of the chromosomally encoded GPI13 gene by homologous recombination with
an insertion cassette (Longtine et al., 1998). A clone in which the PCR-made insertion
cassette was targeted correctly, as verified by whole yeast cell PCR (Huxley et al., 1990),
was grown on YPD plates with or without Calcofluor White (CFW). CFW is a drug that
interferes with cell wall assembly and is toxic for cells having weakened cell walls, a
phenomenon commonly observed in gpi mutants (Ram et al., 1994). Wild-type cells were
able to grow at all dilutions irrespective of the growth medium (Figure 2-2A and B). In
contrast, cells depleted of Gpi13p had a reduced growth rate on YPD plates (Figure 2-2A)
and were hypersensitive to CFW (Figure 2-2B). Cells expressing the myc-tagged version of
Gpi13p grew similar to wild-type cells on YPD medium (Figure 2-2A), and were completely
resistant to CFW (Figure 2-2B), indicating that C-terminally 13myc-tagged Gpi13p is
functional.
Figure 2-2. Cells expressing 13myc-tagged Gpi13p grow like wild-type cells.
Sequential 1:10 dilutions of cell suspensions were prepared and spotted on agar plates
containing either A) YPD medium or B) YPD medium with 1.5 mg/ml CFW. Plates were
photographed after 3 days at 30 °C. The amount and form of Gpi13p is indicated: ↓,
depleted due to repression of GAL1,10 promoter; myc, myc-tagged Gpi13p expressed from
its promoter; wt, normal levels of Gpi13p expressed from its promoter.
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Another experiment was performed in order to verify that the myc tag does not interfere
with the function of Gpi13p. Cells expressing myc-tagged Gpi13p as the only source of
Gpi13p were labeled with [3H]Ins, lipids were extracted and analyzed by TLC. Gpi13p-
depleted cells accumulated lipid 031b (Figure 2-3, lane 3), whereas cells expressing
Gpi13p-myc had a lipid profile that was identical to wild-type (Figure 2-3, lanes 1 and 2).
This result further indicated that the presence of a 13myc tag at the C-terminus of Gpi13p
does not disturb the function of Gpi13p.
Figure 2-3. Cells expressing 13myc-tagged Gpi13p have the same [3H]Ins-labeled
lipids as wild-type cells.
Cells were grown to exponential phase in SDCUA medium and labeled with [3H]Inositol (4
µCi/1-2 x 107 cells) at 30°C as previously described. Lipids were extracted, desalted, and
analyzed by TLC using solvent 1 (CHCl3/CH3OH/H2O 10:10:3 v/v/v) as previously
described. FBY1679, wild-type; FBY1107, GPI13-myc; FBY1102, pGAL1,10-GPI13.
Membrane association of Gpi13p-myc
The amino acid sequence of Gpi13p predicts a protein with multiple transmembrane
domains (Flury et al., 2000). We therefore wanted to confirm the membrane localization of
Gpi13p experimentally. Gpi13p-myc is associated with membranes, since it could be
sedimented by ultracentrifugation of lysates at 100'000 x g for 60 min (Figure 2-4, lanes 1
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and 2). Neither NaCl nor sodium carbonate at pH 11 nor urea was able to dissociate
Gpi13p-myc from membranes, but the protein was solubilized by Triton X-100 and SDS
(Figure 2-4).
Figure 2-4. Membrane association of Gpi13p-myc.
Aliquots of lysate from FBY1107 cells were incubated for 40 min at 0 °C with water, 0.5 M
NaCl, 0.8 M urea, 0.1 M Na2CO3 pH 11, 1% Triton X-100, or 1% SDS. Samples were
subsequently sedimented by ultracentrifugation to get supernatant (S) and pellet (P)
fractions. Samples were processed for SDS-polyacrylamide gel electrophoresis and
Western Blotting with anti-myc antibodies. All lanes contain material derived from 6 OD600
of cells.
Subcellular localization of Gpi13p-myc
Myc-tagged Gpi13p was shown not to reside at the cell surface (Flury et al., 2000).
However, when looking at the immunoblots for Gpi13p-myc therein for the subcellular
localization experiments, one can observe that material reacting with the anti-myc antibody
is also found as a smear of high molecular mass proteins in protein samples that were
denatured in "traditional" sample buffer (Fig. 7B and 7C in Flury et al. (2000)), whereas in
samples denatured with high urea (HU) buffer (Fig. 7A therein), there is almost no such
smear. We repeated the experiment shown in Figure 7B in Flury et al. (2000), but instead
of denaturing proteins in sample buffer at 95 °C, HU buffer (8M urea, 5% SDS, 200 mM
Tris-HCl pH 6.8, 20 mM EDTA, bromophenol blue, 15 mg/ml DTT) was used at 65 °C.
Under these conditions, myc-tagged Gpi13p was found as a distinct band in protein
samples denatured with HU buffer (Figure 2-5).
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Figure 2-5. Protease treatment on intact spheroplasts.
FBY1107 cells were converted to spheroplasts using the indicated concentrations of
zymolyase-20T and then digested with proteinase K or control incubated. Samples were
processed for SDS-polyacrylamide gel electrophoresis and Western Blotting.
Antibodies against the hydrophilic portion of Gpi13p
In order to prepare an antibody recognizing the native form of Gpi13p, we used the same
strategy as for raising of anti-Gpi7p antibodies. We chose a region comprising amino acids
122 to 320 of Gpi13p. The corresponding coding sequence was PCR-amplified from
genomic DNA and cloned into the pET-15b expression vector. The His6-tagged fusion
protein was purified from bacteria and used to immunize two rabbits and to prepare an
affinity column for purification of antibodies. The affinity-purified antibodies were used to
detect Gpi13p in subcellular fractions obtained from wild-type cells and the results obtained
were compared with data from experiments with a strain expressing 13myc-tagged Gpi13p.
As expected, wild-type cells and cells expressing Gpi13p-myc showed no major difference
in the localization pattern of Gpi8p and Och1p (Figure 2-6 A and B). The distribution of
material reacting with anti-Gpi13p antibodies and with anti-myc antibodies was also very
similar. However, when looking at the molecular weight markers, one can observe that the
antibodies recognize bands of very different sizes. The molecular weight of the primary
translation product is 136 kD for Gpi13p-myc, and 115 kD for untagged Gpi13p. Therefore,
if our affinity-purified antibodies really recognize Gpi13p, we expected the antibodies to
react with a protein migrating slightly faster than myc-tagged Gpi13p. As it can be seen in
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Figure 2-6, this is clearly not the case. Indeed, the antibodies recognized predominantly a
protein having the same localization pattern as Gpi8p and Gpi13p-myc, but less mobility on
SDS-PAGE than Gpi13p-myc. This result suggests that the affinity-purified anti-Gpi13p
antibodies recognize a protein unrelated to Gpi13p. The band indicated with an asterisk in
Figure 2-6B is unlikely to be Gpi13p-myc, since a band with the same mobility was also
detected by the antibody in the fraction of soluble proteins S100 (not shown).
Figure 2-6. Subcellular localization of Gpi13p and Gpi13p-myc.
Subcellular fractionation using A) Wild-type cells, and B) cells expressing Gpi13p-myc.
Proteins were analyzed by SDS-PAGE and Western Blotting. Equivalent amounts of
proteins were loaded in all lanes. A) affinity-purified Gpi13p antibodies, and B) anti-myc
antibodies were used to detect Gpi13p. The band indicated by an asterisk was also
contained in the soluble fraction S100.
Discussion
We and Taron et al. (2000) have shown that YLL031c/GPI13 encodes an essential
component of the GPI biosynthetic pathway. Lipids that accumulate in cells depleted of
Gpi13p have been analyzed and it was shown that these GPI intermediates lack the
bridging EthN-P on the third mannose residue, suggesting that Gpi13p is the transferase
that adds EthN-P to this position of the GPI core. The depletion of mature GPI-anchored
proteins but not other secretory proteins in Gpi13p-depleted cells provides additional
evidence that GPI13 is involved in GPI anchor biosynthesis (Flury et al., 2000). We have
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shown that cells depleted of Gpi13p incorporate less inositol into proteins than wild-type
cells (Figure 2-1). This defect is less severe than we would have predicted in view of the
essential role of Gpi13p in GPI anchoring. Since disruption of GPI13 is lethal, we placed
the chromosomally encoded GPI13 gene under control of the GAL1,10 promoter and
depleted the cells from Gpi13p by shifting cells from galactose- to glucose-containing
medium. With this method, we could only partially deplete the cells from Gpi13p, since
these cells were able to grow on glucose-containing medium, albeit at a reduced rate (Flury
et al., 2000). Therefore, the observed inositol incorporation into proteins in cells depleted of
Gpi13p is likely due to residual expression of Gpi13p on glucose-containing medium.
Then, we demonstrated in two different experiments that insertion of a 13myc epitope at
the C-terminus of Gpi13p does not interfere with its function, since cells expressing only
the tagged form of Gpi13p grew like wild-type cells and did not accumulate GPI
intermediates (Figures 2-2 and 2-3). The localization experiments of Gpi13p using
commercially available anti-myc antibodies were based on the finding that myc-tagged
Gpi13p is functional. Therefore, the investigations on the subcellular localization performed
in Flury et al. (2000) as well on the membrane association (Figure 2-4) of Gpi13p were
performed in a strain expressing Gpi13p-myc.
We also provided experimental evidence that Gpi13p is a membrane-anchored protein,
since it could only be solubilized by treating cell lysates with detergents such as SDS and
Triton X-100. As shown in Flury et al. (2000) and in Figure 2-5, treatment of intact
spheroplasts with protease did not diminish ER-resident proteins, whereas proteins located
on the cell surface were digested. Gpi13p-myc as well as the ER protein Gpi8p and the
105 kD ER-form of Gas1p remained intact when spheroplasts were treated with protease,
whereas the 125 kD mature form of Gas1p was strongly diminished, as expected for a
protein residing at the surface. This result clearly shows that Gpi13p-myc is not localized at
the plasma membrane. Consistent with this result, the mammalian homologue of Gpi13p,
PIG-O, was localized in the ER (Hong et al., 2000).
The production of antibodies against a portion of Gpi13p did not give satisfying results,
since affinity-purified antibodies reacted with material that was unlikely to be Gpi13p.
Indeed, the antibody recognized a smear that had significantly less mobility on SDS-PAGE
than we expected from the amino acid sequence of Gpi13p, and also less mobility than the
material recognized by the anti-myc antibody (compare Figure 2-6 A and B). We conclude
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that our affinity-purified anti-Gpi13p antibody recognized a protein other than Gpi13p.
When one compares the sequence of the recombinant proteins used to raise anti-Gpi7p
antibodies (Benachour et al., 1999) and these anti-Gpi13p antibodies, one realizes that in
both cases a large fragment in the hydrophilic region of the protein was chosen. And as
shown in a sequence alignment of Gpi13p and Gpi7p (Flury et al., 2000), the homologous
stretches of Gpi13p and Gpi7p are located in this hydrophilic region. Therefore it might be
conceivable that our anti-Gpi13p antibodies crossreact with Gpi7p or with Mcd4p. The
fragment of Gpi13p used to raise these antibodies contains several regions of up to 6
amino acids that are identical with stretches from Gpi7p, and regions with up to 4 amino
acids identical with Mcd4p. However, a control experiment has shown that protein extracts
of a ∆gpi7 strain also contained material reacting as a smear with affinity-purified anti-
Gpi13p antibodies, suggesting that the smear is not Gpi7p, but rather another protein. The
results presented here showing that a strain expressing 13myc-tagged Gpi13p is functional
suggest that working with this strain and anti-myc antibodies are a good alternative to the
use of anti-Gpi13p antibodies described here which might also recognize the Gpi13p-
homologues. Nevertheless, we are currently raising antibodies against a 16 amino acid
peptide (SKKPDMWRLKETSNYN) in the hydrophilic region of Gpi13p having no homology
to Gpi7p or Mcd4p. Once we have obtained these new antibodies, we will reinvestigate the
localization of Gpi13p in order to rule out the possibility that insertion of the myc epitope tag
at the C-terminus of Gpi13p causes mislocalization. It has been reported that epitope
tagging of the ER-localized protein Ste14p at either end caused mislocalization to the Golgi
apparatus, even though the N-terminally HA-tagged Ste14p was functional (Romano et al.,
1998).
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3. Characterization of Gpi7p
Summary
GPI anchoring is a post-translational modification reaction whereby preassembled GPI
anchors are transferred to proteins bearing a C-terminal GPI signal sequence in the ER.
The GPI anchor precursors are synthesized by stepwise addition of sugars and
ethanolaminephosphate to phosphatidylinositol. Saccharomyces cerevisiae mutants
deficient in the GPI biosynthetic pathway are a convenient tool to identify genes involved in
GPI anchoring. The gpi7 mutant was identified in a screen for Saccharomyces cerevisiae
strains deficient in the surface expression of the GPI-anchored protein α-agglutinin
(Benghezal et al., 1995). The corresponding GPI7 gene was cloned by complementation. It
is a non-essential gene encoding a protein with multiple predicted transmembrane
domains. ∆gpi7 cells accumulate a GPI precursor lacking a previously unrecognized HF-
sensitive substituent on the second mannose residue of the GPI core, suggesting that
Gpi7p may be involved in addition of this side chain. The objective of this thesis work in the
context of GPI7 was the characterization of Gpi7p. Using polyclonal antibodies raised
against its hydrophilic portion, we have shown that Gpi7p is localized at the cell surface.
Publication: Deletion Of GPI7, A Yeast Gene Required For
Addition Of A Side Chain To The Glycosylphosphatidylinositol
(GPI) Core Structure, Affects GPI Protein Transport, Remodeling,
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I have carried out the experiments showing that Gpi7p is localized at the cell surface, and I
have prepared [3H]mannose-labeled CP2 and M4 glycolipids.
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Gpi7 was isolated by screening for mutants defective
in the surface expression of glycosylphosphatidylinosi-
tol (GPI) proteins. Gpi7 mutants are deficient in
YJL062w, herein named GPI7. GPI7 is not essential, but
its deletion renders cells hypersensitive to Calcofluor
White, indicating cell wall fragility. Several aspects of
GPI biosynthesis are disturbed in Dgpi7. The extent of
anchor remodeling, i.e. replacement of the primary lipid
moiety of GPI anchors by ceramide, is significantly re-
duced, and the transport of GPI proteins to the Golgi is
delayed. Gpi7p is a highly glycosylated integral mem-
brane protein with 9–11 predicted transmembrane do-
mains in the C-terminal part and a large, hydrophilic
N-terminal ectodomain. The bulk of Gpi7p is located at
the plasma membrane, but a small amount is found in
the endoplasmic reticulum. GPI7 has homologues in
Saccharomyces cerevisiae, Caenorhabditis elegans, and
man, but the precise biochemical function of this pro-
tein family is unknown. Based on the analysis of M4, an
abnormal GPI lipid accumulating in gpi7, we propose
that Gpi7p adds a side chain onto the GPI core struc-
ture. Indeed, when compared with complete GPI lipids,
M4 lacks a previously unrecognized phosphodiester-
linked side chain, possibly an ethanolamine phosphate.
Gpi7p contains significant homology with phosphodies-
terases suggesting that Gpi7p itself is the transferase
adding a side chain to the a1,6-linked mannose of the
GPI core structure.
Glycosylphosphatidylinositol (GPI)1-anchored proteins rep-
resent a subclass of surface proteins found in virtually all
eukaryotic organisms (1). The genome of Saccharomyces cerevi-
siae contains more than 70 open reading frames (ORFs) encod-
ing for proteins that, as judged from the deduced primary
sequence, can be predicted to be modified by the attachment of
a GPI anchor (2, 3). In about 25 of them, the presence of an
anchor has been confirmed biochemically. A majority of them
lose part of the anchor and become covalently attached to the
b1,6-glucans of the cell wall (4–6). A minority of GPI proteins
retain the GPI anchor in an intact form and stay at the plasma
membrane (PM).
For the biosynthesis of GPI anchors, phosphatidylinositol
(PI) is modified by the stepwise addition of sugars and etha-
nolamine phosphate (EtN-P), thus forming a complete precur-
sor lipid (CP) which subsequently is transferred en bloc by a
transamidase onto newly synthesized proteins in the ER (7, 8).
The identification of genes involved in the biosynthesis of the
CP and its subsequent attachment to proteins has been possi-
ble through the complementation of mammalian and yeast
gpi2 mutants, i.e. mutants being deficient in GPI anchoring of
membrane proteins (7, 9–20). In our laboratory, a series of
recessive gpi2 mutants (gpi4 to gpi10) has been obtained by
screening for yeast mutants that are unable to display the
GPI-anchored a-agglutinin (Sag1p) at the outer surface of the
cell wall, although the synthesis and secretion of soluble pro-
teins is normal (21, 22).
Here we report on the characterization of gpi7. Four inde-
pendent gpi7 mutants accumulated M4, an abnormal GPI in-
termediate that is less hydrophilic than CP2, the precursor
accumulating when the transfer of GPIs to proteins is inter-
rupted (18, 19, 21, 23). Our preliminary characterization of M4
had shown that deacylation by NH3 followed by HF treatment,
used to hydrolyze selectively the phosphodiester bonds (Fig. 1),
yielded the same Man4-GlcN-inositol fragment as CP2, and we
speculated that gpi7 mutants may be unable to add the EtN-P
onto Man3 (Fig. 1) (21). Here we show that this speculation was
wrong, that CP2 differs from M4 with regard to a previously
unrecognized side chain attached to Man2 (Fig. 1), and that
GPI7 is required for the attachment of this side chain.
EXPERIMENTAL PROCEDURES
Strains, Growth Conditions, and Materials—S. cerevisiae strains
were FBY11 (MATa ade2-1 ura3-1 leu2-3,112 trp1-1 his3-11,15 gpi8-1),
FBY15 (MATa ade2-1 ura3-1 leu2-3,112 trp1-1 his3-11,15 gpi7-1),
W303-1B (MATa ade2-1 can1-100 ura3-1 leu2-3, 112 trp1-1 his3-11,15),
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‡ Present address: Universite´ de Caen, IRBA, Laboratoire de Micro-
biologie de l’Environnement, Caen, France.
§ Present address: 0 R. S. Fuller, University of Michigan Medical
Center, Dept. of Biological Chemistry, Ann Arbor, MI 48109-0606.
¶ Present address: 0 H. Pelham, MRC, Laboratory of Molecular
Biology, Cambridge, UK.
i To whom correspondence should be addressed: Institute of Biochem-
istry, Chemin du Muse´e 5, CH-1700 Fribourg, Switzerland. Tel.: 41 26
300 8630; Fax: 41 26 300 9735: E-mail: andreas.conzelmann@unifr.ch.
** Present address: Plant Cell Biology, Research School of Biological
Sciences, Australian National University, Canberra ACT 2601,
Australia.
1 The abbreviations used are: GPI, glycosylphosphatidylinositol;
ASAM, A. satoi a-mannosidase; CP, complete precursor; DAG, diacyl-
glycerol; DHS, dihydrosphingosine; EtN-P, ethanolamine phosphate;
GPI-PLD, GPI-specific phospholipase D; Ins, myo-inositol; JBAM, jack
bean a-mannosidase; Man, mannose; ORF, open reading frame; pC1
and pC2, protein-derived Ceramides 1 and 2; pG1 protein-derived Glyc-
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X2180-1A (MATa lys2), FBY122 (MATa ade2-1 ura3-1 leu2-3,112
trp1-1 his3-11,15 gpi8-1 gpi7-1), FBY182 (MATa ade2-1 ura3-1 leu2-
3,112 his3-11,15 gpi7::KanMX4), HMSF176 (MATa sec18-1), FBY49
(MATa sec18-1 gpi7::KanMX4), C4 (MATa ura3-52 leu2-3,112 pmi40),
HMSF331 (MATa sec53-6), LB2134-3B (MATa mnn9), and YNS3-7A
(MATa ura3 his2 mnn1 och1::LEU2). Diploid strains were FBY118
(MATa/a ade2-1/ade2-1 ura3-1/ura3-1 leu2-3, 112/leu2-3,112 TRP1/
trp1-1 his3-11,15/his3-11,15 LYS/lys2), FBY40 (MATa/a ade2-1/
ade2-1 ura3-1/ura3-1 leu2-3,112/leu2-3,112 TRP1/trp1-1 his3-11,15/
his3-11,15 LYS/lys2 GPI7/gpi7-1), and FBY43 (MATa/a ade2-1/
ade2-1 ura3-1/ura3-1 leu2-3,112/leu2-3,112 TRP1/trp1-1 his3-11,15/
his3-11,15 LYS/lys2 gpi7::KanMX4/gpi7::KanMX4). Maintenance and
growth conditions have been described (19). The absorbance of dilute
cell suspensions was measured in a 1-cm cuvette at 600 nm, and one
A600 unit of cells corresponds to 1–2 3 10
7 cells depending on the strain.
Escherichia coli strains were HB-101, XL1 blue, and M15 [pREP4]
(Qiagen).
Materials were obtained from the sources described recently (22).
Cysteamine was from Sigma; [3H]dihydrosphingosine was synthesized
as described (24); myriocin was a kind gift of Dr. N. Rao Movva (No-
vartis, Basel, Switzerland); antibodies to Och1p, alkaline phosphatase,
Kex2p, and Wbp1p were kindly donated by Dr. Y. Jigami, National
Institute of Bioscience and Human Technology, Ibaraki 305, Japan; Dr.
S. Emr, Howard Hughes Medical Institute, University of California,
San Diego; Dr. R. Fuller, University of Michigan Medical Center, Ann
Arbor, MI; and Dr. M. Aebi, Mikrobiologisches Institut, ETH Zu¨rich,
Switzerland, respectively.
Cloning, Partial Sequencing, and Disruption of GPI7—The GPI7
gene was cloned by complementation of the ts growth phenotype of the
gpi7-1/gpi8-1 double mutant as described (19). The three plasmids
complementing gpi7-1 contained a 4.3-kb common DNA restriction
fragment that was partially sequenced by the dideoxy sequencing
method (25). The complementing insert SphI/SspI of 3.6 kb was cloned
into the SphI/SmaI-digested YEp352 multicopy vector (26) or YCplac33
single copy vector (27) to generate pBF41 (Fig. 3C) and pBF43,
respectively.
One step disruption of GPI7 was done as described (28). Briefly, the
1.5-kb long KanMX4 module was PCR-amplified by using pFA6a-
KanMX4 as template and the following two adapter primers: GPI7-
forwards (59-CTTCACCAAGTTAGCAAGATGAACTTGAAGCAGTTC-
ACGTGCCtcgatgaattcgagctc-39) with 17 nucleotides (nt) of homology to
the pFA6a-KanMX4 multiple cloning site (in lowercase) and 43 nt of
homology to GPI7 (in uppercase) starting 18 nt upstream of the start
codon (bold); GPI7-backwards (59-ATCAAGAGCGCAAAGGAGGGCC-
AATTCAGGTAACCAGCCATTCAcgtacgctgcaggtcgac-39) with 18 nt of
homology to the pFA6a-KanMX4 multiple cloning site (lowercase) and
44 nt of homology to the ORF of GPI7 in the region immediately up-
stream of the stop codon. This PCR DNA fragment was used to tra-
nsform the diploid strain FBY118, homozygous for GPI7, and FBY40, a
heterozygous gpi7-1/GPI7 strain. The correct targeting of the PCR-
made KanMX4 module into the GPI7 locus in geneticin-resistant clones
was verified by PCR with whole yeast cells using primers GPI7-plus
(59-GTTCATCTACCACGCAC-39) starting 36 nt upstream of the ATG,
GPI7-minus (59-GACCCAAGTAATGCAGG-39) starting 631 base pairs
downstream of the ATG and the K2 primer of the KanMX4 module
(59-GTATTGATGTTGGACG-39).
Purification of Recombinant His-tagged Gpi7p and Antibody Produc-
tion—Plasmid pBF41 (Fig. 3C) was digested with BstYI and EcoRV to
generate a 633-base pair fragment of GPI7. This fragment was inserted
into the multiple cloning site of the bacterial expression vector pQE-30
(Qiagen) digested with BamHI/SmaI thus generating the plasmid
pBF402. This plasmid was used to transform the E. coli strain
M15[pREP4]. Expression of the recombinant protein was induced with
isopropyl-1-thio-b-D-galactopyranoside and purified on a nickel-nitrilo-
triacetic acid-agarose column (Qiagen) under denaturing conditions
according to the manufacturer’s instructions. A polyclonal antiserum
was raised against this Gpi7p fragment by repeated intramuscular
injections of 100 mg of recombinant protein into a rabbit. Ten mg of the
recombinant protein were coupled to CNBr-activated Sepharose 4B
(Amersham Pharmacia Biotech) according to the manufacturer’s in-
structions, and antiserum was affinity purified as described (29).
Membrane Association, Protease Sensitivity, and Cellular Localiza-
tion of Gpi7p—The nature of the association of Gpi7p with the mem-
brane was determined following a previously described protocol (30)
except that the EDTA concentration in buffer G was increased from 2 to
20 mM. Gpi7p protease sensitivity was examined by proteinase K di-
gestion of microsomes essentially as described (31). Briefly, 100 A600 of
washed W303 cells were resuspended in 1 ml of lysis buffer (20 mM
HEPES, pH 7.5, 500 mM sucrose, 3 mM magnesium acetate, 20 mM
EDTA, 1 mM dithiothreitol) and were lysed by agitation with glass
beads at 4 °C. The homogenate was centrifuged for 5 min at 600 3 g to
remove unbroken cells, and the supernatant was centrifuged for 15 min
at 13,000 3 g. The membrane pellet was resuspended in 240 ml of the
same lysis buffer and split into 6 aliquots of equal size. Aliquots of
microsomes were incubated for 20 min on ice with or without 0.5%
Triton X-100 and proteinase K. Digestions were stopped by addition of
phenylmethylsulfonyl fluoride (final concentration 4 mM, added from a
200 mM stock in ethanol) and kept on ice for an additional 10 min before
being boiled in sample buffer (32). The subcellular localization of Gpi7p
was determined essentially as described (33). Briefly, 500 A600 units of
mid-log phase W303-1B cells were broken by agitation with glass beads
in 200 mM sorbitol, 25 mM PIPES, pH 6.8, 50 mM KCl, 5 mM NaCl, 10
mM EDTA, 10 mM NaN3/NaF, 1 mM phenylmethylsulfonyl fluoride,
leupeptin, pepstatin, and antipain, each at 30 mg/ml). After removal of
the unbroken cells the homogenate was centrifuged for 10 min at
8,000 3 g at 4 °C to generate pellet P8 and supernatant S8. S8 was
divided in two and either precipitated by the addition of trichloroacetic
acid to 10% or centrifuged at 100,000 3 g for 1 h to generate pellet P100.
For zymolyase treatment the cells were washed and resuspended at 50
A600 units/ml in zymolyase buffer (1.2 M sorbitol, 50 mM K2HPO4 pH 7.5,
40 mM 2-mercaptoethanol, 20 mM EDTA, 10 mM NaN3, 10 mM NaF)
containing zymolyase 20T. After a 40-min incubation at 30 °C, cells
were placed on a cushion of 1.5 M sorbitol, 50 mM K2HPO4, pH 7.5, 20
mM EDTA, 10 mM NaN3, 10 mM NaF and were centrifuged. For Western
blotting, all the samples were denatured during 5 min at 95 °C in
reducing sample buffer and run on a 6, 7.5, or 10% SDS-PAGE for
detection of antigens, respectively (32). Western blotting was carried
out with anti-Wbp1p, anti-alkaline phosphatase, anti-Gas1p, or anti-
Kex2p antisera or with affinity purified anti-Gpi7p or anti-Och1p an-
tibodies, always using the chemiluminescence ECL kit from Amersham
Pharmacia Biotech, Buckinghamshire, UK.
Labeling of Cells—Previously described procedures were used to
label cells with [2-3H]Man (23), [4,5-3H]DHS, or [2-3H]Ins (24) and to
label microsomes with UDP-[3H]GlcNAc (22). Delipidated protein ex-
tracts for SDS-PAGE and lipid extracts were made as described (24).
Lipid extracts were analyzed by ascending TLC using 0.2-mm thick
silica gel 60 plates with the solvent 1 (chloroform/methanol, 0.25% KCl
in water, 55:45:10, v/v) or solvent 2 (chloroform/methanol/water, 10:
10:3, v/v). Radioactivity was detected and quantitated by one- and
two-dimensional radioscanning (LB 2842; Berthold AG, Regensdorf,
Switzerland). TLC plates were sprayed with EN3HANCE and exposed
to film (X-Omat; Eastman Kodak Co.) at 280 °C.
Analytical Methods—Lipid extracts were deacylated with NaOH (34)
and treated with JBAM (35) as described. For GPI-PLD treatment lipid
extracts were dissolved in 20 mM Tris-HCl, pH 7.4, 0.1 mM CaCl2, 20%
1-propanol. Incubations were for 12 h at 37 °C. All treated lipid extracts
were desalted by partitioning between n-butyl alcohol and an aqueous
solution of 0.1 mM EDTA, 5 mM Tris-HCl, pH 7.5, and back extraction
of the butanol phase with water before TLC (23). Lipids were treated
with methanolic NH3 to remove the acyl group on Ins (36) and cleaved
using nitrous acid (37) as described. Lipids were purified by preparative
TLC on 0.2-mm thick Silica Gel 60 plates (Merck, Germany) in solvent
2. Radioactive spots were localized by radioscanning, scraped, and
eluted with solvent 2. A second run on TLC was done to obtain radio-
chemically pure M0, M4, and CP2.
Soluble head groups were obtained from lipids through GPI-PLD
treatment done as above, followed by limiting methanolic NH3 deacy-
lation (36). Non-hydrolyzed GPIs were removed by butanol extraction
(23). The water-soluble head groups were treated with JBAM (0.5 units)
or ASAM (5 microunits) as described (38). HF dephosphorylation was
FIG. 1. Presumed structure of the complete yeast precursor
glycolipid CP2. Relevant cleavage procedures are indicated. Man1,
Man2, Man3, and Man4 designate the a1,4-linked, a1,6-linked, and
a1,2-linked mannoses (Man). X indicates an HF-sensitive group that is
not yet defined chemically. R, alkyl; P, phosphate.
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done as described (39). The generated fragments were analyzed by
paper chromatography in methylethyl ketone/pyridine/H2O (20:12:11)
as described (39). Before paper chromatography the products were
N-acetylated and desalted over mixed-bed ion exchange resin AG-
501-X8 (Bio-Rad) unless indicated otherwise (34). Acetolysis was done
as described (40). Radiolabeled Manx-GlcNAc-[
3H]Ins (x 5 1, 2, 3, 4)
chromatography standards (Figs. 5 and 6, standards 1–4) were gener-
ated through fragmentation of [3H]Man-labeled head groups of CP2,
isolated from pmi40 by acetolysis then HF, HF then ASAM, JBAM then
HF, and HF treatments, respectively. The GlcNAc-[3H]Ins standard
(Figs. 5 and 6, standard 0) was generated by HF treatment of the
[3H]Ins-labeled head group of M0, obtained from sec53 cells. All stand-
ards were N-acetylated. Dionex HPLC analysis of non-dephosphoryl-
ated head groups was done exactly as described (23). Anchor peptides
were prepared from labeled proteins as described (23).
Limiting HF Treatment of Head Groups—For limiting HF treatment,
aliquots of radiolabeled head groups derived from CP2 and M4 and
prepared as above were dephosphorylated with 50 ml of 48% aqueous
HF at 0 °C as described (38) for 0–28 h. After neutralization with
saturated LiOH, samples were desalted by gel filtration through an
8-ml Sephadex G-10 (Amersham Pharmacia Biotech) column. Samples
were then dried in the Speed-Vac and treated with JBAM prior to
complete HF dephosphorylation (60 h, 0 °C). Samples were neutralized
again with LiOH and N-acetylated. Aliquots were dried and then di-
rectly applied to Whatman paper No. 1M and analyzed by descending
chromatography as described above.
RESULTS
Cloning of GPI7—As reported before (19) and shown in Fig.
2, wild type (wt) cells do not contain polar GPIs (lane 1), gpi8-1
accumulates CP2 as the most polar GPI lipid (lane 8), and
gpi7-1 and the gpi7-1/gpi8-1 double mutant accumulate M4
(lanes 4 and 6), thus demonstrating that gpi7-1 is epistatic to
gpi8-1 and suggesting that, during GPI biosynthesis, Gpi7p
may act before Gpi8p. Although the original gpi7 mutants and
the unrelated gpi8-1 mutant were not significantly tempera-
ture-sensitive (ts) for growth, the growth of the gpi7-1/gpi8-1
double mutant was strongly temperature-dependent. Transfec-
tion of a genomic library into this double mutant allowed the
isolation of clones containing complementing plasmids (19).
These clones were labeled with myo-[3H]inositol ([3H]Ins) at
37 °C, and the lipids were extracted and analyzed by TLC.
Upon transfection some gpi7-1/gpi8-1 indeed had regained the
ability to make CP2 (Fig. 2, lanes 6 and 7) and showed the same
lipid profile as gpi8-1 (Fig. 2, lane 8). All these clones harbored
plasmids containing YJL062w as the only complete ORF.
Transfection of a multicopy vector containing YJL062w under
its own promoter (pBF41, Fig. 3C) into gpi7-1 almost com-
pletely cured the accumulation of M4 (Fig. 2, lane 5). As ex-
pected, the accumulation of CP2 by gpi8-1 was not abolished by
the overexpression of YJL062w (Fig. 2, lanes 8 and 9).
YJL062w predicts an 830-amino acid membrane protein with
an N-terminal signal sequence for insertion into the ER, 5
potential N-glycosylation sites, and about 9–11 putative trans-
membrane domains (Fig. 3, A and B). YJL062w was deleted
and replaced by the selectable marker KanMX4. On rich me-
dium the deletants grew about as rapidly as wt cells at all
temperatures. Thus, YJL062w is not an essential gene. We
were unable to sporulate DYJL062/DYJL062 diploids indicat-
ing that YJL062 is required for sporulation. However,
DYJL062/YJL062 heterozygotes sporulated readily and
DYJL062 spores germinated normally. In accordance with pre-
vious results on gpi7 mutants (21), growth of DYJL062 (5
Dgpi7, see below) on plates at 37 °C was severely inhibited by
0.5 mg/ml Calcofluor White. DYJL062 accumulated M4 at even
higher levels than gpi7-1, and this accumulation was almost
completely suppressed by the transfection of pBF41 (Fig. 2,
lanes 2 and 3). Residual accumulation of M4 may be due to2 I. Flury, unpublished observations.
FIG. 2. Complementation of gpi7 mutants by YJL062w. Expo-
nentially growing cells were radiolabeled at 37 °C with [3H]Ins (2 mCi/
A600), and desalted lipid extracts were analyzed by TLC (solvent 2) and
fluorography. The same amount of radioactivity was spotted in each
lane. M(IP)2C, inositol phosphomannosylinositol phosphoceramide. The
upper part of the fluorogram was scanned at higher sensitivity to bring
into view the faint bands of M0. Lane 10 contains [3H]Ins. Samples still
contain residual amounts of free [3H]Ins after extraction into butanol.
The band migrating between CP2 and M4 in gpi8-1 is a GPI-PLD-, mild
base-, and JBAM-sensitive GPI intermediate containing the Man4-
GlcN-Ins core,2 but the structural differences between this species and
CP2 or M4 have not been identified.
FIG. 3. Sequence of GPI7. A, potential N-glycosylation sites are
shown in boldface. The predicted signal peptide is underlined. B shows
a hydrophobicity plot according to Kyte and Doolittle, in which the
hydrophobic sequences get a positive score. C shows the restriction map
of pBF41. The 3.6-kb insert (34–3604) contains GPI7 (5 YJL062w,
broad arrow). The EcoRV/BstYI fragment was expressed in bacteria to
get antigen for raising antibodies.
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some cells that lost the complementing plasmid. Transfection
of YJL062w under its own promoter on a single copy vector
(plasmid pBF43) was sufficient to suppress the accumulation of
M4 in a homozygous DYJL062/DYJL062 diploid (Fig. 2, lanes
11 and 12). As can be seen in Fig. 2, gpi7-1, DYJL062, DYJL062/
DYJL062, and gpi8-1 mutants also show minor amounts of the
GlcNa1,6(acyl3)Ins-P-DAG GPI intermediate M0, the accu-
mulation of which is believed to reflect a build up of GPI
intermediates throughout the biosynthetic pathway (Fig. 2,
lanes 2, 4, 6, 8, and 11). (It should be noted that some inter-
mediates of intermediate size are obscured on TLC by PI and
inositol phosphoceramide (41).) As expected, expression of
YJL062w abolishes the accumulation of M0 in gpi7-1 and
DYJL062 (Fig. 2, lanes 3, 5, and 12) but not in gpi7-1/gpi8-1
nor gpi8-1 (lanes 7 and 9), since in the latter the GPI biosyn-
thesis remains blocked. To evaluate if the mutation in gpi7-1 is
genetically linked to YJL062w, YJL062w was disrupted in a
heterozygous gpi7-1/GPI7 diploid. Correct replacement of one
YJL062w locus was verified by PCR in two independent gene-
ticin-resistant transformants. The verified deletants were
sporulated, and a total of 26 complete tetrads was labeled with
[3H]Ins to analyze the accumulation of M4. In all 26 tetrads
only two of the four segregants showed accumulation of M4,
whereas the other two showed the lipid profile of wt cells.
Geneticin resistance also segregated 2:2 and cosegregated with
M4 accumulation in all cases. This demonstrates that the mu-
tation of gpi7-1 is tightly linked to YJL062w which we hence-
forth call GPI7. Since a construct containing only 348 nucleo-
tides 59 of the initiation codon of GPI7 still retained significant
complementing activity, we also can dismiss the possibility
that the complementing activity of pBF41 is due to one of the
two small ORFs located on the opposite strand in the 59 up-
stream region of GPI7 and starting at 2409 and 2503 with
regard to the start codon of GPI7.
Characterization of the GPI Intermediate M4—We found
that M4, contrary to our initial expectation, contained an HF-
sensitive group on Man3 (Fig. 1). Indeed, treatment of the lipid
extracts of gpi7-1 with jack bean a-mannosidase (JBAM, an
exomannosidase) shifted M4 to a slightly less hydrophilic po-
sition on TLC (Fig. 4A, lanes 1 and 2) but not to the position of
M0. It seemed conceivable that JBAM did not remove more
than one Man from M4 because it was sterically hindered by
the detergent micelle in which M4 was embedded. To circum-
vent this problem, M4 was purified by preparative TLC, and its
hydrophilic head group was liberated by GPI-PLD, O-deacyl-
ated by NH3, and then subjected to several treatments as
indicated at the top of Fig. 5, A–D. The N-acetylated fragment
comigrated with the Man4-GlcNAc-Ins standard (Fig. 5A).
When treated with JBAM before HF, the resulting N-acety-
lated fragment comigrated with the Man3-GlcNAc-Ins stand-
ard, clearly indicating the presence of a blocking group on
Man3 (Fig. 5B). The blocking group on Man3 was HF-sensitive,
since JBAM done after HF produced a fragment comigrating
with GlcNAc-Ins (Fig. 5C). Aspergillus satoi a-mannosidase
(ASAM), a linkage-specific a1,2-exomannosidase, when used
after HF treatment, produced Man2-GlcNAc-Ins (Fig. 5D). The
migration of the fragments shown in Fig. 5, A and B, was much
slower when N-acetylation was omitted (not shown). This par-
tial characterization of M4 is consistent with the presence of a
classical Mana1,2(EtN-P3)Mana1,2Mana1,6Mana1,4-Glc-
Na1,6Ins core structure.
Having recently discovered an additional EtN-P on Man1 of
CP2 (22), we considered the possibility that M4 may be lacking
EtN-P on Man1. We thus proceeded to compare the non-de-
phosphorylated head groups of M4 and CP2 by Dionex HPLC
using a system in which the presence of negatively charged
phosphodiesters greatly retards the elution of oligosaccharides
(42). The non-dephosphorylated head groups of M4 and CP2
eluted as sharp peaks at fractions 22 and 31, respectively (not
shown). This wide separation suggested that the head group of
M4 contains less negative charge than the one of CP2. To assay
directly for a side chain on Man1 of M4, the head group of
[3H]Ins-labeled M4 was first cleaved by acetolysis, a procedure
which, under mild conditions, selectively cleaves a1,6-glyco-
sidic bonds (Fig. 1). Here this procedure is expected to produce
the labeled fragment (X-P3?)Mana1,4-GlcNa1,6-[3H]Ins with
X-P- being the substituent in question. The fragment was then
either treated with JBAM or control incubated and finally
dephosphorylated by HF, N-acetylated, and analyzed by paper
chromatography. As can be seen in Fig. 6, A and B, the (X-
P3?)Mana1,4GlcNa1,6Ins fragment of M4 is JBAM-resistant,
since successive treatment by acetolysis, JBAM, and then HF
generates Mana1,4GlcNa1,6Ins. The same had previously been
found for CP2 (22). Thus, the difference between the head
groups of M4 and CP2 cannot be explained by the presence or
absence of an HF-sensitive substituent on Man1: both lipids
have the same classical Man4-GlcN-Ins carbohydrate core stru-
cture, they both contain HF sensitive groups on Man1 and
Man3 (Fig. 1), but they migrate differently on TLC, and their
non-dephosphorylated head groups elute differently on Dionex
FIG. 4. Characterization of M4. A, gpi7-1 cells were preincubated
at 37 °C for 20 min and were labeled with [3H]Ins (2 mCi/A600). Lipid
extracts were treated (1) or control incubated (2) with either JBAM or
GPI-PLD or were deacylated by mild base treatment (NaOH). Desalted
products were analyzed by TLC (solvent 2) and fluorography. B, sec53
and Dgpi7 were preincubated and labeled with [3H]Ins at 37 °C (5
mCi/A600), and lipid extracts were treated with PI-specific phospho-
lipase C to get rid of labeled PI, and the GPI intermediates M0 and M4
were purified from sec53 and Dgpi7, respectively, by two rounds of
preparative TLC. Anchor peptides were prepared from [3H]Ins-labeled
W303 in the experiment described in Table I. M4 and anchor peptides
were treated with HNO2 to liberate the acyl-[
3H]Ins-P-lipid and
[3H]Ins-P-lipid moieties, respectively (Fig. 1). Samples were incubated
with (1) or without (2) methanolic NH3 to remove the acyl from the Ins,
desalted and separated by TLC (solvent 1), and processed for fluorog-
raphy. pG1, protein-derived glycerophospholipid 1; pC1 and pC2, pro-
tein-derived ceramides 1 and 2, see Sipos et al. (41). Other results of this
same experiment were described before (Ref. 41, therein Fig. 2).
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HPLC (data presented above and in Refs. 22 and 23). We thus
hypothesized that CP2 may contain either additional HF-
sensitive groups on GlcN, Man1, Man2, or Man3 or may con-
tain additional groups linked through the amino group of the
EtN-P on M1. Of these several theoretical possibilities, the only
ones that have been documented in other organisms are the
Man1-P group on the GlcN in Paramecium aurelia (43) and the
EtN-P group on Man2 in several mammalian GPI proteins, e.g.
human erythrocyte acetylcholinesterase (44), CD52-II (45), and
bovine liver 59-nucleotidase (46). We used limiting HF treat-
ment to test specifically if CP2 contains an HF-sensitive group
on Man2. If we assume that during HF treatment the EtN-Ps
are hydrolyzed in a random order, we may expect to find some
reaction intermediates lacking the HF-sensitive group on
Man3 while retaining EtN-P on Man2 or Man1. When such
intermediates subsequently are treated with JBAM and then
are dephosphorylated to completeness with HF, they should
yield Man2-GlcN-Ins and Man1-GlcN-Ins fragments, respect-
ively. For preliminary tests, CP2 head groups were first treated
with HF for 0.5, 1, 3, 9, 12, 18, or 28 h, then with JBAM, and
finally with HF for 60 h. These experiments showed that both
Man2-GlcN-Ins and Man1-GlcN-Ins fragments became visible
after 1 h of limiting HF treatment, peaked at 12 h, and rema-
ined detectable at all time points up to 28 h. In quantitative
terms it appeared that Man3-GlcN-Ins . Man2-GlcN-Ins $
Man1-GlcN-Ins at all time points. Importantly, treatment of
the head group of CP2 with HF for 12 h yielded substantial
amounts of Man2-GlcN-Ins and Man1-GlcN-Ins (Fig. 6C),
whereas the identical treatment performed with the head
group of M4 only yielded Man1-GlcN-Ins but no Man2-GlcN-Ins
(Fig. 6D). This result is compatible with the idea that Dgpi7
cells are unable to add an HF-sensitive group onto Man2 of the
GPI core (Fig. 1). It also confirms the presence of an HF-sensit-
ive group on Man1 of both M4 and CP2.
The Lipid Moieties of GPI Intermediates in Dgpi7 Are Nor-
mal—We looked for additional differences between M4 and
CP2 by analyzing the lipid moiety of M4. M4 is sensitive to
GPI-specific phospholipase D (GPI-PLD) and mild base treat-
ment (Fig. 4A, lanes 3–6), suggesting that its lipid moiety
consists of Ins-P-DAG. We previously reported that M4 is re-
sistant to PI-specific phospholipase C (21). This finding, to-
gether with the GPI-PLD sensitivity, can be taken as an indi-
cation for the presence of an acyl moiety attached to the Ins of
M4. We further released the (acyl3)Ins-P-DAG moiety of M4
with HNO2 as described recently (41). As shown in Fig. 4B, the
treatment of purified M4 by HNO2 produced a very hydropho-
bic species, which migrates very closely to M0, i.e. the
GlcN(acyl3)Ins-P-DAG accumulating in sec53 (Fig. 4B, lanes 7
and 9) (41). (As reported previously, the presence of GlcN on
these early precursors does not significantly influence their
migration in TLC, for discussion see Sipos et al. (41).) Partial
deacylation of the M4-derived lipid moiety by NH3 produced PI
and lyso-PI (Fig. 4B, lane 10). This PI was compared with pG1,
the PI species obtained by HNO2 treatment of protein-bound
GPI anchors from the corresponding wt strain (Fig. 4B, lane
11). The comparison shows that M4 contains a PI moiety that
migrates clearly less than pG1, whereas a lyso-PI of M4 mi-
grates slightly more than the lyso-PI species generated by
methanolic NH3 treatment of anchor peptides (Fig. 4B, lanes 10
and 12). Very similar results had been obtained previously
when comparing protein-derived PI moieties with the PI moi-
eties of M0 from sec53 and of CP2 from gpi8-1 (41). In addition
we isolated from Dgpi7 the recently identified GPI intermedi-
ates that are obscured in TLC by PI and inositol phosphocer-
amides (Ref. 41, therein Fig. 6A), and we found that they are
exactly the same as the corresponding intermediates from wt
cells by all criteria (not shown). Thus, it seems that M4 and
other GPI intermediates of Dgpi7 contain the same PI moiety
as early and late GPI intermediates accumulating in other
mutants or in wt cells, and we therefore conclude that the
difference between CP2 and M4 is solely due the difference in
their head groups.
Lack of Gpi7p Affects the in Vitro Biosynthesis of GPI Pre-
cursor Lipids—When yeast microsomes are incubated in the
presence of UDP-[3H]GlcNAc, ATP, coenzyme A, GDP-Man,
and tunicamycin, they generate labeled GPI intermediates as
the only kind of labeled lipids (22, 47). Wild type microsomes
make GPI intermediates up to CP2. Although a large array of
incomplete intermediates is also generated, the pattern of la-
beled intermediates is fairly reproducible. When we used Dgpi7
FIG. 5. Analysis of the head group of M4 using HF, JBAM, and
ASAM. Dgpi7 was labeled with [3H]Ins at 37 °C; M4 was purified and
used to prepare head groups. Head groups were subjected to HF and
N-acetylation (A); JBAM, then HF, then N-acetylation (B); HF, then
N-acetylation, then desalting, then JBAM (C); HF, then N-acetylation,
then desalting, then ASAM (D). The thus generated fragments were
separated by paper chromatography, and radioactivity contained in
1-cm wide strips was determined through scintillation counting. The
position of standards run in parallel on the same paper are indicated:
2–4, Manx-GlcNAc-Ins with x 5 2, 3, or 4. 0, GlcNAc-Ins.
FIG. 6. M4 of Dgpi7 contains an HF-sensitive substituent on
Man1 but lacks an HF-sensitive substituent on Man2. CP2 and
M4 head groups were obtained from [3H]Man labeled pmi40 and
[3H]Ins labeled Dgpi7, respectively. A and B, head groups of M4 were
subjected to acetolysis and then either treated with JBAM (B) or left
untreated (A). Finally all products were dephosphorylated with HF,
N-acetylated, and analyzed by paper chromatography. C and D, head
groups were treated for 12 h with HF, desalted, treated with JBAM,
treated with HF for 60 h, N-acetylated, and finally analyzed by paper
chromatography. Standards 0–4 are Manx-GlcNAc-Ins (x 5 0, 1, 2, 3, 4).
Free [3H]Man ran out of the paper shown in C.
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microsomes, they reproducibly made all the normal intermedi-
ates down to a band comigrating with M4 of [3H]Ins-labeled
Dgpi7 cells, but they consistently failed to make CP2 (Fig. 7).
When the labeled lipid extract was treated with JBAM, most of
the band comigrating with M4 was shifted to a less hydrophilic
position, much in the same way as seen for [3H]Ins-labeled M4
(Fig. 2, lanes 1 and 2). Thus, the M4 accumulation of Dgpi7 can
be reproduced in vitro. This result implies that the Gpi7p
present in wt microsomes is functional in vitro.
Characterization of Gpi7p—Gpi7p was characterized using
affinity purified rabbit antibody made against the N-terminal,
hydrophilic part of GPI7 (Fig. 3B). As shown in Fig. 8A, the
antibody recognized a heterogeneously glycosylated 208-kDa
protein, the estimated molecular mass of various glycoforms
ranging, after heavy exposure, from about 130 to 230 kDa (Fig.
8A, lane 2). The predicted mass of the protein before and after
removal of the signal sequence is 94,832 and 92,207 Da, respec-
tively. In glycosylation mutants Doch1/mnn1 or mnn9 which
are totally or partially deficient in the elongation of N-glycans
in the Golgi, Gpi7p has an estimated mass of 108 and 115 kDa,
respectively (Fig. 8A, lanes 1 and 7). pmi40 has a ts deficiency
in Man biosynthesis that is partial at 24 °C (48). In pmi40
grown at 24 °C the average mass of Gpi7p is around 150 kDa
(Fig. 8A, lane 6). (This suggests that full elongation of N-
glycans is not necessary for Gpi7p function since, when shifted
from 24 to 37 °C, pmi40 cells are able to make CP2 (23).)
Tunicamycin treatment of wt or pmi40 cells resulted in the
appearance of a single, relatively sharp band of an apparent
molecular mass of about 83 kDa (Fig. 8A, lanes 3 and 5). The
protein could also be deglycosylated to an apparent molecular
mass of 86 kDa by treatment with endoglycosidase H (not
shown). All these data concurrently indicate that Gpi7p con-
tains several N-glycans that are heavily elongated in the Golgi
but contains no or only few O-glycans. In the cell lysate Gpi7p
was rapidly degraded by an endogenous protease which, how-
ever, could be inhibited by 10 mM EDTA. Gpi7p is associated
with membranes since it could be sedimented by ultracentrif-
ugation of lysates at 100,000 3 g for 60 min (Fig. 8B, lanes 1
and 2). Gpi7p was neither dissociated from membranes by
NaCl nor sodium carbonate at pH 11, nor urea, but it was
efficiently solubilized by Triton X-100 or SDS (Fig. 8B). The
presence of an N-terminal signal sequence and the large
amount of N-glycans suggested that the hydrophilic N-termi-
nal part of the protein, which contains 3 of the 5 potential
N-glycosylation sites, would reside on the lumenal or ectocyto-
plasmic side of the membrane. We tried to confirm this orien-
tation by protease protection assays on microsomes. As shown
in Fig. 8C, neither Gpi7p nor Wbp1p, which was used as a
control, were degraded by proteinase K unless microsomes
were permeabilized with Triton X-100. Wbp1p has been dem-
onstrated to be a lumenal ER protein (49), and our result thus
shows that the N-terminal hydrophilic part of Gpi7p is not
accessible to protease in these microsomes. It is noteworthy
that proteinase K did not reduce the molecular mass of Gpi7p,
thus indicating that the cytosolic loops between the predicted
transmembrane domains of the C-terminal part of Gpi7p are
not accessible to proteinase K in native microsomes.
The cellular localization of Gpi7p was investigated by sub-
cellular fractionation as shown in Fig. 8D. Differential centrif-
ugation at 8,000 and 100,000 3 g for 10 and 60 min, respec-
tively, achieved satisfactory separation of the Golgi markers
Kex2p and Och1p from the ER marker Wbp1p and from the
vacuolar alkaline phosphatase. We were concerned that the
relative amounts of these proteins in the 100,000 3 g pellet
FIG. 7. Microsomes of Dgpi7 synthesize M4 and not CP2. Micro-
somes of W303 wild type or Dgpi7 were incubated with 6 mCi of UDP-
[3H]GlcNAc, GDP-Man, tunicamycin, and ATP for 1 h at 37 °C as
described (22). The glycolipid products were extracted and then run on
TLC with solvent 2. The extract in lane 3 was first treated with JBAM.
On the basis of the preceding analysis the band denoted with an
asterisk can be presumed to be an M4 derivative in which Man4 has
been removed.
FIG. 8. Membrane association, orientation, and localization of
Gpi7p. A, exponentially growing cells were broken with glass beads in
TEPI buffer as described (19); lysates were centrifuged at 10,000 3 g for
15 min at 4 °C, and microsomal pellets were processed for SDS-PAGE.
Cells in lanes 3 and 5 had been grown in 20 mg/ml tunicamycin (Tm) for
90 min. B–D, exponentially growing W303 cells were broken with glass
beads using the buffers indicated under “Experimental Procedures,”
and cell wall debris was removed by centrifugation at 600 3 g. B,
aliquots of cell lysate were incubated for 30 min at 0 °C with 0.5 M NaCl,
0.8 M urea, 1% Triton X-100 (TX-100), 0.1 M Na2CO3, pH 11, or 1% SDS.
Subsequently membranes were sedimented by ultracentrifugation to
get supernatant (S) and pellet (P) fractions. C, cell lysate was sedi-
mented at 13,000 3 g for 15 min, and the membrane pellet was thor-
oughly resuspended and digested with 10 or 25 mg/ml proteinase K (prot
K) at 0 °C for 20 min in the presence or absence of 0.5% Triton X-100.
D, cell lysates were subjected to differential centrifugations at 8,000
and 100,000 3 g. These centrifugations generated pellet P8 containing
ER, PM, and vacuolar membranes and pellet P100 which contains Golgi
membranes. The 8,000 3 g supernatant was also precipitated with
trichloroacetic acid (TCA). In all panels the lanes contain material
derived from 1 A600 of cells except for lanes 1 and 7 of A which contain
0.3 A600.
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may be underestimated due to ongoing proteolytic degradation
during the 100,000 3 g spin. Therefore the supernatant of the
8,000 3 g spin was split whereby proteins were immediately
precipitated with trichloroacetic acid in one half, and the other
half was pelleted at 100,000 3 g. Gpi7p was exclusively found
in the 8,000 3 g pellet (P8) and thus is associated with either
the ER, the vacuole, or the PM but not with the Golgi. As shown
in Fig. 9A low amounts of proteinase K added to intact cells
hydrolyzed all of the mature Gpi7p. In contrast, Wbp1p and the
105-kDa ER form of Gas1p were completely resistant to this
treatment unless membranes were permeabilized with Triton
X-100 (Fig. 9A, lane 6). The mature 125-kDa form of Gas1p was
found to be partially resistant to proteinase K, indicating either
a tighter interaction of Gas1p with some cell wall components
or the existence of an internal pool of Gas1p as proposed earlier
(50). Crude zymolyase treatment of intact cells also removed all
of the mature form of Gpi7p (Fig. 9B), whereas recombinant
zymolyase left Gpi7p intact (not shown). Longer exposures
showed the presence of several minor bands of smaller size all
of which were also present in Dgpi7 cells except for a 108-kDa
form of Gpi7p (Fig. 9C, lanes 7 and 8). This material seems to
be an ER form in transit to the surface since it was no more
detectable if cells were preincubated with either cycloheximide
or tunicamycin (Fig. 9C, lanes 1–6). These data also indicate
that mature Gpi7p is relatively rapidly degraded or becomes
resistant to extraction with SDS. Globally these data indicate
that the bulk of Gpi7p is exposed at the cell surface but that a
small amount of core-glycosylated material is found in the ER
in transit to the cell surface. For the moment it is unclear why
Gpi7p was completely protected in microsomes, since it has
been claimed that PM does not form closed vesicles upon ho-
mogenization (51). It is conceivable that Gpi7p resides in spe-
cial PM subdomains that form closed vesicles upon homogeni-
zation or that centrifugation of microsomes generated protease-
resistant membrane aggregates (51).
Deletion of GPI7 Alters GPI Protein Transport and Remod-
eling—We previously reported on the accumulation of the im-
mature 105-kDa ER form of Gas1p in gpi7 mutants (21). We
therefore investigated GPI protein transport in Dgpi7. Indeed,
by pulse-chase experiments we found that the maturation of
GPI proteins Sag1p and Gas1p was slowed 2–3-fold as com-
pared with wt cells, whereas the maturation of carboxypepti-
dase Y proceeded with normal kinetics (not shown). This indi-
cates that the transport of GPI proteins in Dgpi7 is specifically
retarded. Nevertheless, in rich media Dgpi7 cells grow at
roughly the same rate as wt cells. They also incorporate [3H]Ins
with the same efficiency as wt cells.
The lipid remodeling of GPI anchors is significantly altered
in Dgpi7. As seen in Table I, the proportion of ceramides (pC1
and pC2) in anchor peptides from Dgpi7 is drastically de-
creased, whereas the fraction of DAG-containing lipids ((pG1)
is correspondingly increased. It should be noted that at the
time of analysis, i.e. 75 min after addition of [3H]Ins, the
relative amounts of mild base-sensitive and mild base-resistant
anchors are no longer changing and represent the steady state
proportion of these two anchor types (41, 52). It is important to
realize that pG1 also represents a remodeled form of the anchor
lipid in which a long chain fatty acid has replaced the original
fatty acid present in sn-2 of the glycerol of the CP (Fig. 1). It
thus appears that the relative decrease of ceramide remodeling
goes along with a compensatory increase in DAG remodeling. A
relative reduction in ceramide remodeling was also observed
when we compared the efficiency of [3H]Ins and [3H]dihy-
drosphingosine ([3H]DHS) incorporation into GPI proteins. As
can be seen in Fig. 10, the ratio of [3H]DHS/[3H]Ins incorpora-
tion into proteins is much higher in wt than in Dgpi7 (Fig. 10,
lanes 1–4). The lack of incorporation of [3H]DHS in Dgpi7
cannot be explained by an increase of the endogenous produc-
tion of DHS in Dgpi7, since the difference between wt and
Dgpi7 persists, even when all endogenous DHS biosynthesis is
blocked by myriocin (Fig. 10, lanes 5 and 6). The defect in
FIG. 9. Gpi7p is localized at the cell surface. Cells in the early
exponential phase growing at 30 °C in YPD were used. A, intact W303
cells were treated with cysteamine chloride and then treated with the
indicated concentrations of proteinase K (prot K) exactly as described
(65) except that the EDTA concentration was raised to 20 mM. In lane
6, Triton X-100 was added to 1%. B, W303 cells were treated with
zymolyase 20T at the indicated concentrations. C, W303 or Dgpi7 cells
were either lysed directly or after having been incubated for 30 or 60
min at 10 A600/ml in the presence of cycloheximide (200 mg/ml) or
tunicamycin (Tm, 20 mg/ml). Cells were lysed by boiling in sample
buffer and processed for SDS-PAGE and Western blotting with anti-
bodies against Gpi7p, Gas1p, or Wbp1p.
TABLE I
Quantitation of GPI anchor lipids
Cells were labeled with [3H]Ins (5 mCi/A600) for 75 min at 37 °C.
Incorporation of [3H]Ins into lipids ranged from 43 to 49% of the radio-
activity added to cells. Proteins were extensively delipidated, and an-
chor peptides were prepared as described (41). Anchor peptides were
treated with HNO2 to liberate the [
3H]Ins-P-lipid moieties; the products
were desalted by partitioning between butanol and water, and the
labeled lipid products were separated by TLC and quantitated by ra-
dioscanning. Results of the quantitation of anchor lipids pG1, pC1, and
pC2 are given as percentage of the total radioactivity of anchor pep-
tides. The remaining 7–11% that are not accounted for stayed at the
origin and represent residual anchor peptides that had not been cleaved
by HNO2 treatment. An aliquot of W303 anchor lipids is shown in Fig.
4B, lane 11.
pG1 pC1 pC2
W303 22.2 63.6 7.4
X2180 24.2 61.2 4.8
gpi8–1 23.8 63.9 2.6
Dgpi7 68.8 19.3 1.1
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remodeling seems to be affecting mostly the maturation pro-
cesses in the Golgi and/or PM (Golgi/PM remodeling) since, as
shown in Fig. 10, lanes 7–10, the ratio of [3H]DHS/[3H]Ins
incorporation into proteins in the Dgpi7/sec18 double mutant
was the same as in sec18. Also, when using stringent conditions
under which one observes only ER or only Golgi/PM remodelase
(24), remodeling in the ER appeared relatively normal,
whereas remodeling in the Golgi/PM was reduced (Fig. 10,
lanes 11–14, 119, and 129). The relatively low amount of pC2 in
anchor lipids of Dgpi7 (Table I) may be a consequence of this
relative deficiency of Golgi/PM remodeling, since pC2 type an-
chors are only generated by the Golgi/PM but not the ER
remodelase (24, 41). The relationship between the specific re-
tardation of GPI protein transport, reduced Golgi/PM remod-
eling, and increased remodeling toward pG1 is for the moment
unclear.
DISCUSSION
Yeast and mammals contain the same GPI carbohydrate core
structure. This suggests that the GPI anchoring pathway has
been established early in evolution and has rigorously been
conserved in widely diverging organisms. On the other hand,
the side chains added to this core as well as the lipid moieties
of the anchor tend to vary a lot between different species (1).
The GPI anchors of S. cerevisiae contain two types of side
chains as follows: one or two mannoses are linked to Man3 (53)
and an EtN-P side chain is linked to Man1.3 Both side chains
are already present on the precursor lipid CP2 (22, 23). These
two side chains are also found in some vertebrates, including
mammals, and possibly in Dictyostelium discoideum (1), sug-
gesting that not only the GPI core structure but also certain
kinds of side chains have been invented in and conserved since
early times of evolution. Here we present evidence for yet a
further, possibly conserved HF-sensitive substituent on CP2
which is attached to Man2. So far, the only side chain attached
to Man2 reported in the literature is EtN-P. EtN-P was found
by mass spectrometry on 15% of anchors of human erythrocyte
cholinesterase and 3% of bovine liver 59-nucleotidase (44, 46).
Partial acid hydrolysis has also indicated an HF-sensitive sub-
stituent on Man2 in 40% of CD52-II (45). Analysis of the eth-
anolamine/Ins ratio in GPI anchors of porcine renal membrane
dipeptidase and of human placental alkaline phosphatase
yielded values of 2.5 and 2.4, suggesting the presence of EtN-P
on Man2 in 50 and 40% of their anchors, respectively (54, 55).
However, no such side chain was detected in other mammalian
GPI proteins such as rat brain Thy-1 glycoprotein (56) or ham-
ster scrapie prion (57). It may be that in many studies part or
all of EtN-P side chains on Man2 and Man1 were hydrolyzed by
an unspecific phosphodiesterase during the purification of the
respective GPI proteins and preparation of anchor peptides
using Pronase. Such a phosphodiesterase activity may explain
why we failed to detect any EtN-P side chain on GPI-anchored
yeast proteins in the past (53), although we now have firm
evidence for the presence of an HF-sensitive substituent on
Man1.3 The chemical nature of the side chain on Man2 of CP2
remains to be determined. The presence of an HF-sensitive side
chain on Man2 of CP2 has its parallel in human cells. Indeed,
there is evidence for an HF-sensitive group on Man2 of H8, the
most polar GPI lipid of HeLa cells (58). The EtN-P side chains
on Man1 and Man3 being conserved between mammalian or-
ganisms and yeast, it appears reasonable to speculate at this
point that the analogy between mammalian and yeast anchors
may extend to the substituent on Man2, i.e. that also the side
chain on Man2 of yeast GPI structures may consist of an EtN-P
and that this EtN-P may be present on some mature GPI
proteins of S. cerevisiae.
Dgpi7 cells are hypersensitive to Calcofluor White and hence
have some difficulty in constructing their cell walls. Several
reasons can be envisaged. (i) The side chain on Man2 may be
important for the interaction of CPs with the transamidase
complex and for their efficient transfer onto proteins. Recent
data show that a small reduction of Gpi8p renders transami-
dase activity rate-limiting.3 The synthetic effect of gpi7 muta-
tions with gpi8 mutations suggests that deletion of GPI7 may
have a similar effect. A decreased transamidase activity may
particularly affect the anchoring of certain GPI proteins that
have a low affinity for the transamidase even though the global
rate of GPI biosynthesis and [3H]Ins incorporation into pro-
teins of Dgpi7 is not grossly reduced. Thus it is conceivable that
some GPI proteins important for cell wall architecture are
lacking in Dgpi7. (ii) The side chain on Man2 may serve as an
attachment point for the covalent linkage of b1,6-glucans to the
anchor moiety of cell wall proteins although a recent analysis of
the linkage region between the GPI anchor remnant and b1,6-
glucans rather showed a direct glycosidic linkage between
Man1 and the b1,6-glucan (6). (iii) The side chain may serve as
a recognition signal for enzymes or proteins that facilitate the
packaging of GPI proteins into vesicles, for remodelases that
3 I. Imhof, U. Meyer, A. Benachour, I. Flury, E. Canivenc-Gansel, C.
Vionnet, and A. Conzelmann, manuscript in preparation.
FIG. 10. Ceramide remodeling of GPI anchors is reduced in Dgpi7. Cells growing exponentially in SDCUA were used. Cells were labeled
by the addition of either 25 mCi of [3H]DHS (D) or [3H]Ins (I) to an aliquot of 2.5 A600 of cells exactly as described (24). Lanes 1–6, precultures and
labelings were at 30 °C. Cells were preincubated with (1) or without (2) 40 mg/ml of myriocin (myr) for 20 min before addition of the radiotracers.
Lanes 7–10, sec18 or sec18 Dgpi7 double mutants were precultured at 24 °C and preincubated for 10 min at 37 °C before addition of the tracers.
Lanes 11–14, cells were labeled in the presence of cycloheximide under conditions in which only the Golgi/PM remodelase (lanes 11 and 12) or only
the ER remodelase (lanes 13 and 14) is probed (Ref. 24, therein Fig. 7 (Golgi/PM remodelase) and Fig. 8 (ER remodelase)). All samples were
processed for SDS-PAGE under reducing conditions and fluorography. Lanes 119 and 129 were scanned at an increased sensitivity.
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exchange their lipid moieties, or for hydrolases or transglyco-
sidases that remove parts of the GPI anchor of cell wall pro-
teins and hook the GPI remnant onto b1,6-glucans (4, 5).
Our data further show that ceramide remodeling in the
Golgi/PM is significantly reduced in Dgpi7, whereas remodeling
toward pG1 is increased whereby it is not clear if pG1 remod-
eling is increased because ceramide remodeling is decreased or
if ceramide remodeling is decreased because pG1 remodeling is
increased. Moreover, the relationship of the alteration of GPI
remodeling with the other phenotypic changes of Dgpi7can be
explained in several ways. (i) Previous studies showed that
remodeling toward pG1 occurs in the ER and that retention of
GPI proteins in the ER in secretion mutants maintains a high
pG1/pC1 ratio on these proteins (41). Thus, if the substituent
on Man2 of GPI anchors is important for efficient packaging of
GPI proteins into transport vesicles, the delay in export of GPI
proteins out of the ER may give the ER remodelase generating
pG1 prolonged access to the GPI proteins and may thus cause
a relative increase of pG1. (ii) The side chain on Man2 may
serve as a recognition signal for Golgi/PM remodelase. (iii) We
also considered the possibility that Gpi7p itself may be a
Golgi/PM remodelase. This latter hypothesis would not directly
explain why Dgpi7 cells cannot attach the HF-sensitive substit-
uent onto Man2 and would imply that the addition of this side
chain somehow is directed by the prior attachment of a ceram-
ide moiety. This, however, is clearly not the case, since CP2 also
contains the HF-sensitive side chain on Man2, although its
lipid moiety consists of DAG (23). Thus we believe that the
reduced Golgi/PM remodeling of GPI proteins in Dgpi7 is sec-
ondary to the lack of a substituent on Man2.
Our previous data suggested that CP2 can be transferred to
proteins (23), and our working hypothesis until recently as-
sumed that CP2 represents the GPI lipid used for GPI anchor-
ing also by normal cells that do not accumulate this lipid (“CP2
hypothesis”). By consequence we would have predicted that all
the enzymes required for the elaboration of CP2 are localized in
the ER. Paradoxically, the subcellular fractionation experi-
ments and protease treatment of intact spheroplasts strongly
suggest that the bulk of Gpi7p resides at the cell surface (Fig.
9, A and B). Moreover, although we recently succeeded in
demonstrating the presence of an HF-sensitive group on Man1
of immature ER forms of GPI proteins, we presently lack the
tools to look for such a group on Man2. Thus, the so far avail-
able data raise a doubt whether it is CP2 which is added to GPI
proteins in the ER, and we therefore are presently considering
the possibility that other GPI lipids than CP2 are the physio-
logical substrate of the ER transamidase. In fact, neither CP2
nor M4 can be detected in wt cells. It therefore seems possible
that under physiological conditions cells add M4 to GPI pro-
teins (“M4 hypothesis”) and that CP2 is elaborated only in
mutants in which M4 cannot be transferred to proteins, spills
out of the ER, and reaches the PM. It is noteworthy that Dgpi7
incorporates [3H]Ins at a normal rate into proteins suggesting
that the transamidase is perfectly able to transfer M4. Thus,
the side chain on Man2 may normally not be added to GPI
proteins or only be added after GPI proteins arrive at the cell
surface. The M4 hypothesis, however, does not explain why M0
and M4 accumulate in Dgpi7, whereas M0, M4, and CP2 re-
main undetectable in wt cells (Fig. 2, lanes 1 and 2) or why
gpi8-1, deficient in the transfer of GPIs onto proteins, accumu-
lates CP2 (19, 21). It also fails to explain the delayed matura-
tion of GPI proteins and the reduced rate of GPI remodeling
observed in Dgpi7. To save the M4 hypothesis, the accumula-
tion of GPI intermediates in Dgpi7 could be rationalized by
assuming that the substituent on Man2 serves to mark super-
numerary GPIs for degradation, but also this assumption does
not explain the observed accumulation of CP2 in gpi8. Thus,
although our results raised the possibility that M4 is the phys-
iological GPI lipid for GPI anchoring, this M4 hypothesis leaves
many results unexplained and the data are more easily ex-
plained by our original CP2 hypothesis. For one, the synchro-
nous accumulation of M4 and CP2 in all our gpi8 mutants
argues that M4 is not a better substrate for the transamidase
than CP2. CP2 may physiologically be produced by the small
amount of Gpi7p in the ER (Fig. 9C). Alternatively, it is con-
ceivable that M4 is transported from the ER to the PM, is
converted there to CP2, and is then transported back to the ER
by some not yet elucidated mechanism. In this context it is
noteworthy that the biosynthesis of GPIs by wt microsomes in
vitro produces CP2 in good yield, i.e. the in vitro system adds
the substituent on Man2. This in vitro system does not contain
cytosol nor GTP and hence should not support vesicular trans-
port from ER- to Golgi-derived microsomes (59). It is possible,
however, that GPI lipids are transported between microsomes
or membrane fragments by means of lipid transfer proteins or
through direct contact between membranes. It also can be
envisaged that juxtaposition of membranes allows enzymes
present in one membrane to work on lipids in another mem-
brane. The same mechanisms may also operate in intact cells.
Clearly the identity of the physiological GPI lipid substrate of
the transamidase will have to be established by further
experiments.
Homology searches show that two ORFs of S. cerevisiae are
related to GPI7, MCD4 (5 YKL165c), and YLL031c. They be-
long to a novel gene family comprising for the moment the nine
members shown in Table II which, based on the many predicted
transmembrane domains, were previously classified as puta-
tive permeases (60). Pairwise alignment allows us to group
TABLE II
GPI7 has homologues in other species
Homologous sequences were compared by ClustalW at the European Bioinformatics Institute (www2.ebi.ac.uk/clustalw/). The aligned scores for
pairwise alignments are reported; a high score indicates high homology. ORFs that have not received gene names are indicated by their
chromosomal denominator (S. cerevisiae) or the NCBI protein identification number (PID). Subfamilies are separated by blank lines. Alignments
within a given subfamily are in bold. S.c., S. cerevisiae; S.p., Schizosaccharomyces pombe.
1 2 3 4 5 6 7 8 9
1 YJL062w 5 GPI7, S.c.
2 YA93, (1175452), S.p. 29
3 (1132507), C. elegans 22 26
4 YLL031c, S.c. 22 19 16
5 (2984587) homo sapiens 18 20 16 24
6 (2257562) S.p. 20 20 18 28 23
7 (2734088) C. elegans 19 19 16 21 20 23
8 MCD4, YKL165c S.c. 15 15 18 12 12 14 12
9 (2879870) S.p. 16 14 14 12 11 13 1 39
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them into three subfamilies of more closely related ORFs. All
nine ORFs predict membrane proteins of about 100 kDa having
an N-terminal signal sequence, a hydrophilic N-terminal part,
and multiple transmembrane domains in their C-terminal half.
mcd4 mutants were obtained in a screen for cells deficient in
the cell cycle controlled polarization of growth, a phenotype
also generated by mutations in the exocyst or in N-glycosyla-
tion (61). The subfamilies typified by GPI7 and YLL031c are
more closely related to each other than to the MCD4 subfamily.
All nine family members contain two conserved motifs at about
the same position in the hydrophilic N-terminal domain,
namely HXLGXDXXGH and DHGMXXXGXHG. These motifs
are also found in two EST clones from human cDNA that have
high homology to MCD4 (NCBI PID 1779747 and 1765215,
ClustalW alignments giving aligned scores of 46 and 35). Very
interestingly, by a reiterated Psi Blast search at the National
Center of Biotechnology Information (NCBI) (62) one can find a
highly significant homology of all three subfamilies with a
large family of phosphodiesterases. The large majority of these
homologous sequences encode mammalian cell-surface proteins
classified as alkaline phosphodiesterase I, nucleotide pyrophos-
phatase, or alkaline phosphatase. The homology comprises a
region of about 220–240 amino acids in the N-terminal hydro-
philic part of GPI7, YLL031c, and MDC4. The homology of
GPI7 in this region with mammalian and plant phosphodies-
terases amounts to 17–18% identity and 30–34% similarity
and comprises a motif PTXTX8TGX2P which is common to
bacterial, viral, plant, and mammalian phosphodiesterases.
This homology may suggest that Gpi7p itself is the transferase
adding the phosphodiester-linked substituent on Man2. In this
context it is interesting to note that the EtN-P on Man3 of the
GPI anchor has been shown to be transferred by transesterifi-
cation using phosphatidylethanolamine as donor of EtN-P (63,
64). Mutants in YLL031c also accumulate abnormal GPI inter-
mediates which on TLC have about the same mobility as M4
suggesting that YLL031c is similarly involved in adding
EtN-P.2 Thus, it is conceivable that not only the GPI7 subfam-
ily but also other subfamilies are involved in the transfer of
EtN-P onto the GPI core structure. However, the transesteri-
fication activity of Gpi7p will have to be shown directly before
one can exclude that the primary function of Gpi7p is to gen-
erate some signal from the cell wall which regulates GPI pro-
tein transport and remodeling as well as side chain addition to
GPI structures.
It is interesting that subfamily members belonging to differ-
ent species are more closely related to each other than family
members belonging to a single species. This can be seen when
comparing the pairwise alignment scores among the three
ORFs of S. cerevisiae or the three ORFs of Schizosaccharomyces
pombe with the scores among subfamily members (Table II). In
evolutionary terms this suggests that the divergence of these
three subfamilies occurred earlier than the separation of the
lineages leading to S. cerevisiae, S. pombe, and Caenorhabditis
elegans. This implies that the HF-sensitive group on Man2 is of
very ancient origin. GPI7 bears no resemblance with PIG-F, a
mammalian gene encoding for a highly hydrophobic membrane
protein involved in the addition of EtN-P to Man3 (10). The
exact role of PIG-F has not yet been elucidated.
It will be interesting to find the human homologues of GPI7.
It may be that this gene, as in S. cerevisiae, plays a more
dispensable role in GPI anchoring than the enzymes involved
in the elaboration of the carbohydrate core structure such as for
instance PIG-A/GPI3/CWH6/SPT14 (7). Thus, although defi-
ciencies in PIG-A are only acquired by somatic cells, deficien-
cies in the human GPI7 homologue may be transmittable
through the germ line as well.
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Additional results
Construction of a yeast strain expressing a GST-tagged form of Gpi7p
Proteins expressed as fusions with Schistosoma japonica glutathione S-transferase (GST)
can conveniently be purified using the commercially available glutathione sepharose. With
the aim to further characterize Gpi7p, we decided to construct a yeast strain that expresses
GST-tagged Gpi7p as the only source of Gpi7p. The GST tag was inserted in a wild-type
yeast strain at the C-terminus of the genomic copy of GPI7 by homologous recombination
with an insertion cassette containing the GST tag and the selectable marker KanMX6 as
described (Longtine et al., 1998). A clone in which the PCR-made insertion cassette was
targeted correctly, as verified by whole yeast cell PCR (Huxley et al., 1990), was labeled
with [3H]Ins to investigate if the presence of the GST tag interferes with the function of
Gpi7p. As can be seen in Figure 3-1, ∆gpi7 cells accumulate M4, whereas neither wild-type
cells nor cells expressing Gpi7p-GST accumulate this GPI intermediate. We therefore
conclude that the insertion of the GST tag at the C-terminus of Gpi7p does not disturb the
function of Gpi7p.
Figure 3-1. Cells expressing Gpi7p with a GST tag at the C-terminus have the same
lipid profile as wild-type cells.
Exponentially grown cells were labeled with [3H]Inositol (4 µCi/1-2 x 107 cells) at 30°C as
previously described. Lipids were extracted, desalted, and analyzed by TLC using solvent
1 (CHCl3/CH3OH/H2O 10:10:3 v/v/v) and fluorography. FBY413, wild-type; FBY182, ∆gpi7;
FBY1133, gpi7::GPI7-GST.
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Gpi7p migrates as a 245 kD band in blue native gel electrophoresis
In Saccharomyces cerevisiae as well as in mammalian cells, the first step of GPI
biosynthesis is carried out by a complex glycosyltransferase consisting of several proteins
(Leidich et al., 1995; Schönbächler et al., 1995; Vossen et al., 1995; Leidich and Orlean,
1996; Watanabe et al., 1998; Hong et al., 1999b; Watanabe et al., 2000). The GPI
transamidase that transfers the GPI glycolipid onto newly synthesized proteins is also a
multiprotein complex and consists of at least three subunits in yeast and four subunits in
mammalian cells (Fraering et al., 2001; Ohishi et al., 2001). To investigate if Gpi7p is
associated to any proteins under physiological conditions, we prepared digitonin extracts of
microsomes and analyzed the proteins by blue native gel electrophoresis. This technique
allows the analysis of native membrane protein complexes from biological membranes
under conditions that preserve tertiary and quaternary structures of the proteins (Schägger
and von Jagow, 1991; Schägger, 1996). Blue native gel electrophoresis has recently been
successfully used in our laboratory to investigate the interaction of Gpi8p with other
proteins (Fraering et al., 2001). We decided to use cells expressing Gpi7p with a GST tag
at its C-terminus rather than wild-type cells, since the GST tag allows convenient isolation
of Gpi7p (and its potential partners) by affinity chromatography over glutathione-sepharose.
The primary translation product of Gpi7p-GST has a predicted molecular weight of 121 kD.
Using mouse monoclonal anti-GST antibodies, we detected Gpi7p-GST at a molecular
weight of 245 kD, suggesting that Gpi7p-GST is associated with itself or with other
protein(s) (Figure 3-2).
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Figure 3-2. Blue native polyacrylamide gel electrophoresis of microsomal membrane
proteins.
FBY1133 (ura3-52 leu2-∆1 trp1-∆63 his3-∆200 gpi7::GPI7-GST KanMX6) cells were grown
overnight in YPDUA at 30°C. Cells were harvested, microsomes were prepared and
membrane proteins solubilized in digitonin in presence of 6-aminocaproic acid. Proteins
were processed for blue native polyacrylamide gel electrophoresis. Indicated amounts of
proteins were loaded on a 5 – 15% polyacrlyamide gradient gel. Proteins were transferred
onto a PVDF membrane and probed with anti-GST antibodies. Marker proteins were
bovine serum albumin (monomeric form, 66 kD), apoferritin (443 kD) and thyroglobulin
(660 kD).
Affinity purification of Gpi7p-GST and its putative partners
GST-tagged Gpi7p and its putative partner(s) were isolated by affinity chromatography
over glutathione sepharose from digitonin extracts of microsomes as described (Fraering et
al., 2001). Protein samples were analyzed by SDS-PAGE and silver staining. As can be
seen in Figure 3-3, at least four proteins (indicated with a, b, c and d, respectively) were
eluted with reduced glutathione.
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Figure 3-3. Affinity chromatography purification of Gpi7p-GST and its putative
partners.
Lysate of FBY1133 (GPI7-GST) and FBY413 (wt) cells was incubated with glutathione
sepharose 4B. Material bound to the resin was eluted with the use of 10 mM, then 20 mM
reduced glutathione (eluates E10 and E20, respectively, derived from 300 OD600). Crude
lysate (2.5 OD600), material not bound to the resin (5 OD600) and washes (75 OD600) were
loaded on a 6-15% polyacrylamide gel for SDS-PAGE. The gel was stained with silver
nitrate. The bands labeled with a, b, c and d correspond to proteins that are absent in the
control samples.
Discussion
Using the polyclonal antibody raised against the N-terminal hydrophilic part of Gpi7p, we
have shown that the bulk of Gpi7p is localized at the cell surface, and that a small amount
of Gpi7p is found in the ER (Benachour et al., 1999). The cell surface localization of Gpi7p
was unexpected, since the biosynthesis of the GPI anchor is initiated in the ER, and also
the transfer of the preassembled GPI to the protein takes place in this organelle. An
important issue in this context is to determine whether a) the ER-form of Gpi7p and b) the
plasma membrane-bound form of Gpi7p are catalytically active. To date, studies to address
this question have not succeeded (Vionnet and Conzelmann, unpublished results). If
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surface-localized Gpi7p is the only catalytically active form of this enzyme, this could mean
that GPI intermediates cycle between the ER and the plasma membrane before
attachment to proteins, or else that the physiological precursor lipid for GPI anchoring is
M4.
We have shown that insertion of the relatively large GST tag at the C-terminus of Gpi7p
does not interfere with the function of Gpi7p, since cells expressing the tagged form as only
source of Gpi7p do not accumulate GPI intermediates.
Blue native gel electrophoresis was used to investigate if Gpi7p might be present in a
complex under physiological conditions. We prepared microsomes of cells expressing
Gpi7p-GST and analyzed solubilized membrane proteins under conditions that preserve
tertiary and quaternary structures of protein complexes. The results obtained for Gpi7p-
GST were encouraging for further experiments, since using anti-GST antibodies, we could
detect a band of 245 kD, suggesting that Gpi7p might stably interact with another protein
(Figure 3-2). Indeed, a preliminary affinity purification revealed several bands that
specifically co-eluted with Gpi7p-GST (Figure 3-3). These experiments will have to be
repeated in order to prepare sufficient amuonts of proteins for analysis by mass
spectrometry. Since it has been reported that human GPI7 is associated with PIG-F (Hong
and Kinoshita, 2001), it will be interesting to find out if the same is true in yeast.
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4. Further characterization of GPI13, MCD4 and GPI7
Introduction
Results obtained in several studies (Benachour et al., 1999; Gaynor et al., 1999; Hong et
al., 1999a; Flury et al., 2000; Hong et al., 2000; Taron et al., 2000) strongly suggest that
the three homologous proteins Mcd4p, Gpi7p and Gpi13p are required for the addition of
EthN-P to the first, second and third Man residue of the GPI core, respectively. A
hydropathy plot and a sequence alignment of these proteins is shown in Figures 4-1 and 4-
2. Consistent with a role for Mcd4p in addition of EthN-P to Man1, we have shown that
mutants deficient in MCD4 accumulate a GPI intermediate that lacks EthN-P on the first
Man residue. We have also further characterized cells depleted of Gpi13p and Mcd4p,
respectively.
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Figure 4-1. Kyte-Doolittle hydropathy plot of Gpi13p, Gpi7p and Mcd4p.
The hydropathy plots were generated with DNA Strider 1.3 program.
Figure 4-2 (next page). Sequence alignment of Gpi13p, Gpi7p and Mcd4p.
Homologies of Gpi13p, Gpi7p and Mcd4p were identified using the ClustalW (version 1.8)
program at EBI. Asterisks, colons and periods indicate identity, strong similarity and weak
similarity, respectively.
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GPI13           MDEKTIKKSILSSSNDEKIIYKSRIKKFQKNHKFYIILLVFIAILQFISIAFFTRGFLLS 60
GPI7            ----------------------------MNLKQFTCLSCAQLLAILLFIFAFFPRKIVLT 32
MCD4            ----------------------------MWNKTRTTLLAVGVLFHLFYLWSIFDIYFISP 32
                                               :    :  . :    :   ::*   :: .
GPI13           RHVLDNISSQNETSKLPPRFNKAVILVIDALRFDFAIPVNESHSNYNLNYHNNILSLYDS 120
GPI7            GISKQDPDQDRDLQRDRP-FQKLVFVIIDALRSDFLFDSQISHFNNVHQWLN-------- 83
MCD4            LVHGMSPYQSTPTPPAKR----LFLIVGDGLRADTTFDKVTHPVSGKTEFLAPFIR---- 84
                     .  ..             .::: *.** *  :       .   ::
GPI13           FASDKDASSLLLKFIADPPTTTLQRLKGLTTGSLPTFIDAGSNFDG------TVIEEDNF 174
GPI7            -----TGEAWGYTSFANPPTVTLPRLKSITTGSTPSFIDLLLNVAQD-IDSNDLSEHDSW 137
MCD4            --SLVMNNATYGISHTRMPTESRPGHVAMIAGFYEDVSAVTKGWKSNPVNFDSFFNQSTH 142
                       .:      :  ** :     .: :*    .     .          . :...
GPI13           LKQLHLANKTVKFAG-------DDTWMALFHPFLSNDSFPLESLNVWDLDTVDN-GVMDY 226
GPI7            LQQFIQHNNTIRFMG-------DDTWLKLFPQQWFDFADPTHSFFVSDFTQVDNNVTRNL 190
MCD4            TYSFGSPDILPMFKDGASDPNKVDTWMYDHTFEDFTQSSIELDAFVFRHLDQLFHNSTLN 202
                  .:   :    * .        ***:  .       :    .  *
GPI13           FHDHLQQDKEWDVMIGHMLGIDHVGHKYGPDHFTMREKQIQVDQFID-----WILKSIDD 281
GPI7            PGKLFQEWAQWDVAILHYLGLDHIGHKDGPHSKFMAAKHQEMDSILKSIYDEVLEHEDDD 250
MCD4            STLDYEIRQDGNVFFLHLLGCDTAGHSYRPYSAEYYDNVKYIDDQIPILIDKVNKFFADD 262
                     :   : :* : * ** *  **.  *       :   :*. :            **
GPI13           DTLLVILGDHGMDHTGNHGGDSIDELESTLFLYSKKPDMWRLKETSN-------YNIDNL 334
GPI7            DTLICVLGDHGMNELGNHGGSSAGETSAGLLFLSPKLAQFARPESQVNYTLPINASPDWN 310
MCD4            KTAFIFTADHGMSAFGSHGDGHPNNTRTPLVAWGAGLNKPVHNPFPVSDN--YTENWELS 320
                .* : . .****.  *.**..  .:  : *.  .                     . :
GPI13           GHDYRSVRQIDLVSSLALLMGQPIPFNNLGWPIDEIARNDREWSQFVNSAISQLQLYKDT 394
GPI7            FQYLETVQQIDIVPTIAALFGMPIPMNSVGIIIP-------------------------- 344
MCD4            SIKRNDVKQADIASLMSYLIGVNYPKNSVGELPIAYIDGK-----------ESDKLAALY 369
                    . *:* *:.. :: *:*   * *.:*
GPI13           MQIHHGNDEILEPLAKNISNTPPTSDPEKFVKLGHKYQKVFLQTCEELWAKFDYYSIATG 454
GPI7            ----------------------------DFLQLLPNKLASMKENFMHLWKLSDHHGEVAL 376
MCD4            NNARSILEQYLVKQDEVIDSQFFYKEYFKFVEKSHSHYLEEIETLIQRISEGENYLEQEA 429
                                            .*::   .      :.  .     : :
GPI13           ITLLATSLVLLISITKLIPSIVVNQMVPEFVPGIIIMVLVTNLCFHGIFYVYQQPSFVDQ 514
GPI7            DDFTAEDIYTKMYTIQETLTKSATNYNYPLLTLAFVGFLIITIIAIYVLLRYSGPDFWQL 436
MCD4            ITLTEELMQITLEGLHYLTTYNWRFIRTIVTFGFVGWIFFSFIIFLKSFILENVIDDQKA 489
                  :    :   :   :   :         .    .  .:.  :     :   .  .  .
GPI13           FWGTLLATAIGIIIGCYITIFDRYNFIWIAMRLGETLADYWSRIAVMFMIIHALLFTSNS 574
GPI7            RVSSLSVLLVSIILG--VSTFASS--FIEEEHQ------LWWWIVTAFSAVPLFVYRLN- 485
MCD4            SPLSHAVFGSIGILLNWILFYQHSPFNFYMYLLFP--LYFWSYIFTNRSVLRSGIKEFFK 547
                   :  .     *:   :  :                   *  * .    :   :
GPI13           FTIWEDRIVAFLLSTFGMLTLYEFVFLPKRQSTTALLTATISEKEGTTSGVNPSTANSNY 634
GPI7            --------VLIIVRWFIMMACVRSIKFWNNSGQKFIYSNVMSNLLNQNPSWKWCLNMLTF 537
MCD4            G----TSPWKRVLITISIISVYEGIVYGFFHRWTFTLITNILAFYPFICGVRELSVNILW 603
                           ::  : :::  . :        .      :        . .       :
GPI13           LPLTRFARLLGGYHSAVLIIFTRLASMITICREEQGEYCIPTFNNQNNSSWWVLGLCFLM 694
GPI7            LVLIMASAGFQVLHFIVTTILV--------------------------------GLCFTY 565
MCD4            IITSVLLSTFTLFDAVKIEDLNQIHLAG--------------------------LLIILS 637
                :        :   .      :                                  * :
GPI13           IFILPACITGYYNLTSSYQAAAPIWINVFLKGILGLNFVYWSLTSLENNSAVIAIPFLRD 754
GPI7            KIS--WEIVNGN------QAEIPLFMHDLLAKID---FAPT----ES-NLIVLARVFFQA 609
MCD4            AFYALYKIHSRIN-----SYTRAIFAIQISLVAAMLAVTHRSVISLQLRQGLPRESQVAG 692
                 :     * .        .   .::   :        ..       . .  :     .
GPI13           VTIFKFTLARIIAGFSLIASNVGWLMGPLCIKLNIHNTDVKSHEATILGYTNIYGSEFFL 814
GPI7            WAIVVISRLVLTKLKVLNKN------------Y--LIKDMKVYITILLMFQTSSQNIGQF 655
MCD4            WIIFFVSLFVMPILHYRKPNN---D------YKVRLLIIYLTFAPSFIILTISFESLFYF 743
                  *. .:   :        .                      . . ::       .   :
GPI13           LVINVLISILLFNKPLAQLSYFLMCNQLLSILEIIDLLKLKENIIGPIALGLLSYQHFFT 874
GPI7            LVFQILESQIFY---------------FFQNIPTASLTSTSKIYFSNLVSLILQNFTFFQ 700
MCD4            LFTSYMVQWIEIEN-------------KIKEMKTQKDENWLQVLRVSVIGFFLLQVAFFG 790
                *. . : . :                  :. :   .  .  :     :   :*    **
GPI13           TGHQATIPSVQWDIGFM-LSEKVTFPFTQIAIILNTFGPHILVSLSVALLTLWSQPPDVL 933
GPI7            FGGTNSISTIDLGNAYHGVSSDYNIYVVGILMSVANFAPAIYWSMLPWSINYASIP---- 756
MCD4            TGNVASISSFSLESVCR-LLPIFDPFLMGALLMLKLIIPYGLLSTCLGILNLKLN----- 844
                 *   :*.:..       :       .    : :  : *    *     :.
GPI13           KPQTLLGRIVSNCGILLTYNTILCLSSFIWVTHFRRHLMVWKIFCPRFIFASLSLIVTQL 993
GPI7            -AQVKLQTFIRSKLPAFTYHCIFGTCLMTACVVLRFHLFIWSVFSPKLCYFLGWNFVMGL 815
MCD4            FKDYTISSLIISMSDILSLNFFYLLRTEGSWLDIGITISNYCLAILSSLFMLILEVLGHV 904
                  :  :  :: .    :: : :           :   :  : :      :     .:  :
GPI13           VVTFGTIAFASGRLIKHINDIFWK 1017
GPI7            LNGWLPELALLCALD--------- 830
MCD4            LLKNVIIQDKTKKTQ--------- 919
                :
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Results
Mutation or depletion of MCD4 lead to accumulation of GPI lipids
Saccharomyces cerevisiae mcd4-174 mutants are deficient in inositol incorporation into
proteins and accumulate several [3H]inositol-labeled GPI precursors (Gaynor et al., 1999).
We wanted to reproduce the abnormal lipid profile found in mcd4-174 mutants. We have
previously observed that Mcd4p-depleted cells accumulate only very low amounts of GPI
intermediates when labeled with [3H]inositol (Flury et al., 2000), consistent with results
published by Gaynor et al. (1999). We therefore decided to analyze the in vitro GPI
biosynthesis in yeast strains carrying either a temperature-sensitive mutation in
MCD4/SSU21 (Packeiser et al., 1999) or the wild-type MCD4 gene under control of a
galactose-inducible promoter (Flury et al., 2000). Microsomes from a wild-type strain make
the complete GPI precursor CP2 irrespective of the carbon source on which cells have
been grown (Figure 4-3, lanes 1 and 2). In contrast, MCD4-depleted microsomes
accumulate a GPI intermediate termed lipid 4c (Figure 4-3, lane 4). It should however be
noted that these MCD4-depleted microsomes are able to make CP2, although considerably
less than wild-type. When microsomes derived from a strain carrying a temperature-
sensitive mutation in MCD4 are labeled at the restrictive temperature, a stronger block of
GPI biosynthesis is observed (Figure 4-3, lane 5), and neither M4 nor CP2 is made. Lipid
4-c is less polar than lipid 031b, suggesting that it is an earlier intermediate in GPI
biosynthesis.
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Figure 4-3. Cells deficient in MCD4 accumulate GPI intermediates in vitro.
Lanes 1-6, microsomes were prepared as previously described (Flury et al., 2000), except
that all incubations were carried out at the temperatures indicated above. Cells in lanes 5
and 6 were preincubated for 2 h at 37 °C before conversion to spheroplasts. Microsomes
were incubated with 6 µCi of UDP-[3H]GlcNac, GDP-Man, tunicamycin, CoA and ATP at
the indicated temperatures for 1 h. Lane 8, cells were labeled with [3H]inositol (Ins) and
processed as previously described (Flury et al., 2000). Lanes 1 and 2, FBY413 (wild-type);
lanes 3 and 4, FBY1104 (pGAL1,10-MCD4); lane 5, 521-17A-H42 (ssu21/mcd4ts); lane 6,
17A-H42 (wild-type); lane 7, FBY182 (∆gpi7). Lipids were extracted, desalted, and
analyzed by TLC using solvent 1 (CHCl3/CH3OH/H2O 10:10:3 v/v/v) and fluorography.
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Head group analysis of a GPI intermediate accumulating in cells depleted for
MCD4
Mouse embryonal carcinoma cells disrupted for the MCD4-homologue PIG-N accumulate
several GPI intermediates, the two most polar probably having 3 and 4 mannoses
respectively and EthN-P both on Man2 and Man3, but not on Man1 (Hong et al., 1999a).
Together with the finding that the surface expression of Thy-1 was only partially affected in
Pig-n knockout cells, these results indicate that in mammalian cells, EthN-P on Man1 is not
essential for attachment of GPI anchors. To date, there are no reports on the structures of
GPI lipids that accumulate in MCD4-deficient Saccharomyces cerevisiae strains. The
presumed function of Mcd4p is the addition of EthN-P on the first mannose of the GPI core.
If this is true, we would expect that GPI lipids in mcd4 mutants lack this modification. We
therefore wanted to analyze the structure of the major lipid accumulating in a mcd4 mutant.
As shown in Figure 4-3, the mutation present in the strain 521-17A-H42 leads to the
absence of the complete GPI precursor CP2 and accumulation of a GPI intermediate
termed lipid 4-c. For structural characterization of lipid 4-c, microsomes from strain 521-
17A-H42 were labeled with UDP-[3H]GlcNAc and lipid 4-c was purified by preparative TLC.
Analysis of the hydrophilic head group indicates that lipid 4-c contains a Man2-GlcN-Ins
core structure and that both mannoses can be removed by treatment with jack bean α-
mannosidase (JBAM) (Figure 4-4).
Figure 4-4. Head group analysis of lipid 4-c.
Soluble headgroups were obtained by treatment of purified glycolipids with
monomethylamine:water 10:3 for 1 h at 53 °C (Guillas et al., 2001). Non-hydrolyzed lipids
were removed by butanol extraction. The water-soluble headgroups were treated as
indicated above. The generated fragments were analyzed by paper chromatography in
methylethylketone/pyridine/water (20:12:11) and compared to radiolabeled
chromatography standards as previously described (Flury et al., 2000).
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Assay for multicopy suppression
The three putative ethanolamine phosphate transferases Gpi13p, Gpi7p and Mcd4p show
significant homology to each other in the N-terminal, hydrophilic region (Figure 4-2).
Gpi13p and Mcd4p are essential proteins, but Gpi7p is dispensable for yeast viability
(Benachour et al., 1999; Gaynor et al., 1999; Zhang et al., 1999; Flury et al., 2000). We
wanted to investigate if overexpression of these three genes from a 2µ plasmid could
overcome the growth defect of cells depleted for Gpi13p or Mcd4p. For this experiment, we
transformed yeast strains having GPI13 or MCD4 under control of the repressible GAL1,10
promoter as well as a wild-type strain with 2µ-based plasmids which contained the gene of
interest controlled by its own promoter. The growth of plasmid-bearing clones was
monitored on glucose-containing plates with or without the cell wall perturbing drug
calcofluor white (CFW). Wild-type cells transformed with either an empty, URA3-based 2µ-
vector (ø) or 2µ-vectors encoding MCD4, GPI7 and GPI13 respectively, were able to grow
at all dilutions in the presence or absence of CFW (Figure 4-5C). In contrast, both Gpi13p-
and Mcd4p-depleted cells transformed with the same empty vector showed a reduced
growth rate on plates lacking CFW, confirming that both Gpi13p and Mcd4p are required
for viability. In the presence of 100 µg/ml CFW, the growth inhibition of the depletant cells
was significantly enhanced. As can be seen in Figure 4-5A, the growth phenotype of
Gpi13p-depleted cells on both types of plates could only be rescued by overexpression of
GPI13, but not by overexpression of MCD4 and GPI7. In the same way, cells depleted for
Mcd4p could not be rescued by overexpression of GPI7 and GPI13, but growth was
restored when MCD4 was present on a 2µ plasmid (Figure 4-5B). However, Gpi13p- and
Mcd4p-depleted cells "rescued" by the homologous plasmid grew slightly less on CFW-
containing plates than on plates lacking the drug.
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Figure 4-5. Growth test of cells depleted for Gpi13p and Mcd4p.
A) Gpi13p-depleted cells, B) Mcd4p-depleted cells, and C), wild-type cells were
transformed with 2µ plasmids containing MCD4, GPI7, GPI13 ORFs or empty vector (ø),
respectively. The indicated number of cells was spotted onto agar plates with or without
100 µg/ml CFW. Plates were photographed after 3 days at 30 °C.
Depletion of Gpi13p and Mcd4p leads to induction of the Unfolded Protein
Response (UPR) signaling cascade
Accumulation of misfolded or improperly assembled proteins in the ER leads to induction of
the unfolded protein response (UPR) signaling cascade. The UPR pathway is the subject
of numerous reviews (Shamu, 1997; Chapman et al., 1998; Shamu, 1998; Hampton, 2000;
Patil and Walter, 2001). The level of unfolded proteins in the ER is increased in different
situations, e.g. reduced protein glycosylation, increased production of misfolded mutant
proteins, or altered redox status of the ER lumen. In response to UPR, cells increase the
transcription of ER-resident chaperones such as Kar2p (BiP) and protein disulfide
isomerase (PDI). The UPR-element (UPRE) is a 22-bp sequence found in the promoters of
UPR target genes, and it is both necessary and sufficient for transcriptional activation by
the UPR. A convenient reporter system to monitor activation of the UPR is based on
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UPRE. A lacZ reporter gene is fused to an artificial promoter containing UPRE in the
plasmid pUPRE (Menzel et al., 1997). Induction of UPR and thus expression of β-
galactosidase can be monitored on agar plates containing the chromogenic substrate X-
Gal. It has been reported that inhibition of protein glycosylation by tunicamycin disrupts
protein folding and thus activates UPR. We wanted to test if inhibition of GPI anchoring had
the same effect. We transformed cells with the pUPRE reporter plasmid, depleted Gpi13p
and Mcd4p respectively by shifting cells onto glucose-containing plates and monitored the
appearance of blue color. As can be seen in Figure 4-6C, wild-type cells remain white,
whereas both Gpi13p- and Mcd4p-depleted cells turn blue on plates containing X-Gal. This
result indicates that inhibition of GPI anchoring also leads to activation of the UPR
signaling cascade.
Figure 4-6. Depletion of Gpi13p or Mcd4p lead to induction of the unfolded protein
response.
FBY413 (wt), FBY1102 (pGAL1,10-GPI13) and FBY1104 (pGAL1,10-MCD4) cells were
transformed with pUPRE. The indicated number of exponentially grown cells were spotted
onto agar plates containing A) galactose; B) glucose; and C) glucose and X-Gal. Plates
were photographed after 4d at 30 °C. ↑, overexpression; ↓, depletion.
78
Discussion
Mcd4p was previously shown to be an essential component of the GPI biosynthetic
pathway in Saccharomyces cerevisiae (Gaynor et al., 1999). In contrast, the mammalian
MCD4 homologue PIG-N is dispensable for viability, since Pig-n knockout mice were viable
and only partially affected in the surface expression of the GPI-anchored protein Thy-1
(Hong et al., 1999a). GPI precursors in Pig-n knockout mice were not modified with EthN-P
on Man1, suggesting that PIG-N is involved in the addition of this side chain (Hong et al.,
1999a). We have characterized the major lipid accumulating in a mcd4 mutant in order to
demonstrate that yeast Mcd4p is also involved in the transfer of EthN-P to Man1. The
mcd4-174 mutant accumulated trace amounts of several [3H]Ins-labeled GPI lipids (Gaynor
et al., 1999), and the same was found when Mcd4p was depleted using the repressible
GAL1,10 promoter (Flury et al., 2000). We therefore decided to analyze in vitro GPI
biosynthesis in Mcd4p-depleted cells as well as in the temperature-sensitive mcd4/ssu21
mutant (Packeiser et al., 1999). Whereas GPI biosynthesis was not strongly inhibited in
Mcd4p-depleted cells, mcd4/ssu21 mutants were unable to synthesize the complete GPI
precursor CP2 and accumulated predominantly a lipid denoted lipid 4-c. Head group
analysis of lipid 4-c showed that it contained two mannose residues and lacked EthN-P on
Man1. This result was consistent with reports from studies with the fungal product
YW3548, which was shown to specifically inhibit EthN-P addition to Man1 (Sütterlin et al.,
1997b; Sütterlin et al., 1998; Hong et al., 1999a). Indeed, it was shown that yeast cells
treated with YW3548 also accumulated Man2-GlcN-acylPI (Sütterlin et al., 1997b).
Comparison of results obtained in yeast and mammalian cells revealed differences in the
GPI biosynthetic pathway in these organisms. In mammalian in vitro systems, YW3548
inhibited the generation of (EthN-P)Man-GlcN-acylPI in the GPI biosynthetic pathway I (see
Figure 4-7 for a scheme of mammalian GPI biosynthesis), but GPI intermediates containing
more than one mannose and lacking EthN-P on Man1 could nevertheless be formed in
pathway II (Hong et al., 1999a). It seems that when EthN-P is added to Man1 In
mammalian cells, this addition occurs prior to addition of the second mannose residue
(Hirose et al., 1992). In Saccharomyces cerevisiae, EthN-P is likely to be added to Man2-
GlcN-acylPI, since YW3548-treated wild-type cells as well as mcd4/ssu21 mutants
accumulate this intermediate. Yeast Gpi10p, which is responsible for the addition of the
third mannose residue, is unable to use Man2-GlcN-acylPI efficiently as a substrate, since
none of the GPI intermediates synthesized by mcd4ts microsomes contained more than two
mannoses (our unpublished observation). In contrast, PIG-B, the mammalian Man3
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transferase, seems to be able to use the Man2-GlcN-acylPI made in pathway II as a
substrate, since Man3-containing GPIs were formed by cells blocked with YW3548 (Hong
et al., 1999a).
Figure 4-7. A branched pathway for GPI biosynthesis in mammalian cells.
From Hong et al., 1999.
Mammalian as well as yeast results are consistent with a role for Mcd4p in transferring
EthN-P to Man1. However, there is recent evidence that not all alleles of mcd4 show
defects in GPI anchoring, suggesting that Mcd4p might have an additional function. The
mcd4-P301L mutant was identified in a screen designed to isolate yeast strains deficient in
the transport or metabolism of PS and PE (Storey et al., 2001). In a psd1∆ background,
mutation of proline 301 to leucine in Mcd4p caused temperature-sensitivity in absence of
exogenous ethanolamine or choline. The growth of the mutant could be improved by the
presence of PSD2 on multicopy plasmid, suggesting that the activity of Psd2p is somehow
altered by the mcd4-P301L mutation. Both mcd4-174 psd1∆ and mcd4-P301L psd1∆
mutants were ethanolamine auxotrophs, suggesting that ethanolamine requirement is
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common to mcd4 alleles, and that Mcd4p might be important for the function of Psd2p. But
interestingly, unlike the mcd4-174 mutation, the novel mutation in MCD4, mcd4-P301L, did
not affect [3H]Ins incorporation into proteins and did not lead to accumulation of GPI
intermediates, and consistent with this, mcd4-P301L  cells had normal cell wall
maintenance. Neither mcd4-P301L nor mcd4-174 cells were defective in PE synthesis.
However, different reasons could be responsible for the observed ethanolamine
auxotrophy in the mutant cells. In mcd4-174 cells, ethanolamine auxotrophy might be due
to accelerated degradation of PE to free phosphoethanolamine, since increased amounts
of the latter were detected. In contrast, in mcd4-P301L cells, PE turnover was normal,
indicating that the decreased PE pool observed in these cells was not due to PE
degradation, and pinpointing the lesion in this mutant to a process occurring between PS
synthesis and decarboxylation.
In view of the high homologies of Gpi7p, Gpi13p and Mcd4p, we investigated if
overexpression of one of these genes from a 2µ-vector could rescue cells deficient in
another gene (Figure 4-4). The observation that growth could only be restored when the
depleted gene was present on a plasmid, was not suprising. Indeed, a similar experiment
performed in mammalian Pig-o knockout cells showed that in contrast to Pig-o cDNA,
expression of Pig-n cDNA was not able to restore surface expression of Thy-1 (Hong et al.,
2000). We also performed the multicopy suppressor experiment with ∆gpi7 cells, and we
could confirm that ∆gpi7 is hypersensitive to CFW (results not shown). However, none of
the plasmids was able to restore growth of ∆gpi7 cells on CFW-containing plates, not even
the plasmids pBF41 (2µ, GPI7) and pBF43 (CEN, GPI7) containing the GPI7 ORF. This
was unexpected, since both plasmids were shown to suppress the accumulation of the M4-
glycolipid in ∆gpi7 cells (Benachour et al., 1999). However, suppression of the growth
defect on CFW-containing plates by pBF41 or pBF43 had not been tested at that time. We
will repeat the multicopy suppression experiment with the original gpi7 mutants (e.g. gpi7-
1) instead of ∆gpi7 cells (Benghezal et al., 1995; Benachour et al., 1999).
Cellular survival of ER stress such as the accumulation of unfolded proteins requires the
unfolded protein response (UPR), a stress response present in all eukaryotes studied to
date. As a result, the cell induces transcription of genes encoding proteins that help correct
folding, such as Kar2p (BiP) and PDI (protein disulfide isomerase). However, chaperones
such as Kar2p are by far not the only proteins regulated by UPR. In yeast, whole-genome
expression profiling using DNA-microarrays has shown that the UPR regulates more than
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350 genes, which is 5% of the genome (Travers et al., 2000). An important number of
these UPR-regulated genes play a role in different aspects of ER function, such as protein
translocation, folding, glycosylation, GPI anchoring, ER-associated protein degradation
(ERAD), and lipid metabolism. A recent genetic screen for mutants that are dependent on
UPR activation for viability also revealed several classes of mutants deficient in the
secretory pathway (Ng et al., 2000). Cells disrupted for IRE1 are viable under normal
conditions, but not under ER stress. Mutations that were synthetically lethal when
combined with ∆ire1 comprise the GPI biosynthetic genes GPI10 and MCD4 (Ng et al.,
2000). MCD4 was also found to be regulated by the UPR in the study by Travers et al.
(2000), where also GAA1, GPI12 and GPI7, were identified as targets of the UPR.
Therefore, our observations that depletion of Gpi13p and Mcd4p induced the UPR is not
surprising. Both depletion of Gpi13p and Mcd4p lead to a reduction of inositol incorporation
into proteins, suggesting that proteins that do not receive a GPI anchor are somehow
sensed as being unfolded. We speculate that the UPR would also be induced in other
mutants deficient in GPI anchor biosynthesis or attachment. Mutant forms of Gas1p that
have an unacceptable GPI anchor attachment site were shown to accumulate in the ER
(Nuoffer et al., 1993). We would also expect an induction of the UPR in this case, since the
cells somehow have to cope with unanchored Gas1p.
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5. Conclusion
The modification of mammalian GPI anchors with EthN-P side chains on Man1 and Man2
had been known for several years, when similar side chain modifications were first reported
from the yeast Saccharomyces cerevisiae (Canivenc-Gansel et al., 1998; Sütterlin et al.,
1998; Benachour et al., 1999). The presence of EthN-P on Man1 on GPI precursors had
first been revealed in mutants deficient in the transfer of the third Man residue to the GPI
core (Canivenc-Gansel et al., 1998; Sütterlin et al., 1998). Evidence for a further
phosphodiester-linked substituent on Man2 came from studies with yeast gpi7 mutants. In
comparison to the complete GPI precursor glycolipid CP2 which accumulates in
transamidase mutants, the most polar GPI accumulating in gpi7 cells lacked a HF-sensitive
side chain (possibly EthN-P) on Man2, suggesting that the corresponding protein, Gpi7p,
might be involved in the addition of a side-chain to Man2 of the GPI core (Benachour et al.,
1999). The GPI7 gene was cloned by complementation of a gpi7-1 gpi8-1 double mutant.
Homology searches have shown that two ORFs of Saccharomyces cerevisiae encoded
proteins closely related to Gpi7p, YKL165w/MCD4 and YLL031c/GPI13. It was therefore
tempting to speculate that the proteins encoded by YKL165w/MCD4 and YLL031c/GPI13
might play a role in the addition of EthN-P to Man1 and Man3 of the GPI core. The aim of
this thesis was the identification and characterization of EthN-P transferases. Unlike GPI7,
both YKL165w/MCD4 and YLL031c/GPI13 were reported to be essential for viability. To
find out if Mcd4p and Gpi13p play a role in GPI anchor biosynthesis, we placed both genes
under control of the repressible GAL1,10 promoter and studied the phenotype of cells
depleted of either MCD4 or GPI13. We first investigated if cells depleted of Mcd4p or
Gpi13p accumulated [3H]Ins-labeled GPI intermediates, a feature of cells deficient in GPI
biosynthesis or transfer to proteins. Whereas Mcd4p-depleted cells only accumulated
minor amounts of abnormal [3H]Ins-labeled lipids, Gpi13p-depleted cells accumulated two
abnormal lipids in sufficient amount for characterization. We and others have shown that
cells depleted of Gpi13p accumulate GPI intermediates lacking EthN-P on Man3,
suggesting that this protein might be involved in EthN-P transfer to Man3 (Flury et al.,
2000; Taron et al., 2000). Mcd4p was also shown to be required for GPI anchor
biosynthesis, although the step defective in mcd4-174 mutants had not been pinpointed
(Gaynor et al., 1999). Analysis of GPI precursors in mammalian cells disrupted for the
MCD4-homologue Pig-n had revealed that these GPIs lacked EthN-P on Man1, suggesting
that Mcd4p/PIG-N are required for addition of EthN-P to Man1 (Hong et al., 1999a). During
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this thesis work, we have shown that GPI precursors from yeast mcd4ts mutants also lack
EthN-P on Man1.
The subcellular localization of members of the GPI7/MCD4/GPI13 family has recently been
investigated in yeast and in mammalian cells (Benachour et al., 1999; Gaynor et al., 1999;
Hong et al., 1999a; Flury et al., 2000; Hong et al., 2000). Yeast MCD4 contains a KKXX
ER-retention/retrieval sequence, whereas GPI7 and GPI13 lack this signal. Indeed, Mcd4p
is localized in the ER (Gaynor et al., 1999). A myc-tagged form of Gpi13p was also shown
to be localized in the ER (Flury et al., 2000). ER localization was also found for a GST-
tagged form of PIG-O, the mammalian homologue of Gpi13p (Hong et al., 2000).
Interestingly, yeast strains in which the ER retention signal of Mcd4p is mutated grew like
wild-type cells, suggesting that this signal is not required for normal function and
localization of Mcd4p (Gaynor et al., 1999). Gpi13p might be retained in the ER via an
interaction with another protein. Indeed it was shown in mammalian cells that the Gpi13p-
homologue PIG-O is stabilized in the ER because of its interaction with PIG-F (Hong et al.,
2000). PIG-F seems also to be required for the stabilization of human Gpi7p in the ER
(Hong and Kinoshita, 2001). In our studies, the bulk of Gpi7p was shown to be localized on
the plasma membrane, and only a small amount was found in the ER. In view of the
unexpected localization of yeast Gpi7p, future experiments include the production of new
anti-Gpi7p antibodies in order verify the subcellular localization of this protein.
The postulated function of Gpi13p, Gpi7p and Mcd4p, the transfer of EthN-P to GPI
anchors, has however not yet been confirmed in in vitro activity tests with purified enzymes
and putative substrates. Experiments pointing in this direction will surely have to be
performed in the future to show that Gpi13p, Gpi7p and Mcd4p indeed are EthN-P
transferases. The reported homology of Gpi13p and family members with
phosphodiesterases and pyrophosphatases suggested that the conserved domains might
be important for the function of these enzymes. Indeed, the mutation in mcd4-174 maps to
an amino acid not only highly conserved in the mammalian and S. pombe homologues of
Mcd4p, but also in its yeast homologues and in the known phosphodiesterases and
pyrophosphatases (Gaynor et al., 1999). Further indication that the conserved regions are
important for the function came from studies with Gpi7p (Egger, 2000). Amino acids 50 to
192 or 192 to 321 of the Gpi7p protein sequence were deleted, and the resulting truncated
forms of Gpi7p were expressed in ∆gpi7 cells from either 2µ or CEN-based vectors. The
presence of either plasmid did not suppress the accumulation of the M4 glycolipid in the
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∆gpi7 background, indicating that the conserved regions are important for proper function
of Gpi7p.
If Gpi7p is the transferase which adds a HF-sensitive side chain, possibly EthN-P, onto
Man2, it will be intresting to elucidate the physiological function of this side chain. The fact
that Gpi7p is not an essential protein means that either another protein can functionally
replace it in some cases, or that the side-chain transferred by Gpi7p is not required for
growth under certain conditions. However, even though Gpi7p is dispensable for growth
under normal conditions, there is no doubt that Gpi7p-deficient cells have a problem with
GPI-anchoring (Benghezal et al., 1995; Benachour et al., 1999; Flury et al., 2000). Possible
functions of the side chain attached by Gpi7p were discussed (Benachour et al., 1999).
Interestingly, the reported temperature-sensitivity of a ∆gpi7 strain could be suppressed by
1 M sorbitol (Tohe and Oguchi, 1998), suggesting that its failure to grow at 37 °C was due
to cell wall defects as a consequence of the lack of Gpi7p.
Despite the high similarity of yeast and mammalian proteins involved in EthN-P transfer,
several differences seem to exist, as it is the case for the transfer of the bridging EthN-P to
Man3. Yeast cells depleted of Gpi13p are unable to add EthN-P onto Man3, whereas
mammalian Pig-o knockout cells are. Both Gpi11p-deficient yeast cells and mammalian
PIG-F mutant cell lines were unable to express GPI-anchored proteins. However, one of
the two GPI precursors accumulating in Gpi11p-depleted yeast cells contained EthN-P on
Man3 (and was therefore a potential substrate for the transamidase) (Taron et al., 2000),
whereas GPI intermediates from mammalian PIG-F mutant cell lines lacked EthN-P on
Man3 (Sugiyama et al., 1991; Puoti and Conzelmann, 1993). Therefore, results obtained in
mammalian cells suggested that PIG-F rather than PIG-O was required for the addition of
EthN-P to Man3, whereas in yeast, Gpi13p was a better candidate for the EthN-P
transferase than Gpi11p. The finding that PIG-F played a role in the stabilization of both
PIG-O and GPI7 (Hong and Kinoshita, 2001) might be an indication that PIG-F and PIG-O,
but also PIG-F and GPI7 function in concert in mammalian cells. The same could be true in
yeast. This implicates a role for PIG-F/Gpi11p in the transfer of EthN-P onto both Man2
and Man3. Therefore, the observed differences in yeast and mammalian cells might be
explained by different extents of dependence on partnership with Gpi11p/PIG-F (discussed
in Taron et al., 2000). In yeast, transfer of EthN-P to Man3 is independent of Gpi11p,
whereas in mammalian cells, PIG-F plays a major role in this reaction step.
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A branched pathway has been proposed for GPI anchor biosynthesis in mammalian cells
(Figure 4-7). Based on the characterization of GPI intermediates from different yeast
mutants, a branched pathway was also proposed for GPI biosynthesis in Saccharomyces
cerevisiae (Figure 5-1).
Figure 5-1. Model for a branched pathway for GPI biosynthesis in Saccharomyces
cerevisiae.
Adapted from Grimme et al., 2001. Dashed arrows indicate putative pathway branches,
hypothetical intermediates are shown in italics. M, mannose; G, glucosamine; E,
ethanolamine; P, phosphate; Ins, inositol.
The finding of Man3- and Man4-species having a single EthN-P either on Man1 or on Man2
in smp3 mutant cells or Gpi13p-depleted cells respectively, support the idea of a pathway
branching in yeast. As discussed by Grimme et al. (2001), it cannot be ruled out that the
"EthN-P on Man2"-branch of the pathway is observed only in mutant cells, and therefore,
under non-physiological conditions. The pattern of EthN-P modification observed in GPI-
deficient mutants might have arisen from transesterification of the EthN-P side chains from
one mannose residue to another. In this context, it is noteworthy that our preliminary
characterization of the head group of lipid 031b from ∆gpi7 pGAL1,10-GPI13 cells (strain
FBY1106) revealed the presence of a HF-sensitive substituent on Man2 to a similar extent
as for lipid 031b from Gpi13p-depleted cells (result not shown). Assuming that Gpi7p really
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is the transferase which adds a side chain on Man2, our result suggests that yet another
enzyme than Gpi7p can attach a side chain onto Man2. However, we do not know if the
side chain found on Man2 of lipid 031b is attached to the same position as the substituent
of Man2 in CP2. We have shown that Gpi13p-depleted cells also accumulate a Man4-
species lacking EthN-P (lipid 031a). To date, we do not know if and how lipid 031a fits in
the model for yeast GPI biosynthesis, and based on the data of Grimme et al. (2001), we
believe that this lipid is a degradation product from lipid 031b. If lipid 031a is a degradation
product, this could be an indication of aberrant processing of GPI intermediates in GPI-
deficient mutants, an idea that would be consistent with the hypothesis by Grimme et al.
(2001) that a branching of the GPI biosynthesis is only observed in mutants.
Future experiments should include in vitro tests with purified enzymes or complexes, in
order to unambiguously determine the role of Gpi13p, Gpi7p, Mcd4p and Gpi11p in yeast
GPI anchor biosynthesis.
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6. Materials and Methods
Media and Materials
Growth media for Saccharomyces cerevisiae strains were:
YPD medium: 1% yeast extract (Difco), 2% casein hydrolysate (Life Technologies), 2%
glucose (Fluka); YPGal medium: YPD with 2% galactose (Fluka) instead of glucose. SDC
medium: minimal synthetic medium supplemented with 2% casein hydrolysate. Minimal
synthetic medium without casein hydrolysate was supplemented with the required amino
acids (20-400 mg/l), adenine sulfate and uracil. When indicated, yeast nitrogen base
(Difco) was used to prepare minimal medium.
Reagents were purchased from the following sources: [2-3H]myo-inositol, 20 Ci/mmol;
[14C]myo-inositol, 300 mCi/mmol; [2-3H]mannose, 20 Ci/mmol; and uridine diphosphate-N-
acetyl-D-glucosamine [glucosamine-6-3H], 40 Ci/mmol were from Anawa Trading SA,
Zürich; Kodak X-OMat films, anti-mouse and anti-rabbit IgG-peroxidase conjugates,
monoclonal anti-GST antibodies, ATP, coenzyme A, tunicamycin, digitonin, CFW
(fluorescent brightener 28) and GDP-mannose from Sigma; 6-aminocaproic acid and
digitonin from Fluka; anti-c-myc antibodies from BAbCO, Richmond, CA); CNBr-activated
sepharose 4B, glutathione sepharose 4B and ECL chemiluminescence kit and films from
Amersham Pharmacia. 0.2 mm thick silica gel 60 plates from Merck; glass beads (0.45-
0.55 mm) from Braun Melsungen; zymolyase 20-T from Seikagaku Corp.; 5-bromo-4-
chloro-3-indolyl-β-D-galactoside (X-Gal) from Biofinex; AG-501-X8 ion exchange resin from
Bio-Rad laboratories; JBAM from Glyko; PI-PLC from ICN. PCR primers were from
Microsynth GmbH, Balgach. Expand High Fidelity Taq DNA polymerase from Roche;
restriction enzymes from New England Biolabs and Gibco. Anti-Wbp1p and anti-Och1p
antibodies were a gift from Dr. Markus Aebi (ETH Zürich) and Dr. Y. Jigami (Ibarasaki,
Japan), respectively. Yeast strains 17A-H42 and 521-17A-H42 were from A. Packeiser.
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List of Saccharomyces cerevisiae strains
name genotype plasmid source
FBY182 MATα 
ade2-1 ura3-1 leu2-3,112 his3-11,15 gpi7::kanMX4
M. Benghezal
FBY413 MATa
leu2-∆1 trp1-∆63 his3-∆200 ura3-52
A. Benachour
FY1679 MATa/α
ura3-52/ura3-52 leu2∆1/+ trp1∆63/+  his3∆200/+
Eurofan
FBY1102 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yll031c::HIS3 pGAL1,10-YLL031c
I. Flury
FBY1103 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yll031c::HIS3 pGAL1,10-YLL031c
YNR019w::kanMX4
I. Flury
FBY1104 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
ykl165w::HIS3 pGAL1,10-YKL165w
YNR019w::kanMX4
I. Flury
FBY1105 MATa/α
ura3-52/ura3-52 leu2∆1/+ trp1∆63/+  his3∆200/+
yll031c::kanMX4/YLL031c
I. Flury
FBY1106 MATa
l e u 2  h i s 3  u r a 3  g p i 7 : : k a n M X 4
yll031c::HIS3 pGAL1,10-YLL031c
I. Flury
FBY1107 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yll031c::YLL031c-13myc kanMX6
I. Flury
FBY1108 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yll031c::YLL031c-3HA kanMX6
I. Flury
FBY1120 leu2 his sec18 I. Flury
FBY1121 leu2 his I. Flury
FBY1122 trp1-∆63 leu2 ura3-52
yll031c::HIS3 pGAL-YLL031c
I. Flury
FBY1123 sec18 ura3-52 trp1-∆63, leu2
yll031c::HIS3 pGAL-YLL031c
I. Flury
FBY1130 MATa
leu2-∆1 trp1-∆63 his3-∆200 ura3-52
pUPRE I. Flury
FBY1131 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yll031c::HIS3 pGAL1,10-YLL031c
pUPRE
FBY1132 MATα 
ade2-1 ura3-1 leu2-3,112 his3-11,15 gpi7::kanMX4
pUPRE
FBY1133 MATa
leu2-∆1 trp1-∆63 his3-∆200 ura3-52
gpi7::GPI7-GST kanMX6
I. Flury
FBY1134 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yk l165w: :HIS3 pGAL1,10-YKL165w YNR
019w::kanMX4
pUPRE I. Flury
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name genotype plasmid source
FBY1135 MATa
leu2-∆1 trp1-∆63 his3-∆200 ura3-52
pBF639 I. Flury
FBY1136 MATa
leu2-∆1 trp1-∆63 his3-∆200 ura3-52
pBF41 I. Flury
FBY1137 MATa
leu2-∆1 trp1-∆63 his3-∆200 ura3-52
pBF115 I. Flury
FBY1138 MATa
leu2-∆1 trp1-∆63 his3-∆200 ura3-52
pRS426 I. Flury
FBY1139 MATα 
ade2-1 ura3-1 leu2-3,112 his3-11,15 gpi7::kanMX4
pBF639 I. Flury
FBY1140 MATα 
ade2-1 ura3-1 leu2-3,112 his3-11,15 gpi7::kanMX4
pBF41 I. Flury
FBY1141 MATα 
ade2-1 ura3-1 leu2-3,112 his3-11,15 gpi7::kanMX4
pBF115 I. Flury
FBY1142 MATα 
ade2-1 ura3-1 leu2-3,112 his3-11,15 gpi7::kanMX4
pRS426 I. Flury
FBY1143 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yll031c::HIS3 pGAL1,10-YLL031c
pBF639 I. Flury
FBY1144 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yll031c::HIS3 pGAL1,10-YLL031c
pBF41 I. Flury
FBY1145 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yll031c::HIS3 pGAL1,10-YLL031c
pBF115 I. Flury
FBY1146 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yll031c::HIS3 pGAL1,10-YLL031c
pRS426 I. Flury
FBY1147 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yk l165w: :HIS3 pGAL1,10-YKL165w YNR
019w::kanMX4
pBF639 I. Flury
FBY1148 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yk l165w: :HIS3 pGAL1,10-YKL165w YNR
019w::kanMX4
pBF41 I. Flury
FBY1149 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yk l165w: :HIS3 pGAL1,10-YKL165w YNR
019w::kanMX4
pBF115 I. Flury
FBY1150 MATa
l e u 2 - ∆ 1 trp1-∆ 63 his3-∆ 200  u ra3-52
yk l165w: :HIS3 pGAL1,10-YKL165w YNR
019w::kanMX4
pRS426 I. Flury
17A-H42 MATa
trp1-289 ura 3-52 leu2
(Packeiser et al.,
1999)
521-17A-
H42
MATa
trp1-289 ura 3-52 leu2 ssu21 (=mcd4)
(Packeiser et al.,
1999)
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List of plasmids
name insert vector type selectable
marker
E.coli   Yeast
source
pBF115 YLL031c
(= GPI13)
2µ Amp URA3 I. Flury
pBF41 GPI7 2µ Amp URA3 A. Benachour
pBF639 MCD4 2µ Amp URA3 I. Imhof
pET15-b Amp Novagen
pET-15b-
YLL031c
aa 122-320 of
Gpi13p
Amp I. Flury
pRS426 2µ Amp URA3 (Christianson et al. ,
1992)
pUPRE pUPRE-lacZ 2µ Amp URA3 (Menzel et al., 1997)
pYCGYLL031 YLL031c
(= GPI13)
CEN Amp URA3 Euroscarf
List of oligonucleotides
name sequence (5' → 3') purpose
031A4 catcaatgaaagtcggtaagg control insertion of GAL promoter
031S1-1842 gatgaaaaataatatacaaatcgcgaataaagaa
atttcaacgtacgctgcaggtcgac
SFH-PCR for disruption of YLL031c,
together with oligo S2031
165A4 agcaatcatagcaacatgacc control insertion of GAL promoter
A2-031 gcgcgatgacgagcaaggt control oligo for YLL031c disruption,
tagging etc.
A3Gal gagcagttaagcgtattactg control insertion of GAL promoter
A4-031 gctgcagaaaagagatgc control oligo for YLL031c disruption,
tagging etc.
Abint-1 cccgcatgccatatggcaagcgataaggatgca amplification of hydrophilic portion of
YLL031c for cloning into pET15b for
antibody raising
Abint-2 ggggtacccggatcccatgtccggcttcttaga amplification of hydrophilic portion of
YLL031c for cloning into pET15b for
antibody raising
C1-GPI7 cttgtttgatgacggcatg control oligo for insertion of GST tag
C1-myc ctgacactgtggtcacagcc control insertion of genomic myc tag
F2-GPI7 tggctggttacctgaattggccctcctttgcgctcttgat
cggatccccgggttaattaa
tagging of GPI7 in the genome using
plasmids  described in (Longtine et al.,
1998)
F2-YLL031c agtgggagattgattaagcacataaatgacattttttg
gaaacggatccccgggttaattaa
tagging of YLL031c in the genome
using plasmids described in (Longtine
et al., 1998)
K1031 catggtacaattgcaaagt control disruption YLL031c
K2 gtcgcacctgattgcccg control for presence of kanMX4 or
kanMX6
L2-031 ttgaaatttctttattcgcgatttgtatattat oligo L2 for LFH-PCR for disruption of
YLL031c, antiparallel to genomic
sequence in oligo 031S1-1842
L3-031 aatgacgaacttcatttccactctttacttacaaatata
c
oligo L3 for LFH-PCR for disruption of
YLL031c, antiparallel to the genomic
sequence in oligo S2031
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name sequence (5' → 3') purpose
R1-GPI7 catatatgtatacatatttagaccacgtgaacaattct
atggaattcgagctcgtttaaac
tagging of GPI7 in the genome using
plasmids  described in (Longtine et al.,
1998)
R1-YLL031c atatatagtatatttgtaagtaaagagtggaaatgaa
gttcggaattcgagctcgtttaaac
tagging of YLL031c in the genome
using plasmids  described in (Longtine
et al., 1998)
S2031 tatagtatatttgtaagtaaagagtggaaatgaagttc
gtcattatcgatgaattcgagctcg
SFH-PCR for disruption of YLL031c,
together with oligo 031S1-1842
Experimental procedures
Protein extraction methods
Proteins for analysis by SDS-PAGE were extracted by the following methods:
• Rapid protein extraction method (Horvath and Riezman, 1994).
Briefly, pelleted cells were denatured in reducing sample buffer (SB) (Laemmli, 1970)
containing 20 mM EDTA by incubation at 95 °C for 5 min. Usually, a concentration of 1
OD600/20 µl SB was used. A variation of this protocol were tested: addition of protease
inhibitors (1 mM PMSF, 0.7 µg/ml pepstatin A, 0.5 µg/ml leupeptin) to SB and
subsequent denaturation at 37 °C instead of 95 °C, but with this method, less proteins
were obtained.
• Improved rapid protein extraction method (Kushnirov, 2000)
Briefly, pelleted cells were incubated for 5 min at RT with 80 µl/OD600 0.1 M NaOH. The
tube was spun and SB containing 20 mM EDTA was added and proteins were
denatured as described for the rapid extraction method.
• Denaturation in High Urea buffer
Briefly, pelleted cells were denatured by incubating at 65 °C for 10-15 min in HU buffer
(8M urea, 5% SDS, 200 mM Tris-HCl pH 6.8, 20 mM EDTA, bromophenol blue, 15
mg/ml DTT), usually at a concentration of 1 OD600/20 µl HU. Important: add DTT
immediately before use. This extraction method was also tested at denaturation
temperatures of 0 °C, 37 °C and 95°C. At 65°C and 95 °C, the method yields more
proteins than at lower temperatures, and seems also to yield more proteins than with
reducing sample buffer.
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Membrane association of Gpi13p
240 OD600 of exponentially grown cells were lysed in lysis buffer (20 mM HEPES pH 7.4,
0.1 M sorbitol, 50 mM potassium acetate, 2 mM EDTA, 1 mM DTT, 1 mM PMSF, 30 µg/ml
each Antipain, Pepstatin, Leupeptin) at 100 OD/ml by agitation with glass beads. Unbroken
cells were removed by centrifugation at 600xg for 5 min. The supernatant was split in 6
aliquots of equal size. Aliquots were incubated for 40 min on ice in presence of 0.5 M NaCl,
0.8 M urea, 0.1 M Na2C O3, 1% Triton X-100, 1% SDS or control incubated with water.
Samples were centrifuged at 100'000 x g for 1 h at 4 °C in AH-650 rotor. Pellet fractions
were dissolved and denatured in High Urea buffer (8M urea, 5% SDS, 200 mM Tris-HCl pH
6.8, 20 mM EDTA, bromophenol blue, 15 mg/ml DTT) by sonication and incubation at 65
°C for 10 min. The supernatant was precipitated with trichloroacetic acid before
denaturation in High Urea buffer.
Preparation of microsomal membranes and solubilization of membrane
proteins and blue native polyacrylamide gel electrophoresis
Microsomal membranes were prepared as described (Fraering et al., 2001), with the
following modifications: FBY1133 and FBY413 cells were grown in YPDUA medium at
30°C. After thawing, 300 µl TM buffer (50 mM Tris-HCl pH 7.4, 0.2 M mannitol, 0.1 M NaCl,
1 mM MgCl2, 1 mM CaCl2, 1 mM MnCl2 containing 1 mM DTT, and 1 mM PMSF, and 1
µg/ml of each chymostatin, pepstatin, antipain, and leupeptin) were added to every 100 µl
of membrane suspension. DNA was digested with 0.2 mg/ml DNAse I (3000 U/mg; FLUKA,
Buchs, Switzerland) for 45min at 25°C with shaking. Glycerol was adjusted to 10%, and the
protein concentration was determined and diluted to 7 µg/µl with GTM-buffer (TM buffer
with 10% glycerol). The solubilization of membrane proteins was achieved by adding
digitonin (Sigma D5628, recrystallized prior to utilization) and 6-aminocaproic acid to final
concentrations of 1.5% and 620 mM, respectively. After incubating for 45 min at 4°C with
shaking, insoluble material was removed by centrifugation for 30 min at 40,000 rpm
(100'000 x g) at 4°C in a TFT 90.4 fixed angle rotor (Kontron, Munich, Germany). The
concentration of solubilized proteins was determined and samples were shock frozen in
liquid nitrogen and stored at 80°C. Protein samples were then processed for blue native gel
electrophoresis and were loaded onto 5-15 % polyacrylamide gradient gels as described
(Fraering et al., 2001). GST-tagged Gpi7p was detected with monoclonal anti-GST
antibodies (Sigma, St. Louis, MO, USA), and western blots were revealed using the
chemiluminescence ECL kit (Amersham Pharmacia).
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Affinity chromatography of Gpi7p-GST
Analytical scale affinity purification of Gpi7p-GST was carried out essentially as described
(Fraering et al., 2001), except that microsomes from 1000 OD600 units of FBY1133 and
FBY413 cells were solubilized in presence of  6-aminocaproic acid. 0.6 ml glutathione
sepharose 4B (Amersham Pharmacia) was added to the lysate. TM buffer (0.2 M mannitol,
0.1 M NaCl, 50 mM Tris-HCl pH 7.4, 1 mM MgCl2, 1 mM CaCl2, 1 mM MnCl2, 1 mM PMSF,
1 mM DTT and 1 µg/ml of each chymostatin, pepstatin, antipain, and leupeptin) was added
to the lysate in order to dilute digitonin to 0.5%. Beads were incubated overnight at 4 °C on
a wheel and were sedimented by letting them stand for 1 h at 4 °C. The supernatant was
carefully removed (unbound fraction). The glutathione sepharose 4B was washed three
times with 5 ml TM buffer + 0.3% digitonin, rotating the tube on the wheel for 15 min, and
letting stand for 1 h. The supernatants were carefully removed (washes 1-3). The bound
proteins were eluted with 0.5 ml TM buffer + 0.3% digitonin + 10 mM reduced glutathione
(Sigma) by gently rotating the tube for 30 min. The elution was repeated with 0.5 ml TM
buffer + 0.3% digitonin + 20 mM reduced glutathione. pH of elution buffers was adjusted to
pH 7.5 with Tris. Samples were processed for SDS-PAGE by precipitation with
trichloroacetic acid before denaturation in 2x concentrated reducing sample buffer. Proteins
were separated on a 6-15% gradient gel and stained with silver nitrate as described in
Table 6-1.
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Silver staining of proteins
The protocol described in Table 6-1 is adapted for staining of mini gels. Water of milli-Q
quality has to be used.
Table 6-1. Silver staining protocol
step solutions incubation
Fix 40 ml methanol
10 ml acetic acid
50 ml water
10 min
Rinse 100 ml water 10 min
Fix and sensitize 40 ml ethanol
60 ml water
50 µl glutaraldehyde 50%
10 µl formaldehyde 37%
5 min
Rinse 40 ml ethanol
60 ml water
20 min
Rinse 100 ml water 20 min
Sensitize 20 mg sodium thiosulfate
100 ml water
1 min
Rinse 100 ml water per wash 2x 1 min
Silver stain 100 mg silver nitrate
100 ml water
20 min
Rinse 100 ml water 1 min, not more
Develop 2.5 g sodium carbonate
40 µl formaldehyde 37%
100 ml water
incubate gel with 25 ml until
solution turns yellow (about 1
min), discard, develop with the
rest of the solution (4-15 min)
Stop 5 ml acetic acid
95 ml water
5 min
Store 30 mg sodium carbonate
100 ml water
This protocol is not indicated if tryptic digestion and mass spectrometry of proteins is
foreseen.
Preparation of CFW-containing plates and growth test
Calcofluor white (CFW)-containing plates were made based on a protocol published by the
EUROFAN network (http://mips.gsf.de/proj/eurofan/eurofan_2/n7/protocols.html). A stock
solution of 100 mg/ml calcofluor white (Sigma F3543) was prepared by dissolving the dye
in water with dropwise addition of KOH. A suspension of 0.67% yeast nitrogen base, 2%
glucose, 3% agar, amino acids and adenine was sterilized, and buffered with 1% MES (2-
[N-Morpholino]ethanesulfonic acid) pH 6.0 (from a 25% filter-sterilized stock solution). CFW
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was added to a final concentration of 100 µg/ml before pouring the plates. Cells were taken
from exponentially grown overnight cultures in galactose-containing medium lacking uracil.
A tenfold dilution series of cell suspensions containing 20 OD600 units per ml was prepared.
2 µl of each dilution (10x, 100x, 1'000x, 10'000x and 100'000x) were spotted onto agar
plates with or without CFW and growth of cells was scored after 3 d at 30 °C.
Preparation of X-Gal containing plates and growth test
Minimal medium (0.67% Yeast Nitrogen Base without amino acids; 2% glucose or
galactose; all amino acids; adenine; 3% agar) was autoclaved. Sterile KH2PO4 pH 7 was
added to 0.05 M after autoclaving. X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactoside) was
added to 40 µg/ml after autoclaving from a stock solution in DMF. FBY413, FBY1102 and
FBY1104 cells were transformed with pUPRE, and grown to exponential phase in medium
lacking uracil. Sequential 10x dilutions were spotted onto agar plates with or without X-Gal
and growth of cells was scored after 4 d at 30 °C.
Subcellular fractionation and sucrose step
Exponentially grown cells from FBY413 (wild-type) and FBY1107 (GPI13-myc) were
converted to spheroplasts, P13 and P100 pellet fractions were generated as previously
described (Flury et al., 2000), with the following modification: lysis buffer was 0.2 M
sorbitol, 50 mM KOAc, 2 mM EDTA, 20 mM Hepes-KOH pH 6.8, 1 mM DTT, PMSF 20
µg/ml, antipain 5µg/ml, leupeptin 0.5 µg/ml, pepstatin 0.7 µg/ml. One half of the P13
fraction was placed on the top of a sucrose step (800 µl each of 1.5 M and 1.2 M sucrose
in sucrose gradient buffer: 50 mM KOAc, 2 mM EDTA, 20 mM Hepes-KOH pH 6.8, 1 mM
DTT, 1 mM PMSF). The gradient was spun at 85'000 g for 1 h in a AH-650 swing-out rotor.
Five equivalent fractions were removed and precipitated by TCA before denaturation in HU
buffer.
In vitro GPI biosynthesis in mcd4 mutants
In vitro biosynthesis of GPIs with microsomes was performed as previously described
(Flury et al., 2000), with the following modifications: Strains 521-17A-H42 and 17-H42 were
grown to exponential phase in YPD medium at 24 °C and shifted to 37 °C 2h prior to
conversion to spheroplasts. For these strains, all subsequent incubations were at 37 °C.
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The other strains were grown overnight in YPD or YPGal at 30 °C, and subsequent steps
were performed at 30 °C. Microsomes were labeled as previously described (Flury et al.,
2000), except that labeling time with [3H]UDP-GlcNAc was increased to 90 min. Lipids were
extracted, desalted and analyzed by ascending TLC as previously described (Reggiori et
al., 1997).
Head group preparation
Lipids from strain 521-17A-H42 were purified by scraping 1x from silica gel plates. Soluble
head groups were obtained by treatment of purified glycolipids with
monomethylamine:water (10:3) for 1 h at 53 °C (Guillas et al., 2001). Non-hydrolyzed lipids
were removed by butanol extraction. The water-soluble headgroups were divided in two,
and half of the sample was treated with JBAM as descibed. Both samples were then
dephosphorylated by HF. Before paper chromatography in solvent mixture
methylethylketone/pyridine/water (20:12:11), samples were N-acetylated and desalted over
mixed-bed ion exchange resin AG-501-X8 as described (Puoti and Conzelmann, 1993).
Radiolabeled chromatography standards were obtained as described (Benachour et al.,
1999).
Preparation of yeast genomic DNA
Yeast genomic DNA was prepared as described on the following website:
www.fhcrc.org/labs/breeden/methods/genomic_DNAprep.html. Briefly, cells were grown
overnight in 5 ml medium at 30 °C. Cells were spun and washed once with 1 ml water
before resuspension in 500 µl lysis buffer (100 mM Tris-HCl pH 8, 50 mM EDTA, 1% SDS).
1.25 ml glass beads were added and cells were vortexed for 2 min. The liquid was
recovered and transferred in a new tube. After addition of 275 µl 7 M ammonium acetate
pH 7.0, the tube was first incubated at 65 °C for 5 min, and then on ice for 5 min. 500 µl
chloroform was added, the tube was vortexed and spun for 2 min. The supernatant was
removed and precipitated with 1 ml isopropanol. After a 5 min incubation at RT, the tube
was spun for 5 min. The DNA pellet was washed with 70% ethanol, dried and dissolved in
50 µl water. Concentration and purity of DNA was determined by measuring the absorption
at 260 nm and at 280 nm.
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Purification of recombinant His-tagged Gpi13p and antibody production
The region corresponding to aa 122-320 of Gpi13p was PCR-amplified from yeast genomic
DNA with the primers Abint-1 and Abint-2. The PCR fragment was digested with NdeI and
BamHI and cloned into the MCS of the bacterial expression vector pET-15b (Novagen).
The resulting plasmid pET-15b-YLL031c was used to transform the E.coli strain BL21 D3.
Expression of the recombinant protein was induced in a 1 l culture with 1 mM isopropyl-1-
thio-β-D-galactopyranoside (IPTG) for 5 h at 37 °C. Bacteria were lysed by sonication in
lysis buffer (20 mM Tris-HCl pH 8.0, 100 mM NaCl, 8 M urea, 1 mM PMSF). The lysate
was centrifuged at 11'500 rpm in Sorvall centrifuge with SS34 rotor for 15 min at 4 °C. The
lysate was incubated overnight at 4 °C with TALON resin (Clontech). The recombinant
His6-tagged protein was purified under denaturing conditions essentially as described in the
manufacturers instructions (Clontech). From this step on, urea was omitted in the lysis
buffer. Briefly, resin was washed twice with 10 ml lysis buffer and transferred to a 10 ml
syringe. The resin was further washed 5 times with 1ml of lysis buffer containing 1 mM 2-
mercaptoethanol. Then the resin was washed twice with 1 ml lysis buffer containing 10 mM
imidazole. Bound proteins were then eluted with lysis buffer containing 50 mM (4 ml), 100
mM (4 ml), 150 mM (3 ml) and 200 mM (6 ml) imidazole. Protein concentration was
determined with the Bradford method. A polyclonal antiserum was raised against this
Gpi13p fragment by repeated intramuscular injections of 100–150 µg of recombinant
protein into rabbits. 4 mg of the recombinant protein was coupled to CNBr-sepharose 4B
(Amersham Pharmacia) according to the manufacturer's instructions, and antiserum was
affinity-purified as described (Harlow and Lane, 1988).
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